Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3024172	s-epo	u/l (u/l)	3593	4503	0.00%
3024172	s-epo	iu/l (u/l)	1564	1991	0.45%
3024172	s-epo	— (—)	903	1002	100.00%	Distribution not available
3024172	s-erytropoietiini	u/l (u/l)	41	42	0.00%
3024172	erytropoietiini	iu/l (u/l)	34	37	0.00%
3024172	erytropoietiini,seerumista	iu/l (u/l)	31	31	0.00%
3024172	s-erytropoietiini	iu/l (u/l)	29	29	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other diseases of blood and blood-forming organs

834

344

34.24

307.65

1.4

1.2

28.37

44.72

u/l

0.98

737

295

Essential (haemorrhagic) thrombocythaemia

372

191

25.93

307.65

1.3

1.2

29.82

19.73

u/l

0.65

333

164

Liquid cancers, helper endpoint

1817

1668

10.38

307.65

1.4

1.2

65.32

19.00

u/l

18.87

1585

1427

Myeloproliferative diseases (CML excluded)

861

385

30.95

307.65

1.3

1.2

25.57

46.63

u/l

1.36

711

335

Chronic kidney disease

810

1762

4.71

307.65

1.2

1.3

31.92

40.71

u/l

1.10

726

1502

Renal failure

1098

2558

3.93

307.65

1.3

32.48

40.67

u/l

1.26

969

2180

Secondary polycythaemia

435

107

77.91

307.65

1.4

1.2

15.16

52.25

u/l

1.20

382

Other anaemias

1169

2306

5.03

307.65

1.3

85.14

24.24

u/l

13.89

1057

1930

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2541

3073

5.91

307.65

1.3

53.98

18.60

u/l

17.36

2272

2622

Other diseases of blood and blood-forming organs, wide

1150

1121

11.46

307.65

1.3

1.2

47.08

33.97

u/l

1.29

1017

974

L01XX Other antineoplastic agents

601

300

27.21

307.65

1.2

34.16

50.24

u/l

0.67

488

257

Aplastic and other anaemias

1246

2450

4.95

307.65

1.3

84.44

23.84

u/l

15.22

1127

2054

Myeloproliferative diseases

897

417

29.04

307.65

1.3

1.2

29.00

44.52

u/l

0.91

743

365

Myelodysplastic syndrome, including Hilmo

354

150

33.78

307.65

1.4

1.1

134.96

19.02

u/l

14.24

318

132

Polycythaemia vera

472

171

42.88

307.65

1.3

1.2

17.68

23.36

u/l

0.41

357

151

Other and unspecified anaemias

1165

2294

5.06

307.65

1.3

82.78

23.94

u/l

14.31

1053

1919

Anaemias

427

278

10.31

299.85

1.3

1.2

97.51

14.49

u/l

6.90

394

241

All chronic kidney diseases

1112

2659

3.51

296.63

1.3

32.57

38.75

u/l

0.76

994

2272

Primary_lymphoid and hematopoietic malignant neoplasms

674

1450

4.89

292.25

1.3

103.59

30.51

u/l

9.84

615

1238

Other and unspecified diseases of blood and blood-forming organs

220

119

23.53

286.52

1.5

1.2

59.16

36.75

u/l

0.55

192

109

Heart failure, not strict

1299

3017

2.99

254.16

1.2

1.3

39.09

33.40

u/l

0.68

1167

2584

Renal tubulo-interstitial diseases

1400

3847

2.76

244.51

1.3

36.98

35.15

u/l

0.18

1232

3337

Acute myeloid leukaemia and myelodysplastic syndromes

180

23.80

235.01

1.3

1.2

152.41

20.82

u/l

7.45

156

Heart failure and antihypertensive medication

497

552

6.08

233.86

1.2

1.4

39.23

49.83

u/l

0.59

453

471

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1441

3346

2.63

218.02

1.2

1.3

30.26

35.62

u/l

0.68

1269

2894

Chronic myeloproliferative disease

151

32.48

216.33

1.5

1.2

74.79

31.05

u/l

1.60

135

All kidney diseases

1442

3951

2.53

208.81

1.3

37.12

35.63

u/l

0.13

1269

3429

Heart failure,strict

974

2260

3.12

206.61

1.2

1.4

39.84

37.57

u/l

0.19

872

1909

Diabetes, insulin treatment (Kela reimbursement)

1514

3762

2.47

201.02

1.2

1.3

29.71

36.49

u/l

1.00

1334

3256

Multiple myeloma, including Hilmo

236

258

10.43

199.93

1.4

1.2

87.31

20.52

u/l

6.79

224

222

Type 2 diabetes

1429

3347

2.53

198.06

1.2

1.3

31.33

36.42

u/l

0.57

1267

2899

Multiple myeloma and malignant plasma cell neoplasms

238

271

9.98

195.35

1.4

1.2

85.73

39.16

u/l

2.70

227

233

Diabetes mellitus

1443

3427

2.49

194.57

1.2

1.3

32.93

36.15

u/l

0.30

1284

2970

Type 2 diabetes, wide definition

1244

3053

2.65

193.86

1.2

1.3

32.01

36.79

u/l

0.52

1105

2644

Diabetes, varying definitions

1434

3433

2.48

191.55

1.2

1.3

33.03

36.12

u/l

0.28

1277

2974

Diabetes medication

1468

3661

2.41

184.86

1.2

1.3

31.27

36.73

u/l

0.68

1295

3175

Heart failure, strict

1036

2741

2.72

173.78

1.2

1.3

39.80

38.59

u/l

0.10

923

2336

Type 2 diabetes, strict (exclude DM1)

1343

3299

2.42

170.67

1.2

1.3

30.93

36.52

u/l

0.62

1187

2856

Type 2 diabetes, definitions combined

1337

3284

2.42

169.91

1.2

1.3

30.95

36.39

u/l

0.59

1183

2841

Other (not insulin) diabetes medications

1392

3538

2.36

168.56

1.2

1.3

29.18

36.87

u/l

1.18

1222

3067

Hypertensive diseases (excluding secondary)

690

1152

3.53

168.06

1.3

35.00

25.45

u/l

0.77

610

996

Type 2 diabetes, definitions combined, including avohilmo

1320

3233

2.41

165.45

1.2

1.3

31.30

36.71

u/l

0.58

1170

2800

All-cause Heart Failure

1009

2708

2.69

164.98

1.2

1.3

39.08

38.46

u/l

0.05

900

2309

Multiple myeloma

160

137

13.73

161.18

1.4

1.1

78.64

22.36

u/l

9.19

151

121

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

160

137

13.73

161.18

1.4

1.1

78.64

22.36

u/l

9.19

151

121

Dipeptidyl peptidase 4 (DPP-4) inhibitors

928

2866

2.65

152.29

1.2

1.4

33.11

39.60

u/l

0.78

819

2474

Biguanides

1344

3642

2.28

150.85

1.2

1.3

27.13

37.02

u/l

2.03

1185

3157

Hypertension, essential

1012

2212

2.62

149.78

1.3

32.85

35.31

u/l

0.19

904

1915

Hypertension

1018

2240

2.60

147.72

1.3

33.12

35.08

u/l

0.14

906

1938

Hypertensive diseases

1018

2241

2.60

147.66

1.3

33.12

35.08

u/l

0.14

906

1938

Other abnormal findings of blood chemistry

192

237

8.94

147.09

1.4

1.2

18.77

43.82

u/l

1.56

177

206

Other bacterial diseases

1334

4081

2.22

145.31

1.3

54.32

26.69

u/l

7.08

1167

3546

Metabolic disorders

1304

3605

2.23

140.05

1.3

35.44

33.77

u/l

0.16

1145

3133

Endocrine, nutritional and metabolic diseases

957

1848

2.65

139.72

1.3

32.14

37.01

u/l

0.37

848

1599

Other bacterial diseases

1351

4016

2.16

135.04

1.3

50.23

27.25

u/l

5.26

1184

3489

Insulin medication

893

3064

2.49

131.76

1.2

1.3

35.45

37.53

u/l

0.16

790

2645

Glucagon-like peptide-1 (GLP-1) analogues

502

1555

3.31

129.57

1.2

1.3

18.80

33.15

u/l

4.31

446

1342

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

502

1555

3.31

129.57

1.2

1.3

18.80

33.15

u/l

4.31

446

1342

Other heart diseases

566

1149

3.26

127.79

1.2

1.3

36.52

25.25

u/l

1.09

502

992

Acute renal failure

432

1241

3.59

125.98

1.3

32.72

39.69

u/l

0.61

368

1059

Bacterial Sepsis

775

2632

2.56

121.62

1.3

54.36

33.21

u/l

3.22

670

2273

Fever of other and unknown origin

811

2943

2.49

121.27

1.5

1.3

66.11

29.24

u/l

5.67

722

2534

Any reimbursement code in KELA

583

904

3.26

120.43

1.3

1.2

45.90

15.43

u/l

3.44

506

785

Cardiovascular diseases (excluding rheumatic etc)

664

1325

2.91

119.95

1.3

35.72

27.78

u/l

0.56

576

1156

Bacterial infection, other or unspecified

829

2987

2.45

118.74

1.3

65.39

28.00

u/l

8.45

722

2568

Influenza and pneumonia

1334

4177

2.05

117.26

1.3

59.03

25.08

u/l

8.22

1177

3649

Bacterial infection, other or unspecified

868

3129

2.38

116.52

1.3

64.05

27.30

u/l

8.77

758

2693

Antihypertensive medication - note that there are other indications

593

1027

3.09

115.04

1.2

1.3

34.33

41.84

u/l

0.41

519

900

Other disorders of white blood cells

171

246

7.46

114.21

1.4

1.2

51.73

51.26

u/l

0.01

154

208

All pneumoniae

1289

4249

2.05

114.21

1.3

61.46

25.34

u/l

8.60

1137

3712

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1158

3290

2.15

114.02

1.3

62.86

26.65

u/l

7.19

1021

2866

1158

3290

2.15

114.02

1.3

62.86

26.65

u/l

7.19

1021

2866

Implicit Sepsis

1056

3685

2.19

113.77

1.2

1.3

43.64

30.56

u/l

1.74

907

3213

Pneumonias (Asthma/COPD co-morbidities)

1281

4240

2.05

113.76

1.3

61.73

25.15

u/l

8.71

1130

3704

Iron deficiency anaemia

660

2512

2.64

113.24

1.3

48.69

35.13

u/l

1.05

575

2159

Implicit bacterial Sepsis

685

2387

2.59

110.94

1.3

54.27

34.61

u/l

2.40

584

2066

Nutritional anaemias

743

2948

2.47

110.92

1.2

1.3

53.22

35.15

u/l

1.69

649

2531

Dyspnoea

1197

4346

2.06

109.75

1.3

40.81

33.63

u/l

0.90

1067

3756

Atrial fibrillation and flutter

436

821

3.50

109.26

1.2

1.4

29.05

29.77

u/l

0.05

387

701

Implicit Sepsis

1105

3859

2.12

108.90

1.3

41.68

30.01

u/l

1.58

951

3365

Atrial fibrillation and flutter with reimbursement

386

658

3.81

107.69

1.2

1.4

24.38

27.81

u/l

0.29

347

558

Implicit bacterial Sepsis

724

2554

2.49

107.55

1.3

52.29

33.54

u/l

2.42

616

2212

Heart failure and coronary heart disease

724

2083

2.51

104.10

1.2

1.3

32.99

42.49

u/l

1.43

644

1758

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1245

4289

2.00

103.87

1.3

61.46

25.84

u/l

8.07

1100

3741

Other heart diseases, wide

1070

3112

2.12

102.10

1.3

32.97

30.43

u/l

0.26

952

2698

Insulin, intermediate and long-acting

832

3663

2.24

99.71

1.2

1.3

34.55

34.86

u/l

0.02

731

3164

Gout

519

1670

2.80

97.22

1.3

47.73

36.27

u/l

0.87

471

1432

Transplanted organ and tissue status

233

521

4.68

96.64

1.3

87.91

32.14

u/l

2.82

209

448

Pneumonia, organism unspecified

1144

4050

2.00

96.17

1.3

59.06

25.46

u/l

8.21

1003

3534

Disorders of lipoprotein metabolism and other lipidaemias

1098

3351

2.05

96.08

1.2

1.3

30.18

34.07

u/l

0.51

965

2908

Abnormal findings on examination of blood, without diagnosis

753

3044

2.31

95.84

1.4

1.3

39.41

35.00

u/l

0.34

680

2621

Cardiac arrhythmias

635

1614

2.58

95.61

1.3

24.98

32.21

u/l

1.16

565

1389

Cardiovascular diseases

580

1127

2.79

95.45

1.3

33.88

31.55

u/l

0.11

502

985

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

164

274

6.47

95.19

1.4

1.2

50.12

20.16

u/l

4.78

158

235

Unspecified kidney failure

233

528

4.60

94.97

1.4

1.2

25.48

37.97

u/l

1.28

207

452

Other and unspecified disorders of white blood cells

133

178

8.08

94.89

1.4

1.2

57.77

50.02

u/l

0.13

120

156

Insulin, combination of fast acting with intermediate-acting or long-acting

895

3888

2.13

93.85

1.2

1.3

35.47

35.13

u/l

0.02

791

3363

Dialysis, with operation codes

271

698

4.04

93.13

1.2

1.3

37.30

39.88

u/l

0.11

242

605

Non-ischemic cardiomyopathy

504

1484

2.79

92.22

1.3

44.36

44.19

u/l

0.01

453

1254

Condition for Implicit Sepsis (Organ dysfunction codes)

1097

3915

2.00

92.13

1.3

40.53

30.49

u/l

1.26

947

3415

GASTRO-related operations

885

1993

2.25

91.87

1.3

1.2

45.31

21.92

u/l

3.36

765

1743

Any gastric operation

885

1993

2.25

91.87

1.3

1.2

45.31

21.92

u/l

3.36

765

1743

Diseases of arteries, arterioles and capillaries (FINNGEN)

338

654

3.65

91.66

1.2

1.4

29.73

32.46

u/l

0.11

295

552

Sleep apnoea

1205

4067

1.94

90.96

1.3

27.93

35.79

u/l

1.53

1042

3561

Non-invasive ventilation

318

813

3.55

90.00

1.2

1.4

54.53

34.50

u/l

0.96

287

695

Other and unspecified iron deficiency

513

1966

2.66

89.81

1.3

45.13

34.04

u/l

0.66

448

1692

ILD medications

1359

3959

1.88

89.64

1.3

50.62

26.12

u/l

6.03

1217

3413

Medical observation and evaluation for suspected diseases and conditions

840

1913

2.27

89.58

1.3

41.67

28.05

u/l

1.76

726

1643

Septicaemia

631

2489

2.41

88.94

1.3

66.41

30.30

u/l

4.12

552

2132

ILD medications: prednisolone, methylprednisolone, prednisone

1316

3935

1.89

88.90

1.3

47.09

25.44

u/l

5.16

1176

3390

Heart failure and bmi 25plus

604

1632

2.56

88.69

1.2

1.4

42.60

35.61

u/l

0.59

536

1384

Haemolytic anaemias

126

173

7.93

88.09

1.7

1.2

62.20

40.43

u/l

0.68

115

150

Explicit Sepsis

644

2572

2.37

87.85

1.3

68.31

32.73

u/l

4.02

561

2222

Abnormalities of breathing

1057

3073

2.02

87.17

1.2

1.3

36.59

34.92

u/l

0.12

950

2655

Condition for Implicit Sepsis (Organ dysfunction codes)

1094

3893

1.96

86.19

1.3

36.54

29.81

u/l

1.00

956

3388

Neoplasms

828

1984

2.23

86.03

1.3

1.2

51.00

17.40

u/l

4.79

731

1740

Hypothyroidism (congenital or acquired)

242

291

4.75

84.73

1.4

1.2

20.32

14.38

u/l

0.53

218

252

Hypothyroidism and >3 levothyroxin purchases

241

290

4.75

84.44

1.4

1.2

20.25

14.39

u/l

0.52

217

251

Hypothyroidism, levothyroxine purchases

241

290

4.75

84.44

1.4

1.2

20.25

14.39

u/l

0.52

217

251

Sleep apnoea, including avohilmo

1226

4079

1.88

83.74

1.3

29.03

35.93

u/l

1.12

1059

3570

Purpura and other haemorrhagic conditions

274

767

3.70

83.45

1.4

1.2

110.01

34.55

u/l

3.87

253

663

Gout, FINNGEN

519

2072

2.56

83.45

1.3

47.73

36.88

u/l

0.82

471

1768

Coagulation defects, purpura and other haemorrhagic conditions

340

1091

3.20

83.08

1.5

1.2

93.53

34.44

u/l

3.61

312

949

Statin medication

761

1922

2.25

81.80

1.2

1.3

37.58

39.00

u/l

0.08

674

1650

Pure hypercholesterolaemia

972

3189

2.01

81.75

1.2

1.3

35.72

34.82

u/l

0.07

860

2769

Other septicaemia

561

2256

2.43

81.13

1.3

69.84

30.50

u/l

3.90

486

1932

Thrombocytopenia, unspecified

185

398

4.90

80.76

1.4

1.2

117.26

33.06

u/l

4.79

172

348

Infections, IBD-co-morbidities

230

387

4.33

79.18

1.3

1.2

63.21

39.38

u/l

0.85

204

335

Other nutritional deficiencies

793

3645

2.07

77.86

1.2

1.3

34.95

33.96

u/l

0.06

679

3189

Obesity

756

3517

2.10

77.11

1.2

1.3

34.54

34.19

u/l

0.02

648

3083

First line medication for Crohn's disease

1288

3864

1.82

76.75

1.4

1.2

47.04

26.14

u/l

4.29

1153

3326

Obesity and other hyperalimentation

758

3535

2.09

76.50

1.2

1.3

34.49

34.09

u/l

0.02

649

3100

Erysipelas

927

3628

1.97

76.32

1.2

1.3

37.86

27.45

u/l

1.99

808

3150

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1140

4034

1.86

75.96

1.2

1.3

43.43

29.83

u/l

2.18

1000

3521

Continuous positive airway pressure

270

652

3.56

75.21

1.3

1.4

41.67

35.66

u/l

0.19

219

556

Obesity due to excess calories

579

2562

2.29

73.98

1.2

1.3

37.02

31.55

u/l

0.29

494

2235

Examination and observation for other reasons

714

1901

2.19

73.19

1.3

43.84

28.02

u/l

2.22

656

1632

Depression medications

258

318

4.12

73.12

1.4

1.2

48.10

14.02

u/l

1.63

222

278

Non-rheumatic valve diseases

609

1951

2.28

72.11

1.2

1.3

41.13

34.04

u/l

0.68

538

1658

Familial erythrocytosis

30.29

71.97

1.2

1.0

13.73

13.42

u/l

0.03

Valvular heart disease excluding rheumatic fever

610

1960

2.28

71.86

1.2

1.4

41.08

34.01

u/l

0.68

540

1666

Hypertensive heart and/or renal disease

389

1049

2.82

71.47

1.2

1.4

29.96

46.47

u/l

2.22

336

888

Dental caries

382

1364

2.74

70.79

1.5

1.2

83.04

29.02

u/l

4.24

341

1187

L04AD Calcineurin inhibitors

212

560

3.92

70.37

1.3

138.82

29.61

u/l

4.71

193

487

Bleeding

1052

4094

1.85

70.12

1.2

1.3

45.04

31.83

u/l

1.62

927

3544

General symptoms and signs

1217

3408

1.80

69.64

1.3

1.2

40.48

28.37

u/l

1.84

1078

2945

Myeloid leukaemia

106

157

7.43

69.47

1.3

1.2

151.21

32.97

u/l

3.48

140

Caries of dentine

347

1214

2.83

68.65

1.5

1.2

84.40

26.65

u/l

4.54

310

1059

Lymphoid leukaemia

153

323

5.02

68.54

1.3

1.2

115.73

46.15

u/l

1.52

139

285

Nephropathy related operations

251

759

3.43

68.05

1.2

1.3

35.43

46.17

u/l

0.67

224

663

Oral corticosteroids

1247

4251

1.75

67.83

1.3

1.2

44.52

29.54

u/l

2.47

1117

3669

Glomerular diseases

320

1138

2.89

65.37

1.2

1.3

26.82

39.28

u/l

1.43

289

980

Persons encountering health services for specific procedures and health care

1211

4204

1.74

64.30

1.4

1.2

49.77

27.56

u/l

3.70

1074

3636

Tramadol

913

2984

1.90

64.30

1.2

46.02

29.70

u/l

1.58

814

2579

Cerebrovascular diseases (FINNGEN)

345

867

2.85

64.24

1.2

1.3

31.35

29.30

u/l

0.10

308

738

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

429

1064

2.57

63.79

1.3

44.27

26.55

u/l

1.11

386

919

Parasetamol

835

2159

1.97

63.12

1.3

1.2

39.16

31.96

u/l

0.61

732

1874

Other soft tissue disorders, not elsewhere classified

1076

3545

1.79

62.94

1.3

30.13

36.34

u/l

0.92

947

3068

ILD medications: immunosuppressive drugs

736

3508

1.97

62.80

1.3

67.09

25.37

u/l

6.91

666

3032

Malaise and fatigue

644

2514

2.08

62.65

1.4

1.3

38.68

30.06

u/l

1.01

560

2150

Other special examinations and investigations of persons without complaint or reported diagnosis

763

1913

2.04

62.64

1.2

1.3

36.30

28.05

u/l

0.81

673

1643

Inflammatory bowel disease treatment related agents

1293

4312

1.69

60.85

1.4

1.2

48.58

30.02

u/l

3.15

1159

3723

Codeine

1022

3093

1.81

60.49

1.3

35.20

29.45

u/l

0.57

914

2678

Glomerular disorders in diseases classified elsewhere

233

725

3.32

60.35

1.2

1.3

28.31

44.43

u/l

1.23

207

631

Acquired haemolytic anaemia

121

7.75

58.95

1.4

1.2

64.84

37.66

u/l

1.09

105

Haemorrhage from respiratory passages

484

1958

2.26

58.87

1.3

43.09

37.58

u/l

0.28

429

1663

Pain in throat and chest

917

3024

1.83

58.24

1.2

1.3

28.36

34.99

u/l

1.09

805

2612

Pain in limb

932

3468

1.81

58.21

1.3

31.95

36.22

u/l

0.47

822

2999

Sleep disorders (combined)

1265

3986

1.68

57.21

1.2

1.3

29.56

38.19

u/l

1.49

1096

3483

Erysipelas

716

3321

1.93

57.02

1.2

1.3

40.26

26.78

u/l

2.43

626

2877

Anaemia in chronic diseases classified elsewhere

108

8.04

56.81

1.2

60.46

40.09

u/l

0.30

Acute tubulo-interstitial nephritis

690

3081

1.95

56.74

1.3

39.67

38.88

u/l

0.05

604

2645

Percutaneous Coronary Intervention

946

3251

1.80

56.60

1.2

1.3

26.74

36.94

u/l

2.24

842

2808

Polyarthropathies

806

2823

1.88

56.35

1.3

45.34

32.04

u/l

1.31

731

2448

Emergency coronary revascularization (for ACS)

1028

3596

1.75

56.21

1.2

1.3

27.48

36.73

u/l

2.11

908

3100

Disorders of other endocrine glands

526

2465

2.12

55.85

1.2

1.3

29.97

34.74

u/l

0.31

470

2134

Coronary revascularization (ANGIO or CABG)

939

3252

1.78

54.55

1.2

1.3

26.54

36.93

u/l

2.31

839

2809

Codeine or tramadol medication

1272

4252

1.65

54.39

1.3

34.25

34.99

u/l

0.06

1134

3680

Asthma, unspecified (mode), excluding more controls

543

1938

2.11

54.34

1.3

40.53

25.73

u/l

1.27

488

1680

COPD/asthma related infections

1118

3290

1.71

54.10

1.3

46.28

26.65

u/l

3.94

986

2866

COPD/asthma/ILD related infections

1118

3290

1.71

54.10

1.3

46.28

26.65

u/l

3.94

986

2866

Opioids

1041

3131

1.74

53.55

1.3

43.30

29.21

u/l

1.69

914

2714

Diseases of oesophagus, stomach and duodenum

1185

4291

1.66

53.52

1.3

39.99

31.53

u/l

1.27

1036

3738

Any event in cancer register

985

3336

1.75

53.48

1.4

1.2

57.68

20.67

u/l

6.85

848

2918

Episodal and paroxysmal disorders

1178

3598

1.68

52.98

1.3

33.22

36.53

u/l

0.32

1034

3125

Diseases of arteries, arterioles and capillaries

856

3560

1.79

52.63

1.3

36.32

37.46

u/l

0.09

749

3080

Hypertensive Heart Disease

322

979

2.62

52.34

1.3

1.4

31.91

48.26

u/l

1.81

274

830

Insulin, fast-acting

477

2248

2.15

52.33

1.2

1.3

32.19

33.56

u/l

0.08

431

1942

Oedema, not elsewhere classified

419

1860

2.25

51.57

1.3

39.93

32.58

u/l

0.52

371

1580

Hard cardiovascular diseases

941

3230

1.75

51.20

1.2

1.3

31.86

35.59

u/l

0.37

839

2788

Ischemic heart diseases

955

3319

1.74

51.11

1.2

1.3

26.43

36.53

u/l

2.29

849

2867

Genitourinary diseases

685

1764

1.96

50.93

1.4

1.3

41.02

36.42

u/l

0.24

600

1554

Symptoms and signs involving the circulatory and respiratory systems

1045

3075

1.71

50.70

1.2

1.3

32.33

34.90

u/l

0.26

934

2657

Other disorders of fluid, electrolyte and acid-base balance

411

1757

2.26

50.60

1.3

36.81

37.39

u/l

0.04

344

1509

Implicit viral Sepsis

388

1710

2.30

50.37

1.3

63.63

35.71

u/l

1.50

335

1478

Complications of surgical and medical care, not elsewhere classified

1106

4639

1.64

49.20

1.3

46.49

31.50

u/l

1.82

981

4024

Major coronary heart disease event

976

3469

1.71

49.17

1.2

1.3

27.82

36.70

u/l

1.83

874

2991

Asthma, excluding more controls

744

2084

1.87

49.00

1.2

1.3

32.53

25.31

u/l

0.85

673

1810

Implicit viral Sepsis

294

1160

2.58

48.94

1.3

71.74

37.72

u/l

1.42

253

1002

Viral Sepsis

294

1164

2.57

48.60

1.3

71.74

37.75

u/l

1.42

253

1005

Conduction disorders

378

1335

2.33

48.33

1.3

1.4

27.31

35.38

u/l

1.11

322

1126

Gout, idiopatic and unspecified

392

1777

2.25

47.83

1.4

1.3

38.26

37.59

u/l

0.03

357

1523

Certain infectious and parasitic diseases

1032

3079

1.69

47.61

1.3

1.2

43.30

26.01

u/l

2.97

901

2667

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

165

5.87

47.60

1.4

1.2

114.39

22.60

u/l

1.35

145

Chronic lymphocytic leukaemia

165

5.87

47.60

1.4

1.2

114.39

22.60

u/l

1.35

145

Chronic lymphocytic leukaemia, helper endpoint

165

5.87

47.60

1.4

1.2

114.39

22.60

u/l

1.35

145

Care involving dialysis

164

480

3.54

47.02

1.2

28.38

43.55

u/l

0.81

148

415

Secondary hypertension

117

265

4.47

46.78

1.2

40.88

40.47

u/l

0.01

107

222

Combinations of oral blood glucose lowering drugs

385

1754

2.23

46.30

1.2

1.4

23.04

40.45

u/l

3.55

335

1516

Gout, strict definition

308

1278

2.47

46.28

1.4

1.3

39.33

37.53

u/l

0.08

277

1090

Used for control exclusion in common control thyroid runs

1146

3592

1.62

45.39

1.3

37.64

31.62

u/l

0.61

1022

3092

Disorders of gallbladder, biliary tract and pancreas

1102

4330

1.62

45.07

1.2

1.3

34.94

33.58

u/l

0.11

969

3754

Insulin, fast-acting or short human

478

2385

2.03

45.07

1.2

1.3

32.14

33.89

u/l

0.11

432

2059

Hypothyroidism, drug reimbursement

119

183

4.64

44.86

1.2

18.82

9.45

u/l

2.07

108

154

Gout, unspecified

326

1407

2.37

44.79

1.4

1.3

37.89

38.68

u/l

0.03

300

1205

Asthma (only as main-diagnosis), excluding more controls

674

2084

1.86

44.57

1.3

35.48

25.31

u/l

1.07

606

1810

AV-block

252

834

2.69

44.56

1.3

1.4

28.09

37.93

u/l

1.11

222

696

Diverticular disease of intestine

861

3228

1.72

44.46

1.4

1.3

44.17

32.43

u/l

1.04

764

2791

Other pulmonary diagnosis

840

2414

1.75

44.38

1.2

1.3

45.24

25.53

u/l

2.61

741

2099

Persons encountering health services for examination and investigation

702

1913

1.85

44.24

1.3

44.90

28.05

u/l

1.87

620

1643

Neurological diseases, wide definition

275

507

2.74

43.41

1.2

30.79

35.79

u/l

0.20

239

446

Persons encountering health services in other circumstances, wide

1283

4264

1.56

43.25

1.3

43.60

31.56

u/l

1.66

1130

3702

Hypogonadotropic hypogonadism

159

5.63

42.84

1.2

1.3

51.51

40.91

u/l

0.10

139

Excluding asthma or asthma-COPD overlap

830

2414

1.73

42.11

1.3

45.15

25.53

u/l

2.54

730

2099

Asthma, unspecified (mode)

558

2225

1.90

41.93

1.3

40.32

26.16

u/l

1.25

500

1934

Covid-19 confirmed case

465

2363

1.99

41.75

1.3

55.40

34.40

u/l

1.92

423

2027

Iron deficiency anaemia secondary to blood loss (chronic)

239

923

2.64

41.73

1.3

1.2

65.72

39.81

u/l

0.78

209

798

Other diseases of intestines

1096

3933

1.59

41.67

1.3

34.46

32.38

u/l

0.20

975

3415

Cardiomyopathy

239

923

2.64

41.66

1.2

1.4

30.87

33.58

u/l

0.14

219

780

ILD differential diagnosis

825

2410

1.73

41.23

1.3

44.67

25.52

u/l

2.43

726

2097

COPD differential diagnosis

825

2411

1.72

41.17

1.3

44.67

25.51

u/l

2.44

726

2098

Hernia of abdominal wall, postoperative

226

854

2.69

41.09

1.3

1.2

42.28

20.27

u/l

1.19

197

741

Diseases of spleen

8.11

40.91

1.2

1.1

84.30

33.55

u/l

0.62

Presence of cardiac and vascular implants and grafts

590

2400

1.85

40.13

1.2

1.3

32.60

35.50

u/l

0.29

520

2062

Paroxysmal tachycardia

219

677

2.74

39.88

1.2

1.4

25.07

33.60

u/l

0.70

195

574

Ulcer of lower limb, not elsewhere classified

233

914

2.61

39.52

1.3

1.2

38.47

43.56

u/l

0.26

203

793

General examination and investigation of persons without complaint and reported diagnosis

659

1910

1.81

39.27

1.4

1.3

37.08

28.05

u/l

0.97

576

1641

Oxycodone

475

2237

1.94

39.05

1.7

1.3

60.22

33.63

u/l

4.29

415

1917

Asthma

778

2393

1.71

38.54

1.2

1.3

33.00

25.62

u/l

0.95

703

2084

Coronary atherosclerosis

758

2834

1.71

38.33

1.2

1.3

30.30

37.66

u/l

1.07

668

2431

Gastrointestinal diseases

574

1537

1.88

38.14

1.3

42.21

22.17

u/l

2.18

502

1321

Hyperlipidaemia, other/unspecified

480

2335

1.91

37.91

1.3

35.97

40.12

u/l

0.37

416

2009

STROKE

584

2195

1.82

37.65

1.2

1.3

38.74

35.11

u/l

0.21

514

1884

Neurological diseases

860

2621

1.66

37.28

1.3

37.36

37.37

u/l

0.00

755

2285

Provisional assignment of new diseases of uncertain etiology

584

3304

1.78

37.18

1.3

50.87

33.97

u/l

1.74

528

2858

Codes for special purposes

585

3316

1.78

37.00

1.3

50.83

34.02

u/l

1.73

529

2868

Complications of procedures, not elsewhere classified

867

4501

1.60

36.40

1.4

1.3

39.67

31.89

u/l

0.74

773

3902

Ischaemic heart disease, wide definition

875

3375

1.62

36.01

1.2

1.3

27.91

36.76

u/l

1.75

778

2918

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

362

836

2.19

35.91

1.2

1.3

41.14

29.27

u/l

0.57

314

712

Asthma (only as main-diagnosis)

705

2393

1.72

35.85

1.3

34.84

25.62

u/l

1.00

630

2084

Cholelithiasis, broad definition with cholecystitis

931

3985

1.58

35.59

1.2

1.3

38.97

35.00

u/l

0.28

818

3447

Autoimmune diseases excluding thyroid diseases

1097

3914

1.54

35.53

1.3

47.85

32.47

u/l

1.87

982

3373

Osteopathies and chondropathies

619

3368

1.73

35.07

1.3

36.36

33.73

u/l

0.23

550

2906

Complications of medical and surgical care

795

4552

1.62

35.02

1.4

1.3

50.72

32.74

u/l

1.90

691

3954

Disorders of mineral metabolism

137

432

3.26

34.87

1.3

26.00

39.18

u/l

1.09

123

371

COPD (mode)

386

1523

2.02

34.42

1.2

1.3

32.47

27.22

u/l

0.55

325

1301

1185

4088

1.51

34.41

1.3

42.62

32.23

u/l

1.38

1029

3556

Asthma (mode)

749

2410

1.67

34.25

1.2

1.3

32.90

25.52

u/l

0.92

679

2097

Other disorders of skin and subcutaneous tissue

764

4208

1.62

34.17

1.3

45.58

35.11

u/l

0.95

660

3654

Pacemaker

438

2246

1.89

33.67

1.3

26.90

40.95

u/l

3.20

381

1915

Myocardial infarction

590

2388

1.75

33.65

1.2

1.3

30.20

40.44

u/l

1.60

520

2040

Cholelithiasis

889

3917

1.57

33.46

1.2

1.3

35.68

35.23

u/l

0.03

782

3384

Type 1 diabetes

273

1234

2.23

33.41

1.2

1.4

35.05

35.90

u/l

0.03

249

1058

Periodontitis

1040

4599

1.52

33.40

1.3

43.79

32.80

u/l

0.99

900

4013

Autoimmune diseases excluding thyroid diseases, strict definition

1048

3777

1.53

33.03

1.3

49.00

32.56

u/l

1.94

936

3251

Major coronary heart disease event excluding revascularizations

701

2828

1.67

32.83

1.2

1.3

30.06

38.23

u/l

1.33

614

2421

Other arrhythmias

605

2671

1.72

32.82

1.3

32.54

30.75

u/l

0.08

547

2301

Hypopituitarism

120

364

3.39

32.56

1.2

39.38

45.94

u/l

0.09

104

313

Intestinal infectious diseases

970

4846

1.53

32.47

1.3

47.37

32.74

u/l

1.68

848

4222

Certain infectious and parasitic diseases

759

2316

1.65

32.46

1.2

1.3

47.53

26.37

u/l

2.67

666

2012

Other blood glucose lowering drugs, excl. Insulins

223

941

2.41

32.37

1.3

26.85

44.12

u/l

1.80

198

801

Chronic periodontitis, including avohilmo

1032

4604

1.51

32.16

1.3

43.81

32.84

u/l

0.98

893

4017

Diseases of the skin and subcutaneous tissue

1042

3442

1.53

32.13

1.4

1.3

43.26

30.38

u/l

1.60

912

2983

Factors influencing health status and contact with health services

341

807

2.14

32.05

1.2

1.3

45.67

22.57

u/l

1.61

300

696

Cardiomyopathies, Primary/intrinsic

171

643

2.71

31.64

1.2

1.4

17.94

32.55

u/l

2.41

156

545

Infections of the skin and subcutaneous tissue

620

3699

1.67

31.63

1.2

1.3

32.71

35.14

u/l

0.18

543

3221

Autoimmune diseases

1143

3922

1.49

31.53

1.3

38.91

32.42

u/l

0.77

1018

3381

Diarrhoea and gastroenteritis of presumed infectious origin

726

4089

1.61

31.39

1.3

44.12

32.16

u/l

1.21

630

3559

Finngen Rheumatological endpoints

960

3573

1.54

31.35

1.2

1.3

42.30

29.69

u/l

1.35

843

3093

Chronic gastritis

341

1726

2.00

31.18

1.4

1.3

48.14

35.56

u/l

0.55

301

1487

Cardiomyopathy (excluding other)

174

668

2.66

30.90

1.2

1.3

17.82

31.84

u/l

2.40

159

567

Exclusions for E4_PCOS_BROAD

212

893

2.41

30.80

1.2

32.54

40.07

u/l

0.20

185

779

Myocardial infarction, strict

550

2269

1.74

30.77

1.2

1.3

32.76

40.26

u/l

0.89

486

1936

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

133

300

3.19

30.23

1.2

1.3

45.22

47.72

u/l

0.05

119

257

Peripheral artery disease

550

2577

1.72

29.74

1.2

1.3

38.69

40.29

u/l

0.10

478

2219

All influenza

291

1417

2.08

29.61

1.5

1.3

65.36

24.15

u/l

2.29

257

1216

Diseases of the digestive system

528

3091

1.71

29.60

1.2

1.3

36.58

34.45

u/l

0.17

466

2654

Other antidepressants

1089

3782

1.48

29.45

1.3

39.16

35.57

u/l

0.26

943

3311

Disorders of lens

740

2908

1.60

29.30

1.2

1.3

38.53

33.03

u/l

0.48

643

2536

Other diseases of the digestive system

398

2173

1.85

28.95

1.2

1.3

40.04

36.23

u/l

0.25

347

1869

Obesity, other/unspecified

327

1675

1.97

28.84

1.2

37.88

33.23

u/l

0.17

289

1467

Chronic apical periodontitis

1142

4490

1.46

28.79

1.3

42.98

32.39

u/l

1.21

1004

3903

Agranulocytosis

142

511

2.83

28.64

1.3

1.2

138.97

36.30

u/l

4.11

126

444

Diseases of the respiratory system

645

1952

1.66

28.61

1.3

48.50

25.74

u/l

2.33

566

1694

Cardiodefibrillation

464

2657

1.76

28.60

1.3

33.14

40.33

u/l

0.83

419

2273

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

357

1891

1.91

28.54

1.2

39.06

34.65

u/l

0.13

321

1645

Type 1 diabetes, wide definition, subgroup 1

222

987

2.27

28.42

1.2

1.3

38.65

36.94

u/l

0.05

200

858

Other medical care

513

2716

1.71

28.25

1.7

1.2

85.17

30.90

u/l

7.84

462

2312

GI-bleeding

397

2184

1.84

28.19

1.2

1.3

40.07

36.40

u/l

0.24

350

1876

Symptoms and signs involving the urinary system

824

4123

1.53

28.09

1.3

31.05

35.51

u/l

0.67

703

3595

Benign neoplasms

983

3648

1.49

27.96

1.3

36.85

33.06

u/l

0.32

859

3181

Intracranial trauma

532

2202

1.71

27.96

1.3

36.12

37.59

u/l

0.08

471

1920

Calcific aortic valvular stenosis, operated

386

2045

1.85

27.93

1.2

1.3

47.09

39.44

u/l

0.63

338

1746

Calcific aortic valvular stenosis

386

2045

1.85

27.93

1.2

1.3

47.09

39.44

u/l

0.63

338

1746

Calcific aortic valvular stenosis, including rheumatic fever

387

2050

1.85

27.93

1.2

1.3

46.97

39.38

u/l

0.62

339

1749

Failure and rejection of transplanted organs and tissues

6.87

27.83

1.4

1.2

166.58

33.22

u/l

1.28

Viral pneumonia

171

687

2.53

27.69

1.3

1.2

61.53

24.90

u/l

2.13

155

596

Diabetic nephropathy, excluding more controls

254

982

2.18

27.69

1.2

29.58

26.25

u/l

0.26

226

841

Operations 2 for CAVS

385

2044

1.85

27.68

1.2

1.3

47.19

39.44

u/l

0.64

337

1745

Calcific aortic valvular stenosis, diagnosis (helper)

385

2044

1.85

27.68

1.2

1.3

47.19

39.44

u/l

0.64

337

1745

Chronic lower respiratory diseases

1204

4502

1.43

27.36

1.2

1.3

38.96

34.22

u/l

0.41

1062

3917

Soft tissue disorders

1020

3573

1.48

27.17

1.3

28.81

36.14

u/l

1.22

897

3092

Low back pain

759

3535

1.55

27.09

1.3

33.53

34.62

u/l

0.10

657

3064

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1124

4252

1.44

26.92

1.3

42.13

31.52

u/l

1.27

1003

3694

Kidney transplant status

267

3.56

26.91

1.3

1.2

38.39

39.49

u/l

0.03

227

Hyperkalaemia

102

317

3.32

26.76

1.3

52.51

49.63

u/l

0.07

275

Persons encountering health services in other circumstances

413

2323

1.78

26.70

1.3

45.98

29.70

u/l

0.75

351

2005

Spondylopathies

844

3335

1.52

26.67

1.4

1.3

36.46

33.53

u/l

0.20

750

2881

Gingivitis and periodontal diseases

1069

3803

1.46

26.65

1.3

36.98

32.15

u/l

0.45

938

3306

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

718

4172

1.55

26.52

1.3

43.69

35.05

u/l

0.93

631

3617

Diabetic maculopathy, excluding more controls

147

563

2.66

26.32

1.2

1.3

17.62

49.56

u/l

3.48

133

486

Other diseases of pleura

543

2898

1.66

26.31

1.3

41.87

38.92

u/l

0.23

453

2507

Obesity related asthma

381

2118

1.82

26.18

1.3

35.85

32.91

u/l

0.12

342

1831

Other CVD (FINNGEN)

123

322

3.01

26.10

1.2

1.5

34.44

42.56

u/l

0.30

112

267

Explicit bacterial Sepsis

149

579

2.62

25.91

1.4

1.2

66.09

41.39

u/l

0.91

140

508

Disorders of thyroid, IBD co-morbidities

152

403

2.67

25.61

1.3

26.86

41.18

u/l

0.60

139

353

Disorders of choroid and retina

875

4209

1.49

25.58

1.3

43.55

33.75

u/l

0.92

752

3666

Type 1 diabetes, wide definition

226

1059

2.15

25.45

1.2

1.3

38.08

36.76

u/l

0.04

204

915

Senile cataract

678

2652

1.58

25.32

1.2

1.3

40.96

33.74

u/l

0.63

592

2303

Diseases of liver

393

2228

1.78

25.31

1.3

35.80

32.91

u/l

0.18

352

1924

Hypertensive Renal Disease

150

4.41

25.25

1.2

1.3

17.09

68.18

u/l

2.28

124

Other autoimmune haemolytic anaemias

6.61

25.01

1.4

1.2

64.16

22.83

u/l

1.42

Chronic periodontitis, complicated

607

3830

1.58

24.92

1.3

33.55

35.54

u/l

0.17

526

3342

Intestinal infectious diseases

1149

4668

1.41

24.74

1.3

43.52

32.31

u/l

1.35

1003

4069

Benign neoplasm of colon, rectum, anus and anal canal

704

4014

1.53

24.67

1.3

36.80

36.56

u/l

0.02

610

3480

Abnormalities of heart beat

355

1930

1.82

24.49

1.2

1.3

42.95

35.16

u/l

0.29

307

1650

Other acute lower respiratory infections

550

3277

1.61

24.21

1.3

47.83

31.63

u/l

1.70

477

2838

Atherosclerosis, excluding cerebral and coronary sclerosis

506

2440

1.66

24.17

1.3

38.09

40.48

u/l

0.14

431

2100

Infarction of spleen

10.52

24.03

1.3

1.1

67.28

12.52

u/l

1.29

Myocardial infarction, without ST-elevation

494

2748

1.65

23.93

1.3

31.67

38.95

u/l

0.94

426

2358

Extracorporeal dialysis

106

362

3.02

23.77

1.2

24.07

53.95

u/l

1.80

309

Asthma-related infections

590

3698

1.57

23.59

1.3

47.33

34.24

u/l

0.99

523

3191

Asthma, hospital admission 2, infections

590

3698

1.57

23.59

1.3

47.33

34.24

u/l

0.99

523

3191

Amputation

157

655

2.45

23.59

1.2

43.43

45.30

u/l

0.07

142

562

Adjustment and management of implanted device

242

1202

2.04

23.56

1.2

29.87

33.15

u/l

0.27

213

1021

Enterocolitis due to Clostridium difficile

153

631

2.47

23.55

1.2

61.73

37.58

u/l

1.08

133

539

Bronchitis

1057

4729

1.41

23.38

1.3

39.48

33.90

u/l

0.68

915

4125

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

633

4073

1.54

23.37

1.3

52.38

33.66

u/l

1.49

549

3532

Diseases of the musculoskeletal system and connective tissue

514

1549

1.67

23.37

1.3

37.75

31.07

u/l

0.48

450

1355

Volume depletion

133

515

2.63

23.37

1.1

1.3

23.93

51.50

u/l

2.24

109

437

Idiopathic thrombocytopenic purpura

147

4.32

23.32

1.3

1.2

97.08

36.83

u/l

0.96

126

Gastro-oesophageal reflux disease

689

3932

1.52

23.30

1.3

32.42

31.47

u/l

0.09

591

3420

Amputation of toe

123

461

2.74

23.19

1.2

46.49

46.37

u/l

0.00

112

400

Disorders of calcium metabolism

318

3.10

22.66

1.3

23.47

43.84

u/l

1.55

275

Peripheral arterial reconstruction

236

1181

2.03

22.56

1.3

34.52

43.39

u/l

0.62

212

1010

Angina pectoris

612

2625

1.56

22.54

1.2

1.3

30.07

39.01

u/l

1.45

548

2253

Bacterial pneumoniae

435

2299

1.68

22.46

1.3

76.44

25.18

u/l

4.58

390

1978

Dorsalgia

958

3592

1.43

22.32

1.3

32.86

34.89

u/l

0.20

840

3113

Other disorders of skin and subcutaneous tissue, not elsewhere classified

181

822

2.24

22.29

1.2

35.72

43.52

u/l

0.32

157

714

Other bacterial intestinal infections

217

1057

2.08

22.29

1.3

64.85

37.53

u/l

1.27

191

916

Nerve, nerve root and plexus disorders

1063

4667

1.40

22.26

1.3

30.63

35.49

u/l

0.60

944

4043

Pain (limb, back, neck, head abdominally)

747

2491

1.51

22.16

1.3

37.67

36.27

u/l

0.09

663

2143

Dental operations

683

2303

1.53

21.79

1.2

1.3

48.28

33.72

u/l

1.29

588

1983

Cerebrovascular diseases

797

3846

1.46

21.74

1.3

39.10

36.67

u/l

0.20

701

3334

Cholecystectomy

706

4109

1.49

21.72

1.3

41.41

34.99

u/l

0.41

629

3547

Syncope and collapse

460

2417

1.64

21.58

1.2

1.3

34.55

30.30

u/l

0.37

385

2066

Diseases of the eye and adnexa

759

2554

1.49

21.55

1.3

32.47

32.30

u/l

0.01

656

2248

Testicular hypofunction

188

3.77

21.54

1.3

1.2

13.58

43.28

u/l

1.79

161

Unspecified haematuria

491

2539

1.62

21.52

1.3

33.38

38.13

u/l

0.49

417

2212

Diabetic nephropathy

256

1327

1.94

21.37

1.2

29.56

30.70

u/l

0.07

228

1168

Cutaneous abscess, furuncle and carbuncle

282

1531

1.86

21.07

1.2

1.3

36.34

33.16

u/l

0.12

246

1336

Other diseases of liver

211

1040

2.06

21.03

1.4

1.3

26.74

39.87

u/l

0.82

186

899

Venous thromboembolism

578

3654

1.54

20.99

1.3

49.25

36.02

u/l

0.98

510

3138

Other retinal disorders

690

3630

1.49

20.89

1.3

44.43

35.33

u/l

0.65

595

3144

Bacterial intestinal infections, IBD co-morbidities

219

1097

2.02

20.87

1.3

64.65

39.07

u/l

1.18

193

948

Symptoms and signs involving cognition, perception, emotional state and behaviour

948

4610

1.41

20.85

1.3

35.56

34.19

u/l

0.13

830

4009

Hernia

924

4403

1.41

20.68

1.3

39.72

32.84

u/l

0.66

809

3826

Other dorsopathies, not elsewhere classified

968

3602

1.41

20.64

1.3

31.20

34.81

u/l

0.42

850

3123

Respiratory insufficiency

115

440

2.66

20.64

1.1

1.2

60.02

24.25

u/l

1.32

376

Exclusions for E4_PCOS_CONSORTIUM

583

2364

1.55

20.63

1.2

1.3

40.69

35.37

u/l

0.26

502

2082

Benign neoplasm: Colon

593

3743

1.52

20.55

1.3

38.07

37.95

u/l

0.01

517

3233

Headache

577

3009

1.54

20.52

1.3

39.05

29.35

u/l

0.72

506

2595

Use of hypnotics and sedatives

1056

4398

1.38

20.41

1.4

1.3

37.35

34.13

u/l

0.28

926

3829

Hypo-osmolality and hyponatraemia

206

1012

2.05

20.40

1.3

35.23

39.92

u/l

0.27

173

871

Nausea and vomiting

285

1537

1.83

20.28

1.4

1.3

39.92

37.62

u/l

0.11

246

1302

Presence of other functional implants

620

2847

1.52

20.28

1.2

1.3

50.22

33.44

u/l

1.28

516

2456

Bacterial pneumonia (organism specified)

483

2772

1.59

20.21

1.3

78.45

30.69

u/l

4.58

433

2378

Disorders resulting from impaired renal tubular function

206

3.53

20.20

1.1

1.2

30.85

41.87

u/l

0.35

179

Acute bronchitis

423

2549

1.64

20.19

1.3

45.94

33.55

u/l

0.93

364

2190

Testicular dysfunction

206

3.52

20.19

1.3

1.2

13.57

53.22

u/l

1.93

175

Diseases of oral cavity, salivary glands and jaws

640

2168

1.53

20.17

1.3

45.63

32.64

u/l

1.10

547

1864

Gonarthrosis [arthrosis of knee](FG)

779

3122

1.46

20.15

1.3

30.47

30.62

u/l

0.01

681

2688

Other disorders of urethra and urinary system

658

3191

1.50

20.14

1.2

1.3

27.07

40.09

u/l

3.27

571

2749

Implicit fungal Sepsis

341

2.88

20.05

1.3

40.34

35.62

u/l

0.15

290

Bacterial pneumonia, not elsewhere classified

407

2178

1.66

20.02

1.3

74.19

24.96

u/l

4.38

364

1871

L04AA Selective immunosuppressants

238

1246

1.93

19.95

1.3

36.88

36.40

u/l

0.02

221

1080

Asthma, hospital admissions 3, pneumonia

387

2332

1.67

19.91

1.4

1.3

61.79

36.01

u/l

1.51

343

1990

Asthma-related pneumonia or sepsis

387

2332

1.67

19.91

1.4

1.3

61.79

36.01

u/l

1.51

343

1990

Asthma-related pneumonia

386

2326

1.67

19.86

1.4

1.3

61.94

36.08

u/l

1.51

342

1985

Streptococcal septicaemia

126

517

2.49

19.73

1.5

1.2

58.05

32.67

u/l

1.02

119

444

Early onset COPD, excluding more controls

226

1169

1.95

19.60

1.3

31.38

22.67

u/l

0.91

191

1001

Care involving use of rehabilitation procedures

617

3815

1.49

19.57

1.4

1.2

47.79

27.56

u/l

1.93

564

3284

Lower back pain or/and sciatica

1018

4854

1.37

19.39

1.3

36.70

34.27

u/l

0.23

896

4224

Pulmonary heart disease, diseases of pulmonary circulation

355

2116

1.69

19.24

1.3

57.62

37.12

u/l

1.14

313

1809

DVT of lower extremities and pulmonary embolism

452

2850

1.59

19.19

1.3

53.53

35.67

u/l

1.10

400

2442

Non-Hodgkin lymphoma, all, including Hilmo

166

775

2.18

19.18

1.3

1.2

84.07

23.41

u/l

3.84

145

660

Pain, not elsewhere classified

267

1470

1.83

19.08

1.2

48.10

29.01

u/l

0.65

249

1256

Cytomegaloviral disease

117

4.38

19.04

1.4

1.2

88.37

29.00

u/l

0.92

102

COPD

516

2741

1.55

19.01

1.3

32.20

38.08

u/l

0.77

441

2352

Other intervertebral disc disorders

817

3463

1.43

19.01

1.3

37.41

33.90

u/l

0.23

728

2997

Osteomyelitis

100

374

2.74

19.00

1.5

1.2

34.21

46.09

u/l

0.45

326

Symptoms and signs involving the skin and subcutaneous tissue

676

4566

1.46

18.93

1.3

48.69

33.65

u/l

1.40

604

3958

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

959

4459

1.38

18.87

1.3

45.40

32.14

u/l

1.24

834

3882

Diarrhoea and gastroenteritis of presumed infectious origin

964

4626

1.38

18.75

1.3

42.32

31.66

u/l

1.08

833

4037

Diseases of pulp and periapical tissues and dental caries

687

2393

1.48

18.61

1.2

1.3

46.99

35.35

u/l

0.83

595

2049

Other bacterial intestinal infections

250

1361

1.86

18.60

1.2

1.3

58.13

33.68

u/l

1.32

218

1184

Cytomegalovirus infection, IBD co-morbidity

115

4.37

18.59

1.5

1.2

88.37

19.85

u/l

1.18

102

Fall on same level

1089

4400

1.36

18.45

1.3

38.04

32.25

u/l

0.63

960

3828

Malignant neoplasm, wide definition for exclusion

830

3459

1.41

18.26

1.4

1.2

63.73

19.75

u/l

7.21

729

3002

Chronic ulcer of skin, not elsewhere classified

103

399

2.64

18.25

1.2

29.09

39.32

u/l

0.61

337

Dental caries, including avohilmo

754

2683

1.44

18.16

1.3

41.97

35.39

u/l

0.45

661

2305

Arthrosis

722

2744

1.45

18.08

1.2

1.3

37.50

32.13

u/l

0.33

630

2380

Symptoms and signs involving the digestive system and abdomen

1001

3666

1.37

18.06

1.2

1.3

33.60

34.24

u/l

0.05

889

3168

Other chronic obstructive pulmonary disease, including avohilmo

594

3324

1.49

18.03

1.3

30.90

38.25

u/l

1.15

509

2870

Other diseases of urinary system

960

3944

1.37

17.73

1.3

33.77

36.60

u/l

0.29

840

3420

Arthropathies

836

3016

1.41

17.66

1.2

1.3

41.41

31.14

u/l

0.85

737

2626

Peripheral artery operations in Hilmo

168

814

2.09

17.64

1.2

1.3

42.13

42.42

u/l

0.01

150

690

L01XE Protein kinase inhibitors

327

2.80

17.58

1.3

1.2

110.10

45.36

u/l

1.11

289

Dizziness and giddiness

735

4119

1.42

17.57

1.3

31.17

34.93

u/l

0.50

640

3567

Diaphragmatic hernia

381

2369

1.62

17.55

1.4

1.3

42.32

37.24

u/l

0.28

333

2046

Sulfonylureas

384

1891

1.63

17.43

1.2

1.4

30.51

45.06

u/l

1.94

328

1618

Dorsopathies

970

3610

1.37

17.38

1.3

35.85

34.74

u/l

0.08

857

3131

Diseases of pulp and periapical tissues, including avohilmo

1018

3895

1.36

17.33

1.3

40.88

33.41

u/l

0.71

887

3383

Other disorders of kidney and ureter

166

811

2.08

17.11

1.2

1.3

24.51

42.68

u/l

1.92

146

706

Later onset COPD, excluding more controls

242

1022

1.85

17.07

1.2

1.4

30.23

32.31

u/l

0.14

208

866

Concussion

421

2185

1.58

17.01

1.3

31.29

37.63

u/l

0.44

368

1904

Other diseases of hard tissues of teeth

613

2149

1.48

16.99

1.2

1.3

42.89

32.53

u/l

0.73

532

1849

Abnormal findings on diagnostic imaging of lung

520

3346

1.50

16.88

1.4

1.3

46.20

37.03

u/l

0.71

457

2891

Exposure to unspecified factor

939

4996

1.36

16.87

1.3

39.88

33.98

u/l

0.58

823

4353

Vascular disorders of the intestines

380

2.61

16.81

1.4

1.2

79.13

43.66

u/l

0.67

320

Spinal stenosis

540

2759

1.50

16.73

1.3

30.41

34.84

u/l

0.44

483

2370

Symptoms and signs concerning food and fluid intake

122

533

2.32

16.55

1.6

1.2

24.57

36.38

u/l

0.78

114

454

Asthma (diagnoses ohter than nonallergic)

812

4906

1.38

16.41

1.3

39.36

34.67

u/l

0.34

729

4252

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

106

439

2.46

16.35

1.3

1.2

93.87

46.62

u/l

1.00

375

Malignant neoplasm

799

3407

1.39

16.31

1.4

1.2

64.22

19.69

u/l

7.28

698

2959

Other chronic obstructive pulmonary disease

485

2654

1.52

16.29

1.3

31.95

38.80

u/l

0.91

412

2271

Missing teeth due to accident, extraction or parodontitis

607

3984

1.44

16.24

1.2

1.3

36.56

36.69

u/l

0.01

511

3468

Phlebitis and thrombophlebitis (not including DVT)

242

1362

1.79

16.23

1.3

1.2

53.13

35.66

u/l

0.66

211

1178

Thiazolidinediones

141

663

2.16

16.11

1.2

1.3

24.44

42.66

u/l

1.95

126

568

Caries of dentine, including avohilmo

783

2867

1.40

16.06

1.3

41.14

35.46

u/l

0.39

683

2472

Gonarthrosis

655

2603

1.44

15.99

1.3

29.59

31.72

u/l

0.16

568

2255

Acute sinusitis

456

2787

1.52

15.94

1.3

38.30

32.94

u/l

0.39

402

2433

Sub-endpoint used in defining T1D endpoints

295

1733

1.69

15.92

1.2

34.75

35.32

u/l

0.02

266

1502

Other cataract

449

2228

1.54

15.77

1.3

49.37

37.43

u/l

0.63

384

1937

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

561

3876

1.45

15.72

1.3

44.05

35.61

u/l

0.52

486

3362

Pneumonia due to other infectious organisms, not elsewhere classified

169

3.42

15.59

1.4

1.2

100.95

24.59

u/l

2.28

147

Viral hepatitis, IBD co-morbidity

145

3.56

15.43

1.3

1.1

52.95

44.79

u/l

0.10

122

Other and unspecified polyneuropathies, also in other diseases

228

1282

1.80

15.42

1.3

28.54

38.20

u/l

1.14

206

1106

Other specific joint derangements/joint disorders

643

2921

1.43

15.41

1.2

1.3

28.60

31.23

u/l

0.22

575

2547

Abdominal and pelvic pain

976

3666

1.34

15.33

1.2

1.3

32.24

34.24

u/l

0.18

874

3168

Nonischemic cardiomyopathy

126

578

2.21

15.31

1.5

1.3

17.99

44.52

u/l

3.23

116

493

Constipation

851

4359

1.36

15.19

1.2

1.3

39.96

34.67

u/l

0.42

748

3779

Other/unspecified cytomegaloviral diseases

102

4.21

15.17

1.5

1.2

101.59

17.31

u/l

1.23

Injuries to the head

1033

4822

1.32

15.16

1.3

35.74

34.83

u/l

0.07

910

4191

Polyneuropathies and other disorders of the peripheral nervous system

252

1466

1.74

15.13

1.3

32.18

37.35

u/l

0.44

225

1265

Cough

366

2206

1.58

15.13

1.2

1.3

25.54

36.58

u/l

2.15

321

1884

Other diseases of arteries and capillaries

113

502

2.29

14.89

1.2

57.29

41.29

u/l

0.30

430

Other respiratory disorders and diseases

231

1317

1.77

14.89

1.3

42.53

41.57

u/l

0.03

183

1140

Other diseases of the respiratory system

231

1317

1.77

14.89

1.3

42.53

41.57

u/l

0.03

183

1140

Elevated blood glucose level

103

440

2.38

14.86

1.2

27.26

51.20

u/l

1.32

379

Ischaemic Stroke, excluding all haemorrhages

600

3141

1.43

14.78

1.2

1.3

39.41

39.34

u/l

0.00

517

2699

Nonalcoholic fatty liver disease

114

510

2.27

14.77

1.4

1.2

17.35

38.79

u/l

2.35

439

Coxarthrosis [arthrosis of hip](FG)

550

2675

1.45

14.74

1.3

50.61

33.31

u/l

1.07

481

2296

Endocarditis

176

3.27

14.61

1.3

59.34

35.16

u/l

0.31

147

Second line medication for Crohn's disease

527

3661

1.45

14.46

1.2

1.3

44.58

33.13

u/l

1.71

475

3187

Valvular operations

148

743

2.01

14.19

1.2

1.4

39.13

34.52

u/l

0.22

129

627

Stroke, excluding SAH

627

3272

1.41

14.08

1.2

1.3

40.71

38.57

u/l

0.14

539

2820

Disorders of parathyroid gland

215

1207

1.78

14.01

1.3

1.2

35.04

41.14

u/l

0.40

197

1030

Unstable angina pectoris

392

2027

1.54

13.97

1.4

1.3

32.08

41.91

u/l

1.13

342

1719

L04AX Other immunosuppressants

513

3571

1.44

13.95

1.2

1.3

44.17

32.42

u/l

1.79

462

3108

Fungal Sepsis

208

3.01

13.88

1.3

62.15

35.62

u/l

0.64

184

431

2662

1.49

13.80

1.3

45.71

41.43

u/l

0.23

383

2277

Secondary right heart disease

236

2.87

13.80

1.2

46.72

42.09

u/l

0.12

205

Gastroduodenal ulcer

279

1707

1.64

13.70

1.4

1.3

56.60

35.26

u/l

0.74

241

1463

Other and unspecified dermatitis

475

3272

1.46

13.70

1.2

1.3

47.54

31.52

u/l

0.99

420

2815

Any death

642

3317

1.39

13.64

1.5

1.3

76.65

29.65

u/l

7.22

557

2875

Stroke, including SAH

651

3416

1.39

13.63

1.2

1.3

39.90

38.42

u/l

0.10

563

2946

Amiodarone users

137

681

2.05

13.63

1.2

1.3

24.12

45.43

u/l

2.38

122

591

Asthma, hospital admissions , main diagnosis only

735

4804

1.35

13.56

1.3

38.52

34.00

u/l

0.30

655

4173

Coxarthrosis

511

2340

1.45

13.38

1.3

51.97

33.85

u/l

1.03

445

2023

Artrosis, including avohilmo

808

3293

1.35

13.38

1.2

1.3

36.20

35.31

u/l

0.05

705

2862

Disorders of the thyroid gland

865

4257

1.33

13.35

1.3

31.25

37.06

u/l

0.59

770

3679

Osteoporosis

258

1459

1.67

13.28

1.3

1.2

43.19

40.23

u/l

0.12

234

1238

Diseases of male genital organs

583

2074

1.43

13.26

1.3

34.58

35.40

u/l

0.04

511

1821

Psychiatric diseases

963

3680

1.31

13.24

1.3

30.56

35.56

u/l

0.69

844

3212

Pulmonary embolism

307

1946

1.59

13.20

1.3

51.36

37.28

u/l

0.69

272

1661

Skin changes due to chronic exposure to nonionizing radiation

408

2532

1.50

13.19

1.4

1.3

47.51

42.25

u/l

0.28

362

2164

Other headache syndromes

337

2180

1.55

13.14

1.4

1.3

37.30

35.35

u/l

0.08

303

1886

389

2577

1.51

13.12

1.2

1.3

41.13

33.47

u/l

0.36

346

2228

Dermatitis

565

4037

1.40

13.04

1.2

1.3

43.11

32.88

u/l

0.66

504

3493

Mycoses

265

1627

1.64

13.02

1.3

1.2

43.41

34.47

u/l

0.67

228

1404

Viral pneumonia (unknown virus, not influenza)

361

2.42

12.97

1.4

1.2

46.69

46.95

u/l

0.00

313

Asthma, including avohilmo

1094

4795

1.28

12.97

1.2

1.3

34.34

35.30

u/l

0.07

972

4165

Asthma/COPD (KELA code 203)

863

4497

1.32

12.93

1.3

38.72

34.23

u/l

0.31

765

3915

Personality disorders, excluding more controls

205

1177

1.75

12.89

1.2

34.27

31.20

u/l

0.13

179

1043

Other diseases of upper respiratory tract

1049

4240

1.29

12.89

1.3

38.08

34.83

u/l

0.24

923

3682

Pulmonary heart disease

307

1959

1.58

12.84

1.3

51.36

38.36

u/l

0.61

272

1672

Dilated cardiomyopathy

157

837

1.90

12.75

1.2

1.3

17.90

41.81

u/l

4.52

142

724

Depression or dysthymia

663

2665

1.38

12.70

1.3

33.58

36.74

u/l

0.19

570

2331

Implicit fungal Sepsis

192

2.99

12.66

1.3

49.42

33.96

u/l

0.38

172

Migraine

352

1869

1.53

12.65

1.3

1.2

21.38

36.54

u/l

2.50

322

1624

COPD, hospital admission 2, with asthma infections

352

1983

1.53

12.64

1.3

33.86

37.98

u/l

0.37

296

1710

Hypothyroidism, other/unspecified

796

3944

1.33

12.62

1.3

28.53

37.06

u/l

1.46

707

3403

Non-allergic asthma (mode), excluding more controls

162

864

1.87

12.62

1.4

1.3

28.55

24.55

u/l

0.28

151

739

Glomerulonephritis

119

578

2.09

12.61

1.2

1.3

21.76

45.89

u/l

2.37

111

499

Enlarged lymph nodes

156

832

1.89

12.57

1.2

101.39

30.83

u/l

1.77

146

712

Extreme obesity with alveolar hypoventilation

215

2.86

12.53

1.2

1.3

24.29

30.80

u/l

0.29

184

Actinic keratosis

395

2474

1.49

12.48

1.3

47.95

42.03

u/l

0.31

349

2113

Cardiomyopathy, other and unspecified

382

2.34

12.32

1.1

1.3

31.93

34.57

u/l

0.08

319

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

477

2255

1.44

12.28

1.4

1.2

43.16

22.54

u/l

2.77

409

1932

Polycystic ovarian syndrome, consortium definition

475

1949

1.45

12.27

1.2

24.52

36.99

u/l

1.71

406

1703

Benzodiazepine use

926

4930

1.30

12.25

1.3

32.19

35.26

u/l

0.38

792

4309

Pain in joint

528

2386

1.42

12.22

1.2

1.3

31.38

36.42

u/l

0.36

474

2054

Abnormality of white blood cells, not elsewhere classified

5.57

12.22

1.5

1.1

63.00

17.30

u/l

1.07

Gastric ulcer

193

1109

1.76

12.21

1.4

1.3

72.66

37.57

u/l

0.90

168

951

Other disorders of ear

869

4362

1.31

12.19

1.3

37.27

32.50

u/l

0.41

743

3800

Viral infections characterized by skin and mucous membrane lesions

770

4989

1.32

12.19

1.2

1.3

45.24

33.78

u/l

1.22

680

4346

Osteonecrosis

342

2.42

12.12

1.6

1.2

51.59

40.98

u/l

0.33

294

Hypokalaemia

125

627

2.02

12.11

1.3

29.55

43.41

u/l

1.15

103

541

Other metabolic disorders

113

546

2.09

12.10

1.3

1.2

83.41

34.25

u/l

1.06

104

474

COPD related to multimorbidity

430

2508

1.46

12.07

1.2

1.4

30.99

40.15

u/l

1.30

365

2161

125

628

2.01

12.04

1.5

1.2

48.76

27.73

u/l

1.29

114

538

All influenza (not pneumonia)

147

781

1.90

12.01

1.3

81.55

23.35

u/l

1.63

127

679

Candidiasis

250

1545

1.63

11.99

1.3

34.13

37.52

u/l

0.23

214

1343

COPD, hospital admissions

484

2892

1.42

11.98

1.3

32.09

40.69

u/l

1.23

409

2489

Migraine with aura

173

967

1.80

11.97

1.3

1.2

20.90

39.31

u/l

1.45

151

836

Other pulmonary heart/vessel disease

267

2.61

11.91

1.2

75.36

45.45

u/l

0.44

232

Pruritus

112

544

2.08

11.86

1.2

60.97

34.49

u/l

0.56

461

COPD, early/later onset

487

2910

1.42

11.84

1.3

31.90

40.57

u/l

1.26

413

2505

Other functional intestinal disorders

402

2565

1.46

11.67

1.3

43.33

35.11

u/l

0.34

356

2201

Sequelae of external causes of morbidity and mortality

255

1597

1.61

11.63

1.4

1.2

71.81

35.94

u/l

1.12

234

1380

Hyperparathyroidism

185

1055

1.75

11.55

1.3

1.2

37.40

40.39

u/l

0.15

171

904

Vocal cord dysfunction

106

453

2.11

11.55

1.2

1.4

50.26

36.35

u/l

0.31

383

Hypothyroidism, strict autoimmune

632

3069

1.36

11.52

1.3

29.17

31.62

u/l

0.27

554

2623

Hypothyreosis and Thyroxine purchase for inclusion criteria

814

4093

1.31

11.47

1.3

28.59

36.06

u/l

1.25

723

3534

Shoulder lesions

715

3255

1.34

11.45

1.2

1.3

38.63

35.18

u/l

0.21

636

2811

Charcot foot

4.12

11.32

1.1

1.3

19.14

53.38

u/l

0.82

Certain disorders involving the immune mechanism

189

1105

1.73

11.28

1.2

1.3

58.01

38.38

u/l

0.52

173

961

Irritable bowel syndrome

230

1417

1.63

11.20

1.2

25.02

35.67

u/l

1.27

206

1214

Visual disturbances and blindness

469

3349

1.41

11.19

1.2

1.3

36.21

35.49

u/l

0.04

407

2902

Other joint disorders

754

3014

1.32

11.09

1.2

1.3

31.79

31.16

u/l

0.04

660

2624

Accidents

753

2856

1.32

11.04

1.3

1.2

37.45

32.45

u/l

0.41

653

2476

Hyperkinetic disorders, excluding more controls

263

2.49

11.01

1.1

1.2

10.98

30.08

u/l

1.40

227

Other neurological diseases

694

4135

1.32

10.94

1.2

1.3

35.88

36.26

u/l

0.03

611

3575

Other noninfective gastroenteritis and colitis

228

1411

1.63

10.90

1.2

1.3

57.71

38.44

u/l

0.57

204

1225

Malignant neoplasm of skin

478

2338

1.41

10.87

1.3

1.2

56.14

22.41

u/l

3.23

407

2002

Hernia of abdominal wall

450

3211

1.41

10.85

1.2

1.3

40.09

34.06

u/l

0.35

392

2791

Selective serotonin reuptake inhibitors

928

3787

1.28

10.84

1.2

1.3

33.05

35.55

u/l

0.18

796

3315

Postprocedural endocrine and metabolic disorders, not elsewhere classified

104

509

2.06

10.82

1.3

1.2

88.56

35.21

u/l

1.07

444

Ventral hernia

239

1503

1.60

10.76

1.2

1.3

40.06

36.54

u/l

0.12

202

1298

Acute upper respiratory infections

945

4583

1.27

10.74

1.3

39.96

34.28

u/l

0.49

824

3982

Basal cell carcinoma

426

2067

1.43

10.74

1.3

1.2

52.48

22.55

u/l

2.56

359

1770

Secondary and unspecified malignant neoplasm of lymph nodes

466

2.11

10.66

1.2

122.31

21.78

u/l

1.77

403

Other malignant neoplasms of skin (=non-melanoma skin cancer)

441

2136

1.42

10.65

1.3

1.2

49.02

22.29

u/l

2.74

370

1830

Basal cell carcinoma, including avohilmo

440

2141

1.42

10.65

1.3

1.2

51.78

22.22

u/l

2.66

372

1835

Traumatic subdural haemorrhage

151

808

1.81

10.60

1.3

52.67

40.46

u/l

0.32

129

683

Diseases of the ear and mastoid process

1041

4154

1.26

10.53

1.3

33.14

32.45

u/l

0.06

905

3633

Vitreous haemorrhage

120

627

1.94

10.44

1.2

1.3

69.06

39.85

u/l

0.60

105

549

Gonarthrosis,primary

872

4207

1.28

10.39

1.3

34.86

34.64

u/l

0.01

764

3650

Viral infections characterized by skin and mucous membrane lesions

378

2636

1.44

10.33

1.3

46.83

30.26

u/l

1.42

337

2291

Idiopathic gout

118

617

1.94

10.27

1.4

1.3

45.53

45.36

u/l

0.00

104

538

Cellulitis

214

1326

1.63

10.26

1.2

1.3

27.51

35.74

u/l

0.87

184

1146

Other specified/unspecified arthritis

242

1544

1.58

10.25

1.5

1.3

28.15

33.84

u/l

0.52

220

1331

Cholecystitis

149

838

1.80

10.24

1.2

1.3

60.43

46.12

u/l

0.22

130

730

Other viral diseases

241

1532

1.58

10.21

1.4

1.3

66.18

32.81

u/l

1.15

212

1352

Mood disorders, excluding more controls

852

3977

1.28

10.21

1.2

1.3

32.38

35.32

u/l

0.32

747

3473

Other diseases of pericardium

216

2.64

10.20

1.2

1.3

37.08

32.39

u/l

0.12

182

Other systemic involvement of connective tissue (FG)

222

1372

1.61

10.16

1.2

35.91

34.88

u/l

0.04

197

1171

Visual disturbances

428

3067

1.40

10.09

1.2

1.3

35.09

35.72

u/l

0.03

372

2659

Insulin, fast-acting (human)

132

719

1.85

10.07

1.2

49.91

41.81

u/l

0.16

116

628

Acute upper respiratory infections of multiple and unspecified sites

641

3601

1.32

10.06

1.3

41.71

32.93

u/l

0.62

562

3134

COPD-related respiratory insufficiency

143

800

1.81

10.06

1.1

1.3

41.26

43.76

u/l

0.10

109

691

Zoster [herpes zoster]

458

3269

1.39

10.04

1.2

1.3

54.97

34.89

u/l

1.50

396

2819

Noninfective enteritis and colitis

408

2905

1.41

9.91

1.2

1.3

49.72

32.19

u/l

0.91

364

2527

Coxibs

280

955

1.55

9.90

1.2

42.45

41.35

u/l

0.03

244

821

Retention of urine

361

2059

1.45

9.88

1.5

1.3

35.69

42.10

u/l

0.52

316

1786

Misadventures to patients during surgical and medical care

144

813

1.79

9.80

1.7

1.2

28.22

36.50

u/l

0.71

130

712

Other external causes of accidental injury

741

2856

1.30

9.76

1.3

1.2

37.11

32.45

u/l

0.38

647

2476

Heart failure and hypertrophic cardiomyopathy

102

3.46

9.71

1.2

57.79

25.75

u/l

0.39

COPD, hospital admissions 3, with asthma pneumonia sepsis

293

1679

1.50

9.69

1.3

34.50

39.17

u/l

0.43

244

1446

Other arthritis (FG)

270

1789

1.52

9.66

1.5

1.3

27.96

31.84

u/l

0.37

245

1540

Unspecified acute lower respiratory infection

152

876

1.75

9.64

1.2

44.96

37.39

u/l

0.32

136

761

Coronary artery bypass grafting

278

1370

1.52

9.62

1.1

1.4

37.31

48.07

u/l

0.79

248

1168

Other skin changes

184

1119

1.66

9.56

1.4

1.3

85.59

38.92

u/l

1.68

165

968

Myalgia

195

1203

1.63

9.54

1.3

1.2

22.05

39.15

u/l

2.75

171

1036

Non-allergic asthma (mode)

162

943

1.71

9.53

1.4

1.2

28.55

24.17

u/l

0.33

151

810

Hypercalcemia

248

2.47

9.52

1.3

26.36

42.28

u/l

0.78

211

Other pleural conditions

121

655

1.87

9.49

1.4

1.3

40.41

44.34

u/l

0.17

105

566

Injuries to the abdomen, lower back, lumbar spine and pelvis

366

2553

1.43

9.49

1.3

33.62

33.43

u/l

0.01

317

2191

Other diseases of anus and rectum

277

1850

1.50

9.45

1.3

34.36

35.55

u/l

0.06

240

1586

Mycoses

746

5082

1.28

9.38

1.3

34.68

35.14

u/l

0.04

627

4458

Other/unspecified dorsalgia

323

2213

1.45

9.35

1.2

1.3

27.55

33.71

u/l

0.73

286

1887

Carpal tunnel syndrome

542

3592

1.34

9.29

1.2

1.3

28.78

34.40

u/l

0.50

480

3100

Primary hyperparathyroidism

113

603

1.90

9.27

1.3

1.2

41.33

35.43

u/l

0.23

105

521

Other coagulation defects

345

2.20

9.25

1.8

1.2

24.61

29.88

u/l

0.36

296

Other disorders of lacrimal gland

306

2099

1.47

9.25

1.4

1.2

35.20

40.37

u/l

0.29

260

1812

Abnormal blood-pressure reading, without diagnosis

186

2.68

9.23

1.4

1.3

23.25

47.22

u/l

0.77

150

Arthropathies in other diseases classified elsewhere

175

2.74

9.21

1.1

1.3

30.58

30.85

u/l

0.01

147

Diabetic retinopathy, excluding more controls

324

1241

1.48

9.15

1.1

1.2

34.88

27.43

u/l

0.58

287

1067

Cirrhosis of liver, NAS

348

2.20

9.12

1.3

1.2

50.66

45.39

u/l

0.13

300

Mood [affective] disorders

895

4636

1.25

9.12

1.2

1.3

31.31

34.86

u/l

0.43

786

4042

Mood disorders

897

4640

1.25

9.12

1.2

1.3

31.26

34.83

u/l

0.43

788

4046

Other viral diseases

285

1918

1.48

9.10

1.4

1.3

58.48

34.15

u/l

0.93

254

1686

Hypothyroidism, strict autoimmune, 3 medication purchases required

702

3684

1.29

9.09

1.3

29.02

36.64

u/l

1.28

613

3180

Lumbar disc prolapse

571

3320

1.32

9.08

1.4

1.3

37.56

34.26

u/l

0.16

510

2881

Systemic connective tissue disorders

309

2132

1.46

9.07

1.2

37.10

37.29

u/l

0.01

277

1842

ILD, hospital admission 2, with pulmonary infections

104

544

1.93

9.07

1.3

1.2

56.17

27.18

u/l

0.71

468

DVT of lower extremities

188

1166

1.63

9.06

1.3

1.2

53.73

36.63

u/l

0.51

167

1004

Disorders of skin appendages

387

2776

1.40

9.06

1.2

1.3

37.55

33.10

u/l

0.20

350

2411

Disorder of lipoprotein metabolism, unspecified

141

813

1.75

8.98

1.2

1.3

26.21

41.66

u/l

1.29

133

700

Any mental disorder

1011

4089

1.24

8.98

1.3

32.85

35.25

u/l

0.23

883

3568

Osteonecrosis due to drugs

3.65

8.93

1.4

1.2

69.89

22.24

u/l

1.53

Early onset COPD

226

1470

1.55

8.89

1.3

31.38

36.28

u/l

0.34

191

1263

Pregnancy hypertension

236

1382

1.54

8.86

1.3

1.2

31.71

28.76

u/l

0.16

213

1210

Sequelae with surgical and medical care as external cause

200

1267

1.59

8.84

1.4

1.3

82.52

37.63

u/l

1.09

183

1102

Cystitis

721

3347

1.28

8.83

1.3

37.14

39.25

u/l

0.16

637

2894

Excessive, frequent and irregular menstruation

246

873

1.55

8.83

1.4

1.2

23.20

35.73

u/l

1.48

208

753

Other and unspecified drugs and medicaments

439

2.03

8.81

1.6

1.2

50.52

40.58

u/l

0.30

372

Disorders of eyelid, lacrimal system and orbit

761

4566

1.27

8.80

1.4

1.3

30.70

36.22

u/l

0.79

658

3966

Cardiac arrest

217

2.39

8.73

1.3

1.4

33.15

37.53

u/l

0.12

180

Zoster [herpes zoster]

179

1110

1.63

8.66

1.2

1.3

60.56

43.03

u/l

0.63

152

968

Disorders of lacrimal system

365

2611

1.40

8.65

1.4

1.2

34.07

38.14

u/l

0.27

312

2251

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

456

2.00

8.63

1.6

1.2

49.75

36.32

u/l

0.48

400

Symptoms and signs involving the nervous and musculoskeletal systems

512

3873

1.33

8.58

1.2

1.3

22.39

37.27

u/l

5.82

454

3349

Autoimmune diseases related-to ILD

738

4996

1.27

8.57

1.2

1.3

39.96

33.57

u/l

0.59

652

4341

Hyperplasia of prostate

405

1658

1.39

8.54

1.3

36.50

36.89

u/l

0.02

358

1449

Disorders of adult personality and behaviour

216

1406

1.54

8.46

1.2

1.3

34.61

31.16

u/l

0.16

190

1234

ILD medications: azathioprine

123

694

1.79

8.44

1.2

35.17

20.77

u/l

0.99

105

602

Bipolar affective disorders

148

880

1.69

8.42

1.2

1.3

33.72

34.69

u/l

0.03

125

771

Other diseases of lip and oral mucosa

342

2442

1.41

8.35

1.3

45.65

35.30

u/l

0.40

299

2117

Benign neoplasm of other and ill-defined parts of digestive system

174

1082

1.62

8.35

1.4

1.3

38.48

39.54

u/l

0.04

161

940

Disease of hard tissues of teeth, NOS

527

2074

1.33

8.34

1.4

1.3

33.99

32.39

u/l

0.08

455

1795

Acute pancreatitis

191

1215

1.58

8.32

1.2

1.3

25.63

37.09

u/l

1.32

165

1049

Candidiasis

123

698

1.78

8.30

1.4

1.2

39.43

39.51

u/l

0.00

105

607

Weight loss

105

569

1.87

8.27

1.6

1.2

24.01

41.67

u/l

1.43

490

Transient ischemic attack

505

3094

1.33

8.26

1.2

1.3

35.37

38.98

u/l

0.25

442

2661

Disturbances of skin sensation

222

1463

1.53

8.23

1.3

1.2

24.89

32.11

u/l

0.67

200

1272

Abnormal weight loss

531

1.89

8.07

1.7

1.2

24.30

42.77

u/l

1.39

458

Special screening examination for other diseases and disorders

511

1.89

7.96

1.1

1.2

25.10

27.10

u/l

0.09

423

Personality disorders

205

1341

1.54

7.89

1.2

1.3

34.27

30.04

u/l

0.19

179

1177

Vasculitis limited to skin, not elsewhere classified

138

2.82

7.88

1.2

82.73

42.90

u/l

0.42

122

Follow-up examination after treatment for conditions other than malignant neoplasms

329

1544

1.41

7.86

1.4

1.3

37.16

29.28

u/l

0.41

289

1318

Polyarthrosis

182

1076

1.58

7.83

1.3

1.2

44.52

39.93

u/l

0.09

161

923

Dermatitis and eczema

973

4949

1.22

7.80

1.3

41.16

33.16

u/l

0.74

862

4304

Substance use, excluding alcohol

176

1118

1.58

7.74

1.1

1.3

62.31

31.78

u/l

0.81

140

982

Other gastritis (incl. Duodenitis)

212

1404

1.52

7.74

1.5

1.3

49.56

35.29

u/l

0.74

192

1206

Intracranial injury

516

3753

1.30

7.70

1.3

38.81

35.71

u/l

0.18

458

3246

Irregular menses

268

1459

1.45

7.69

1.2

24.75

32.14

u/l

0.48

231

1278

Depression

802

4384

1.24

7.68

1.2

1.3

30.67

33.60

u/l

0.32

711

3823

Problems related to lifestyle

525

1.86

7.68

1.2

1.3

30.35

30.84

u/l

0.02

454

Other extrapyramidal and movement disorders in other diseases

219

1468

1.50

7.56

1.2

1.3

38.16

37.77

u/l

0.01

184

1276

Benign neoplasm: Colon, unspecified

252

1740

1.46

7.50

1.3

45.56

35.80

u/l

0.44

213

1503

Renal tubulo-interstitial disorders in diseases classified elsewhere

4.18

7.45

1.1

14.47

48.93

u/l

0.75

Pleural effusion

163

1028

1.60

7.44

1.5

1.3

56.91

40.52

u/l

0.97

144

890

Allergic asthma (mode), excluding more controls

155

943

1.62

7.43

1.2

43.62

22.54

u/l

0.59

138

825

ILD, hospital admissions 3, with pneumonia sepsis

497

1.87

7.37

1.3

1.2

61.11

24.13

u/l

0.87

425

Fracture of lumbar spine and pelvis

208

1387

1.51

7.32

1.4

1.3

36.13

41.94

u/l

0.37

175

1200

Fibrosis and cirrhosis of liver

458

1.90

7.22

1.3

46.83

44.19

u/l

0.07

391

Other embolism and thrombosis

126

751

1.69

7.21

1.6

1.2

64.98

41.20

u/l

0.48

113

646

Restless leg syndrome

124

736

1.70

7.21

1.2

38.70

40.01

u/l

0.02

106

639

External causes of morbidity and mortality

563

2186

1.29

7.20

1.3

1.2

44.42

28.77

u/l

1.27

489

1899

Rheumatism, unspecified

112

647

1.74

7.17

1.2

34.86

33.96

u/l

0.03

560

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

159

1007

1.59

7.16

1.3

42.22

38.77

u/l

0.15

146

873

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

109

626

1.76

7.15

1.6

1.2

57.19

23.21

u/l

0.91

532

Other disorders of veins

335

2436

1.37

7.15

1.2

1.3

45.36

33.02

u/l

0.61

284

2098

Spondylosis

488

3062

1.30

7.14

1.4

1.3

37.51

33.47

u/l

0.20

437

2641

Mental and behavioural disorders due to opioids

151

2.62

7.14

1.1

1.2

106.12

38.87

u/l

0.48

131

Injury, poisoning and certain other consequences of external causes

464

1757

1.33

7.14

1.2

41.09

31.28

u/l

0.65

403

1509

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

101

568

1.80

7.12

1.4

1.2

100.98

39.84

u/l

1.24

495

Paracetamol or NSAID medication

147

445

1.67

7.12

1.2

41.30

35.39

u/l

0.18

131

374

Functional dyspepsia

220

1495

1.48

7.11

1.5

1.2

38.03

34.15

u/l

0.13

195

1293

Chronic rhinitis, nasopharyngitis and pharyngitis

255

1782

1.44

7.10

1.2

1.3

26.10

30.56

u/l

0.48

233

1542

Other and unspecified vasculitis limited to skin

129

2.78

7.09

1.2

89.37

45.10

u/l

0.42

114

Anxiety disorders, excluding more controls

686

3570

1.25

7.09

1.3

30.66

32.56

u/l

0.15

597

3116

Status post-ami

264

1407

1.44

7.08

1.2

1.4

37.53

47.97

u/l

0.78

233

1197

Oter anti-inflammatory and antirheumatic agents, non-steroids

229

851

1.49

7.02

1.3

1.2

39.95

41.18

u/l

0.04

203

729

Other abnormal uterine and vaginal bleeding

163

737

1.59

7.01

1.3

1.2

30.35

31.64

u/l

0.08

141

629

Redundant prepuce, phimosis and paraphimosis

205

1366

1.50

6.97

1.4

1.3

20.35

34.11

u/l

2.69

181

1200

Menorrhagia

223

831

1.49

6.92

1.4

1.2

26.40

33.43

u/l

0.68

188

713

Unspecified fall

438

3302

1.31

6.89

1.2

1.3

44.57

35.11

u/l

0.42

380

2853

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

193

1280

1.51

6.88

1.3

1.2

23.20

33.40

u/l

0.64

161

1133

Squamous cell neoplasms and carcinomas of the skin

474

1.86

6.80

1.3

1.2

60.99

22.08

u/l

2.08

396

Other reaction to severe stress, and adjustment disorders

261

1847

1.42

6.80

1.4

1.2

32.44

31.99

u/l

0.02

233

1639

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

25.75

6.80

1.8

1.0

125.28

11.64

u/l

—

Carcinoma in situ of skin of other and unspecified parts of face

556

1.79

6.75

1.3

1.2

59.17

40.95

u/l

0.36

479

Disorders of synovium and tendon

437

2932

1.31

6.72

1.2

1.3

34.01

34.47

u/l

0.02

394

2535

Rotator cuff syndrome

550

3103

1.28

6.72

1.3

39.51

35.44

u/l

0.20

489

2679

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

121

729

1.67

6.62

1.5

1.2

62.00

22.95

u/l

2.42

108

616

Injuries to the shoulder and upper arm

751

4946

1.23

6.60

1.3

35.84

33.62

u/l

0.18

656

4304

Conductive and sensorineural hearing loss

724

3970

1.23

6.58

1.3

41.83

33.48

u/l

0.65

626

3458

Other respiratory diseases principally affecting the interstitium

181

1205

1.51

6.54

1.2

1.3

52.65

38.49

u/l

0.40

156

1036

Emphysema

445

1.87

6.54

1.4

1.2

37.69

47.18

u/l

0.40

381

Secondary uncertain malignant neoplasm

124

757

1.65

6.52

1.5

1.2

109.39

22.84

u/l

2.01

108

643

Other disorders of bone

165

1077

1.54

6.52

1.2

1.3

21.91

35.57

u/l

1.61

137

932

Azathioprine

123

751

1.65

6.45

1.2

35.17

35.21

u/l

0.00

105

652

Sciatica+with lumbago

425

3005

1.31

6.45

1.3

35.42

32.32

u/l

0.17

386

2600

Non-follicular lymphoma

106

624

1.72

6.43

1.3

92.23

43.06

u/l

1.62

542

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

142

901

1.59

6.39

2.7

1.2

91.31

22.76

u/l

1.73

122

769

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

113

599

1.69

6.38

1.2

31.69

36.81

u/l

0.09

523

Sensorineural hearing loss

695

3832

1.23

6.37

1.3

35.95

34.18

u/l

0.11

601

3334

Acute pancreatitis (for exclusion)

191

1294

1.49

6.35

1.2

1.3

25.63

39.09

u/l

1.61

165

1120

Other arthrosis

469

2525

1.29

6.29

1.3

37.32

31.62

u/l

0.30

419

2188

Impotence

359

1.95

6.29

1.2

1.3

25.28

48.94

u/l

1.00

319

Anxiety (asthma-related co-morbidities)

439

2625

1.30

6.23

1.2

27.59

32.94

u/l

0.35

388

2312

Malignant neoplasm of kidney, except renal pelvis

540

1.76

6.23

1.6

1.1

61.24

22.67

u/l

0.88

468

COPD, hospital admissions 1, only main diagnosis

339

2171

1.34

6.22

1.3

29.75

37.91

u/l

1.16

283

1867

Hypertrophic cardiomyopathy

252

2.14

6.19

1.2

55.70

43.00

u/l

0.18

213

Other benign neoplasms of skin

322

2399

1.35

6.19

1.3

49.77

34.03

u/l

0.71

276

2070

Other peripheral vascular diseases

403

1.88

6.18

1.2

24.76

33.65

u/l

0.60

350

Poisoning by drugs, medicaments and biological substances

179

1205

1.49

6.13

1.2

1.3

28.23

32.97

u/l

0.22

148

1058

Specific personality disorders

169

1125

1.51

6.11

1.2

1.3

35.18

31.41

u/l

0.15

150

989

Abnormal findings on diagnostic imaging of other body structures

124

771

1.62

6.09

1.3

1.2

39.35

40.79

u/l

0.05

111

667

Disturbance of activity and attention

327

1.96

6.08

1.1

1.3

11.33

31.59

u/l

1.29

286

Mixed hyperlipidaemia

234

2.17

6.08

1.2

1.3

26.05

52.01

u/l

0.91

202

Other systemic involvement of connective tissue

230

1629

1.42

6.05

1.2

36.66

37.41

u/l

0.03

205

1412

Falls/tendency to fall

930

3895

1.20

6.03

1.3

36.59

31.73

u/l

0.46

817

3387

Injuries to the thorax

418

3243

1.29

6.00

1.4

1.3

50.70

33.66

u/l

0.89

362

2818

In situ neoplasms

320

2397

1.34

5.95

1.2

1.3

49.60

34.80

u/l

0.89

284

2073

Allergic asthma (mode)

155

997

1.53

5.94

1.2

43.62

21.03

u/l

0.66

138

876

Right bundle-branch block

166

2.39

5.92

1.1

1.3

35.54

35.75

u/l

0.00

140

Other CVD

191

1316

1.46

5.86

1.3

35.97

41.30

u/l

0.35

171

1125

Thoracic aortic aneurysm

151

993

1.53

5.85

1.4

34.88

39.73

u/l

0.27

130

864

Malignant neoplasm of urinary organs

588

1.70

5.85

1.6

1.2

58.63

22.82

u/l

0.86

505

Exposure to other specified factors

616

4599

1.23

5.84

1.3

36.42

34.06

u/l

0.14

535

4018

Other infectious diseases

528

1.74

5.84

1.2

118.77

43.15

u/l

1.64

452

Migraine without aura

108

655

1.66

5.84

1.3

1.2

18.07

29.94

u/l

1.55

103

559

Soft tissue disorders related to use, overuse and pressure

234

1676

1.40

5.79

1.2

1.3

24.50

38.72

u/l

2.31

213

1441

Fracture of rib(s), sternum and thoracic spine

284

2100

1.36

5.78

1.3

53.85

36.02

u/l

0.57

243

1813

Ovarian cyst

213

852

1.45

5.75

1.3

1.2

39.14

32.53

u/l

0.22

191

734

Injuries to the hip and thigh

428

3035

1.28

5.69

1.3

39.68

35.68

u/l

0.19

381

2607

Thyrotoxicosis, other and/or unspecified

151

999

1.52

5.67

1.3

1.2

30.09

37.10

u/l

0.29

138

858

Neurotic, stress-related and somatoform disorders

710

4100

1.21

5.63

1.3

1.2

33.16

32.63

u/l

0.03

617

3589

Other disorders of adrenal gland

215

2.17

5.63

1.3

1.2

21.42

35.43

u/l

0.74

183

Hypotension

166

1123

1.49

5.62

1.3

33.49

43.84

u/l

0.74

147

957

Substance abuse, excluding more controls

484

3282

1.26

5.60

1.2

1.3

40.78

34.25

u/l

0.36

403

2875

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

252

1593

1.38

5.58

1.3

1.2

30.54

29.17

u/l

0.07

228

1383

Anxiety disorders

718

4138

1.21

5.58

1.3

1.2

32.85

32.67

u/l

0.01

625

3622

Congenital malformations of the urinary system

276

2.02

5.58

1.2

28.69

31.86

u/l

0.09

239

Hyperkinetic disorders

358

1.87

5.57

1.1

1.3

10.98

37.08

u/l

1.69

314

Acetic acid derivatives and related substances

255

951

1.40

5.57

1.2

31.65

41.49

u/l

0.65

223

817

Umbilical hernia

250

1824

1.38

5.56

1.3

32.04

32.13

u/l

0.00

224

1586

Sequelae of cerebrovascular disease

342

2249

1.32

5.56

1.3

32.94

38.49

u/l

0.54

293

1924

Tobacco use

263

2.04

5.55

1.2

40.26

37.35

u/l

0.07

224

Emotionally unstable personality disorder

469

1.76

5.53

1.2

1.3

42.67

26.18

u/l

0.42

403

ILD-related respiratory insufficiency

204

2.20

5.53

1.2

1.3

78.66

51.52

u/l

0.23

175

Other viral diseases, not elsewhere classified

146

962

1.52

5.53

1.5

1.3

84.50

38.56

u/l

0.92

128

844

Congenital malformations of the urinary system

291

1.98

5.51

1.2

28.11

37.06

u/l

0.29

252

Superficial injury of lower leg

200

1408

1.43

5.48

1.4

1.3

37.68

35.92

u/l

0.07

179

1236

Undetermined asthma, excluding more controls

583

1.67

5.46

1.6

1.3

68.30

26.97

u/l

0.65

503

Use of pramipexole

196

1378

1.43

5.43

1.2

1.3

29.16

40.96

u/l

1.07

161

1202

Other disorders of glucose regulation and pancreatic internal secretion

443

1.78

5.42

1.6

1.2

55.32

40.93

u/l

0.18

386

Stomatitis and related lesions

155

1045

1.49

5.35

1.3

57.98

38.54

u/l

0.62

140

909

Noninfectious colitis NAS

117

743

1.59

5.32

1.3

1.2

71.92

44.93

u/l

0.41

107

645

Benign neoplasm: Stomach

589

1.66

5.31

1.6

1.2

42.03

40.88

u/l

0.03

501

Recurrent or chronic depression

301

1589

1.34

5.29

1.2

26.80

30.54

u/l

0.25

261

1394

Diagnoses used for exclusion with ILD

231

1679

1.38

5.29

1.3

38.60

37.05

u/l

0.06

198

1443

severe traumatic brain injury, does not include concussion

210

1504

1.40

5.25

1.3

44.76

40.72

u/l

0.13

179

1285

Other symptoms and signs involving the circulatory and respiratory systems

304

1.93

5.21

1.2

20.32

55.15

u/l

1.67

255

Inflammatory diseases of female pelvic organs

363

2063

1.30

5.20

1.3

1.2

29.93

35.46

u/l

0.34

311

1802

Other diseases of pancreas

479

1.73

5.20

1.2

21.41

43.57

u/l

2.15

417

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

137

879

1.52

5.18

1.1

1.3

31.90

38.98

u/l

0.38

122

766

Leiomyoma of uterus

394

1739

1.29

5.13

1.2

36.55

31.89

u/l

0.25

343

1513

Hodgkin lymphoma, hilmo

140

2.40

5.10

1.2

78.96

36.32

u/l

0.64

120

Other anxiety disorders

316

2091

1.31

5.10

1.2

31.08

33.88

u/l

0.12

279

1858

Amyloidosis

128

2.48

5.10

1.4

1.2

30.25

43.81

u/l

0.41

109

Bronchitis, not specified as acute or chronic

459

1.74

5.10

1.2

1.3

72.55

35.35

u/l

0.65

395

Disorders of vitreous body and globe

441

3383

1.26

5.06

1.3

56.43

35.67

u/l

1.44

381

2930

Paralytic ileus and intestinal obstruction

221

1606

1.38

5.06

1.2

1.3

41.07

37.68

u/l

0.10

189

1372

Amenorrhoea

178

2.21

5.06

1.1

1.2

66.10

19.29

u/l

0.52

154

Unspecified privation

100

620

1.63

5.06

1.2

37.20

43.46

u/l

0.15

541

Benign neoplasm of other and unspecified endocrine glands

121

785

1.55

5.05

1.2

1.3

26.01

40.17

u/l

1.17

108

685

Other and unspecified disorders of skin and subcutaneous tissue

322

1.88

5.04

1.3

1.2

24.09

35.39

u/l

0.97

272

Disorders of vitreous body

428

3294

1.26

5.02

1.3

51.11

35.85

u/l

1.06

370

2855

N06DA Anticholinesterases

183

2027

0.71

5.02

1.3

39.91

39.68

u/l

0.01

146

1743

Use of anticholinesterases

183

2027

0.71

5.02

1.3

39.91

39.68

u/l

0.01

146

1743

Pre-eclampsia or eclampsia

120

777

1.55

5.02

1.4

1.2

48.20

28.11

u/l

0.84

107

678

Diabetic retinopathy, strict definition

206

1309

1.40

4.99

1.1

1.2

37.22

28.77

u/l

0.30

180

1159

Other diseases of intestine

131

867

1.52

4.98

1.2

1.3

32.48

38.70

u/l

0.31

120

749

All anxiety disorders

443

2794

1.26

4.98

1.2

27.38

32.46

u/l

0.34

392

2473

Other disorders of penis

595

1.63

4.87

1.4

1.2

23.49

40.60

u/l

1.01

517

ILD, hospital admissions

148

1010

1.48

4.87

1.2

1.3

44.29

41.50

u/l

0.06

131

871

Pre-eclampsia or poor fetal growth

150

1021

1.47

4.86

1.3

1.2

48.62

27.17

u/l

0.90

136

899

Myocardial infarction, with ST-elevation

176

1242

1.43

4.84

1.2

1.3

32.47

38.87

u/l

0.42

156

1059

Other interstitial pulmonary diseases

150

1028

1.47

4.83

1.2

1.3

43.84

39.48

u/l

0.11

133

889

Chronic sinusitis

332

2577

1.29

4.83

1.4

1.3

30.78

32.17

u/l

0.09

300

2224

Hypoparathyroidism

176

2.19

4.81

1.3

1.2

20.86

21.52

u/l

0.04

151

Congenital malformations, deformations and chromosomal abnormalities

426

3247

1.25

4.80

1.3

42.56

31.22

u/l

0.61

382

2846

Fissure and fistula of anal and rectal regions

201

1453

1.39

4.80

1.3

23.51

34.47

u/l

1.58

174

1257

Hypoplasia of dental enamel

9.17

4.79

2.6

1.4

25.26

24.92

u/l

—

Deforming dorsopathies

218

1597

1.37

4.79

1.6

1.2

33.34

32.29

u/l

0.07

199

1375

Unspecified dementia

670

0.48

4.79

1.1

1.2

59.85

46.14

u/l

0.26

565

Other bursopathies

117

764

1.54

4.76

1.2

22.13

45.01

u/l

2.76

103

657

Localized swelling, mass and lump of skin and subcutaneous tissue

260

1959

1.33

4.76

1.4

1.3

42.76

31.58

u/l

0.50

230

1690

Other or ill-defined heart diseases

251

1.97

4.74

1.1

1.3

14.28

41.52

u/l

1.62

208

Other disorders starting during childhood or adolecense, excluding more controls

2.83

4.74

1.3

1.2

12.43

43.41

u/l

0.56

Urticaria and erythema

261

1968

1.33

4.73

1.3

1.2

30.42

34.18

u/l

0.17

229

1716

Interstitial lung disease endpoints

150

1033

1.46

4.73

1.2

1.3

43.84

41.31

u/l

0.06

133

890

Interstitial lung disease

150

1033

1.46

4.73

1.2

1.3

43.84

41.31

u/l

0.06

133

890

Ascites

455

1.71

4.72

1.2

1.3

54.19

42.17

u/l

0.40

391

Cholangitis (primary sclerosing, PSC)

337

1.83

4.71

1.2

56.31

42.64

u/l

0.25

288

Benign neoplasm: Caecum

107

689

1.57

4.66

1.3

1.2

30.11

41.37

u/l

0.81

598

Persistent mood disorders

152

1052

1.45

4.65

1.3

27.49

35.49

u/l

0.55

128

916

Abscess of anal and rectal regions

472

1.69

4.65

1.2

1.3

21.10

46.25

u/l

1.97

411

ILD, hospital admissions 1, main diag only

133

898

1.49

4.64

1.2

1.3

47.55

40.89

u/l

0.15

116

777

Diseases of peritoneum

588

1.61

4.62

1.2

19.79

40.02

u/l

2.60

508

Subjective visual disturbances

201

1463

1.38

4.62

1.2

30.32

35.44

u/l

0.37

175

1271

Persons encountering health services for specific procedures, not carried out

420

1.73

4.62

1.3

1.2

98.90

29.76

u/l

0.90

358

Meniscus derangement

479

2619

1.24

4.58

1.2

1.3

25.35

31.44

u/l

0.69

404

2273

Other and unspecified types of non-Hodgkin lymphoma, hilmo

241

1.98

4.57

1.3

1.2

72.67

44.95

u/l

0.42

209

Pre-eclampsia

109

707

1.55

4.56

1.4

1.2

50.26

26.89

u/l

0.93

617

Retinal haemorrhage

135

2.34

4.56

1.2

83.64

49.91

u/l

0.46

120

Hydronephrosis

582

1.61

4.56

1.6

1.2

51.60

37.90

u/l

0.23

499

Abnormal results of function studies

467

1.68

4.56

1.4

1.2

55.24

41.24

u/l

0.20

402

Necrosis of pulp, including avohilmo

445

3598

1.24

4.53

1.3

32.44

30.06

u/l

0.19

382

3157

Arterial embolism and thrombosis

334

1.81

4.53

1.1

1.2

67.08

51.00

u/l

0.16

291

Other follicular disorders

349

1.79

4.51

1.2

48.70

38.88

u/l

0.12

299

Abnormalities of gait and mobility

117

776

1.52

4.47

1.2

1.3

22.72

41.65

u/l

2.43

669

Benign neoplasm: Transverse colon

107

700

1.54

4.37

1.5

1.3

65.93

42.47

u/l

0.46

607

Aortic aneurysm

225

1651

1.34

4.36

1.4

1.3

32.71

40.09

u/l

0.64

187

1424

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

126

825

1.49

4.36

1.1

1.3

33.34

38.34

u/l

0.23

111

720

Familial hypercholesterolemia

136

935

1.46

4.35

1.2

1.4

35.85

40.77

u/l

0.23

121

809

Other infectious diseases

466

1.67

4.35

1.2

129.72

40.63

u/l

1.70

398

Oxicams

216

901

1.37

4.33

1.4

1.2

25.05

43.17

u/l

2.04

185

773

L02BA Anti-estrogens

796

0.52

4.33

1.3

1.2

18.43

25.64

u/l

0.91

694

Acute generalized exanthematous pustulosis

218

2.00

4.33

1.3

1.2

48.45

27.00

u/l

0.39

187

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

424

3344

1.23

4.28

1.2

1.3

38.78

33.46

u/l

0.33

375

2909

Diseases of external ear

279

2159

1.30

4.26

1.6

1.3

30.88

33.74

u/l

0.15

235

1874

Budesonide

106

696

1.53

4.24

1.6

1.2

72.85

37.51

u/l

0.77

597

Other retinal artery occlusion

127

2.33

4.24

1.1

1.2

62.32

61.24

u/l

0.01

110

Thyroiditis, ILD-related definition

523

1.62

4.23

1.2

30.94

37.37

u/l

0.28

448

Open wound of forearm

539

1.61

4.23

1.2

46.97

51.51

u/l

0.06

473

Undefined dementia

680

0.51

4.23

1.1

1.2

57.71

49.02

u/l

0.16

573

Other symptoms and signs involving cognitive functions and awareness

399

2934

1.24

4.21

1.3

36.24

38.19

u/l

0.12

358

2520

Injuries to unspecified part of trunk, limb or body region

580

1.58

4.18

1.2

17.24

47.23

u/l

3.34

496

Generalized anxiety disorder

635

1.55

4.16

1.2

12.24

30.03

u/l

3.05

552

Injuries to the knee and lower leg

1001

4839

1.15

4.15

1.3

27.89

36.44

u/l

1.35

858

4231

Migraine with aura and triptan purchases

565

1.58

4.14

1.3

25.55

28.73

u/l

0.08

490

Congenital malformations, deformations and chromosomal abnormalities

469

3556

1.22

4.13

1.3

41.80

32.61

u/l

0.51

421

3120

Anti-inflammatory and antirheumatic products, non-steroids

256

974

1.33

4.12

1.2

43.41

40.65

u/l

0.09

224

839

Degeneration of macula and posterior pole

429

2781

1.23

4.12

1.4

1.3

49.34

39.48

u/l

0.47

362

2391

Gestational [pregnancy-induced] hypertension

121

820

1.48

4.11

1.2

36.22

28.25

u/l

0.28

110

719

Benign neoplasm: Rectum, anus and anal canal

184

1349

1.37

4.11

1.3

47.90

38.42

u/l

0.31

156

1167

Undetermined asthma

629

1.55

4.11

1.6

1.2

68.30

25.82

u/l

0.67

543

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

428

1.67

4.09

2.2

1.2

26.06

39.17

u/l

0.89

368

Benign neoplasm: Adrenal gland

459

1.65

4.09

1.3

1.2

28.84

38.06

u/l

0.40

400

Other or unspecified ileus, impaction or obstruction

159

1139

1.40

4.07

1.2

1.3

42.55

37.23

u/l

0.13

135

974

Crohn disease

102

671

1.53

4.07

1.2

49.85

41.46

u/l

0.15

584

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

193

1427

1.36

4.07

1.3

23.20

31.35

u/l

0.50

161

1257

Molar incisor enamel hypoplasia, with caries

8.13

4.06

2.8

1.5

11.04

39.59

u/l

—

Neuromuscular dysfunction of bladder

522

1.60

4.05

1.1

1.2

30.07

40.26

u/l

0.42

453

Coxarthrosis, primary

536

3789

1.20

4.04

1.3

47.42

35.71

u/l

0.75

465

3266

Use of other anti-dementia drugs

140

1635

0.71

4.04

1.3

27.00

40.86

u/l

2.11

117

1395

Use of memantine

140

1635

0.71

4.04

1.3

27.00

40.86

u/l

2.11

117

1395

Urticaria

204

1526

1.34

3.99

1.3

27.05

33.45

u/l

0.25

179

1334

Benign neoplasm: Ascending colon

131

912

1.45

3.97

1.7

1.3

51.57

39.77

u/l

0.30

114

794

Open wound of head

469

3739

1.21

3.97

1.3

31.09

34.36

u/l

0.24

410

3235

Somatoform disorder

123

846

1.46

3.96

1.2

42.98

35.36

u/l

0.16

104

734

Alzheimer’s disease, strict definition

126

1483

0.70

3.94

1.4

1.3

35.18

40.81

u/l

0.31

103

1260

Internal derangement of knee

296

2323

1.27

3.92

1.2

1.3

22.08

30.72

u/l

1.97

259

2017

Medicines for HER+ breast cancer

143

1890

0.71

3.91

1.2

28.24

35.42

u/l

0.58

119

1639

Peritonsillar abscess

152

1089

1.40

3.91

1.2

27.85

30.92

u/l

0.12

134

948

Postmenopausal bleeding

185

719

1.38

3.90

1.3

1.2

39.48

32.49

u/l

0.17

169

614

Degenerative diseases of the nervous system

203

1974

0.75

3.87

1.3

41.36

41.34

u/l

0.00

174

1696

Retinal vascular disorders

114

777

1.48

3.87

1.3

45.13

45.96

u/l

0.02

100

680

Other viral diseases, not elsewhere classified

182

1338

1.36

3.86

1.4

1.3

70.13

33.49

u/l

0.93

162

1175

Recurrent aphthous stomatitis , including avohilmo

109

737

1.49

3.84

1.3

1.2

66.75

39.76

u/l

0.64

100

639

Other enthesopathies

225

1718

1.31

3.84

1.2

1.3

42.09

35.32

u/l

0.16

202

1482

Complications of internal orthopaedic prosthetic devices, implants and grafts

192

1435

1.34

3.82

1.4

1.2

49.97

36.39

u/l

0.34

165

1226

L02BG Aromatase inhibitors

113

1630

0.69

3.81

1.2

31.06

34.74

u/l

0.20

1421

Other disorders of the musculoskeletal system and connective tissue

128

895

1.44

3.80

1.7

1.3

45.14

39.51

u/l

0.12

117

780

Heartburn

586

1.55

3.80

1.3

18.63

40.81

u/l

2.46

503

Superficial injury of head

191

1427

1.34

3.79

1.2

1.3

35.38

37.02

u/l

0.05

175

1217

Cervical disc disorders

299

2372

1.26

3.79

1.3

21.57

33.69

u/l

3.48

259

2048

Dermatitis due to substances taken internally

265

1.83

3.78

1.3

1.2

46.06

43.93

u/l

0.03

221

Vitamin B12 deficiency anaemia

611

1.53

3.77

1.3

1.2

99.52

34.25

u/l

1.01

520

Diabetic maculopathy

144

970

1.41

3.77

1.2

17.80

26.45

u/l

1.51

130

856

Collagenous colitis

485

1.60

3.76

1.2

43.17

40.59

u/l

0.05

417

Non-selective monoamine reuptake inhibitors

300

2296

1.26

3.75

1.2

1.3

24.09

35.59

u/l

2.22

253

1988

Retinal vascular occlusion

112

766

1.47

3.75

1.3

45.74

46.32

u/l

0.02

670

Fitting and adjustment of other devices

303

2174

1.26

3.74

1.4

1.2

45.12

32.89

u/l

0.45

261

1841

Diabetic retinopathy

393

1995

1.23

3.73

1.2

39.01

30.17

u/l

0.56

345

1751

Benign neoplasm: Sigmoid colon

172

1271

1.36

3.70

1.2

1.3

34.34

38.06

u/l

0.24

154

1103

Pain in thoracic spine

116

801

1.46

3.69

1.2

35.01

32.76

u/l

0.08

109

689

Cervicalgia

163

1196

1.37

3.66

1.4

1.2

24.59

34.07

u/l

1.20

140

1021

Diabetes mellitus in pregnancy

132

591

1.43

3.64

1.2

1.3

20.77

36.71

u/l

0.88

118

534

Gestational diabetes (for exclusion)

150

749

1.40

3.63

1.2

16.32

31.43

u/l

1.72

133

673

Viral hepatitis

358

1.69

3.63

1.3

1.2

49.03

38.01

u/l

0.20

304

Diplopia

111

764

1.46

3.61

1.3

39.74

44.24

u/l

0.08

663

Acute appendicitis

547

4329

1.18

3.60

1.2

1.3

41.61

31.88

u/l

0.60

489

3774

264

1806

1.28

3.60

1.3

43.09

39.02

u/l

0.26

216

1567

Superficial injury of abdomen, lower back and pelvis

116

808

1.44

3.54

1.2

31.72

42.29

u/l

0.52

104

704

Chronic laryngitis and laryngotracheitis

111

767

1.46

3.54

1.2

1.3

27.82

34.20

u/l

0.37

653

SLE (Finngen)

151

2.08

3.53

1.1

1.2

125.97

18.41

u/l

1.11

130

KRA_PSY_EATING, excluding more controls

177

1.98

3.53

1.1

1.2

35.47

31.27

u/l

0.06

149

Other complications of surgical and medical care, not elsewhere classified

509

1.56

3.52

1.2

49.26

35.38

u/l

0.50

441

Otalgia

370

1.66

3.49

1.4

1.2

36.53

37.37

u/l

0.01

319

Dermatophytosis

117

820

1.44

3.47

1.2

1.3

28.28

42.31

u/l

1.21

103

713

Arterial embolism and thrombosis of lower extremity artery

201

1.91

3.45

1.2

32.10

46.48

u/l

0.53

177

Polyuria

195

1485

1.32

3.45

1.2

1.3

28.19

40.07

u/l

1.25

163

1297

Mixed and other personality disorders

356

1.67

3.44

1.3

1.2

33.24

34.46

u/l

0.03

305

Other abnormalities of plasma proteins

2.55

3.41

1.1

51.21

39.88

u/l

0.20

Suicide or other Intentional self-harm

174

1306

1.34

3.40

1.2

1.3

24.71

31.76

u/l

0.36

143

1148

Diseases of salivary glands

243

1909

1.28

3.39

1.2

1.3

24.71

33.23

u/l

1.02

203

1668

Malignant neoplasm of bladder, including Hilmo

107

737

1.45

3.37

1.1

1.2

29.05

21.59

u/l

0.47

622

Disorders of oesophagus in diseases classified elsewhere

108

2.26

3.35

1.1

1.2

36.89

24.41

u/l

0.38

Benign neoplasm: Rectum

163

1216

1.35

3.34

1.3

37.06

38.16

u/l

0.05

138

1055

Convulsions, not elsewhere classified

167

1233

1.34

3.34

1.3

30.36

27.54

u/l

0.18

142

1053

Excessive vomiting in pregnancy

247

1.79

3.31

1.2

12.35

18.33

u/l

1.36

208

Follicular cysts of skin and subcutaneous tissue

149

1098

1.36

3.31

1.2

1.3

42.01

36.25

u/l

0.17

130

952

Solid cancers, helper endpoint

663

3376

1.16

3.30

1.4

1.2

46.87

19.79

u/l

3.73

573

2933

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

112

787

1.43

3.29

1.2

1.3

30.92

34.97

u/l

0.11

679

Maternal care for other conditions predominantly related to pregnancy

586

1.49

3.28

1.2

30.93

31.06

u/l

0.00

518

Post-traumatic stress disorder

270

1.75

3.28

1.9

1.2

14.45

23.18

u/l

0.88

230

Other disorders starting during childhood or adolescence

2.31

3.26

1.3

1.6

12.43

38.44

u/l

0.63

Hepatic failure, not elsewhere classified

213

1.85

3.24

1.7

1.3

90.38

42.38

u/l

0.65

180

Crohn's disease of small intestine

324

1.68

3.24

1.2

68.79

41.86

u/l

0.28

277

Intestinal adhesions without obstruction

472

1.56

3.24

1.3

36.52

39.31

u/l

0.06

403

Injuries to the wrist and hand

811

4930

1.14

3.24

1.2

1.3

36.21

34.95

u/l

0.08

710

4306

Viral warts

472

1.56

3.24

1.2

25.80

38.21

u/l

0.71

406

Mental and behavioural disorders due to psychoactive substance use

502

3951

1.18

3.23

1.2

1.3

40.21

32.45

u/l

0.48

418

3457

Mental and behavioural disorders due to use of other stimulants, including caffeine

103

2.26

3.23

1.1

1.2

19.52

36.23

u/l

0.33

Pilonidal cyst

433

1.58

3.22

1.2

17.81

37.59

u/l

1.50

370

Malignant neoplasm of lip, including Hilmo

2.92

3.22

3.2

1.2

32.03

21.69

u/l

0.37

Polymyalgia rheumatica

120

858

1.41

3.22

1.2

1.3

31.94

43.72

u/l

0.98

109

749

Alzheimer’s disease (Late onset)

118

1379

0.72

3.22

1.4

1.3

36.53

41.57

u/l

0.25

1169

Primary gonarthrosis, bilateral

442

3182

1.19

3.20

1.4

1.3

32.25

36.98

u/l

0.41

389

2748

Trochanteric bursitis

103

717

1.44

3.20

1.2

23.20

38.47

u/l

1.45

617

Appendicitis, broad definition

582

4528

1.16

3.19

1.2

1.3

41.13

32.01

u/l

0.59

520

3948

Other symptoms and signs involving the nervous and musculoskeletal systems

317

2586

1.23

3.19

1.2

1.3

21.07

36.13

u/l

3.99

289

2240

Paralytic strabismus

427

1.58

3.18

1.3

1.2

56.23

41.77

u/l

0.17

368

Other viral hepatitis

288

1.71

3.18

1.3

1.2

53.79

34.71

u/l

0.32

244

Phobic anxiety disorders

529

1.52

3.18

1.2

47.10

25.37

u/l

0.61

460

Polyp of the female genital tract

185

804

1.33

3.18

1.3

1.2

41.27

30.81

u/l

0.27

166

690

Injury of unspecified body region

427

1.58

3.17

1.2

16.96

40.06

u/l

2.44

361

Visual impairment including blindness (binocular or monocular)

357

1.64

3.17

1.2

38.92

38.29

u/l

0.02

308

Artificial joint operation, meniscal resection

803

4577

1.14

3.17

1.4

1.3

30.83

35.05

u/l

0.42

708

3968

Fracture of femur

231

1649

1.27

3.17

1.3

33.81

41.15

u/l

0.58

209

1403

Poisoning by medicine

147

1089

1.35

3.16

1.2

1.3

29.60

34.10

u/l

0.17

121

956

Propionic acid derivatives

247

974

1.28

3.16

1.2

44.80

40.65

u/l

0.15

215

839

Later onset COPD

265

1687

1.26

3.16

1.2

1.4

32.28

40.08

u/l

0.78

225

1448

Left ventricular outflow tract obstruction (LVOTO), broad definition

588

1.49

3.15

1.3

26.34

43.07

u/l

1.03

507

Drug-induced cataract

131

2.10

3.15

1.3

1.2

64.28

15.05

u/l

0.86

113

Open wound of ankle and foot

580

1.49

3.15

1.2

27.46

41.41

u/l

0.72

502

Non-Hodgkin lymphoma, all

237

1.79

3.15

1.3

1.1

49.55

23.37

u/l

0.66

207

Fibroblastic disorders

195

1506

1.30

3.15

1.4

1.3

50.97

35.49

u/l

0.37

172

1290

Suppurative and unspecified otitis media

229

1596

1.27

3.14

1.2

1.3

43.48

35.29

u/l

0.28

198

1396

Disorders of sclera, cornea, iris and ciliary body

431

3629

1.19

3.13

1.4

1.3

42.09

33.25

u/l

0.64

381

3152

Haemorrhoids and perianal venous thrombosis

256

2041

1.26

3.13

1.4

1.3

24.24

35.66

u/l

2.12

227

1747

Aortic valve malfunction, age under 60 years

557

1.50

3.12

1.3

26.32

44.31

u/l

1.08

480

Other noninflammatory disorders of uterus, except cervix

143

706

1.37

3.12

1.2

37.84

32.97

u/l

0.16

126

601

Covid-19 suspected case

148

1101

1.35

3.11

1.2

1.3

41.96

33.01

u/l

0.30

132

954

Malignant neoplasm of breast, HER-positive

116

1253

0.72

3.10

1.2

30.54

22.06

u/l

0.65

1083

Secondary sideroblastic anaemia

7.85

3.09

1.3

1.1

70.28

12.64

u/l

—

Alzheimer disease, including avohilmo

219

1957

0.79

3.09

1.3

39.23

41.47

u/l

0.11

189

1674

Decubitus ulcer and pressure area

352

1.63

3.09

1.2

62.83

48.15

u/l

0.27

300

Appendectomy

481

3913

1.18

3.07

1.2

1.3

35.05

32.50

u/l

0.15

430

3414

Superficial injury of hip and thigh

121

874

1.39

3.06

1.2

68.41

45.11

u/l

0.37

107

750

Myocardial infarction, unclassifiable

204

1418

1.29

3.06

1.3

35.31

41.58

u/l

0.37

172

1211

Cerebral cysts

285

1.70

3.02

1.4

1.2

42.83

39.00

u/l

0.07

241

Thyrotoxicosis

179

1375

1.31

3.02

1.2

45.22

35.52

u/l

0.22

162

1200

Other diseases of oesophagus

553

1.49

3.02

1.3

1.2

46.06

36.09

u/l

0.37

476

Malignant neoplasm of pancreas, including Hilmo

504

0.51

3.01

1.1

1.2

18.20

22.86

u/l

0.40

437

Hypoglycaemia, other or unspecified

355

1.62

2.99

1.7

1.2

70.30

42.84

u/l

0.28

309

Transport accidents

346

2464

1.21

2.98

1.2

24.52

31.77

u/l

0.96

309

2141

Diseases of appendix

585

4566

1.16

2.97

1.2

1.3

41.58

32.08

u/l

0.63

523

3982

Papilloedema, unspecified

101

2.21

2.95

1.0

1.1

26.93

17.69

u/l

0.28

Other sleep disorders

598

1.46

2.92

1.2

21.86

41.77

u/l

1.86

517

Dementia

278

2348

0.81

2.92

1.3

40.68

43.11

u/l

0.10

235

2018

Schizophrenia or delusion, excluding more controls

213

1664

1.27

2.92

1.2

1.3

28.85

31.93

u/l

0.15

179

1445

Substance abuse

484

3891

1.17

2.91

1.2

1.3

40.78

32.26

u/l

0.52

403

3402

Acute appendicitis, no complications

412

3464

1.19

2.91

1.2

1.3

35.13

30.00

u/l

0.31

370

3034

Fentanyl

565

1.47

2.91

1.3

1.2

35.98

39.51

u/l

0.17

482

Any dementia

242

2092

0.80

2.90

1.3

51.70

39.86

u/l

0.51

209

1794

Other diseases of gallbladder

236

1.75

2.90

1.2

28.42

28.57

u/l

0.00

199

Malignant neoplasm of breast, ER-positive, including Hilmo

120

1260

0.73

2.89

1.2

30.73

21.97

u/l

0.70

1090

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

156

1169

1.32

2.89

1.2

29.29

37.45

u/l

0.41

138

1031

Viral and other specified intestinal infections

130

937

1.36

2.88

1.3

1.2

45.01

31.88

u/l

0.24

121

820

Alzheimer disease

185

1735

0.78

2.87

1.3

42.68

40.86

u/l

0.07

157

1484

Any dementia, excluding more controls

223

1924

0.79

2.86

1.3

51.79

41.17

u/l

0.41

193

1637

Open wound of lower leg

120

878

1.37

2.85

1.2

1.3

66.54

43.22

u/l

0.41

758

Fibromyalgia

344

1.61

2.84

1.2

21.28

20.86

u/l

0.03

294

Lesion of ulnar nerve

119

870

1.37

2.84

1.3

30.86

40.21

u/l

0.54

109

755

Extrapyramidal and movement disorders

310

2560

1.21

2.83

1.2

1.3

36.23

37.21

u/l

0.04

261

2197

Viral infections of the central nervous system

353

1.60

2.82

1.2

57.10

37.10

u/l

0.27

297

Erectile dysfunction

579

1.46

2.82

2.2

1.3

29.23

49.53

u/l

1.48

516

Other and unspecified hereditary haemolytic anaemias

9.14

2.82

8.8

1.0

53.44

6.15

u/l

—

Sarcoidosis

107

770

1.40

2.81

1.2

28.44

45.11

u/l

1.15

670

Conjunctivitis (acute, non atopic)

198

1552

1.27

2.80

1.2

1.3

25.67

32.88

u/l

0.62

170

1361

Duodenal ulcer

679

1.42

2.79

1.3

19.91

39.39

u/l

2.75

582

Asthma and allergy, excluding more controls

427

1.53

2.78

1.3

1.2

14.90

17.26

u/l

0.29

373

Trigger finger

107

772

1.39

2.77

1.1

1.2

29.55

40.23

u/l

0.37

102

670

Deviated nasal septum

279

2284

1.22

2.76

1.3

28.76

29.63

u/l

0.06

247

1983

Acute suppurative otitis media

151

1071

1.32

2.75

1.2

38.31

35.83

u/l

0.08

129

937

Disorders of conjunctiva

620

4350

1.15

2.75

1.3

32.99

34.37

u/l

0.12

533

3799

Unspecific neurodegenerative disorder

268

2239

0.82

2.73

1.3

42.09

41.15

u/l

0.04

227

1916

Acute gastritis

412

1.54

2.72

1.3

1.2

93.65

30.38

u/l

0.56

348

Shock, not elsewhere classified

3.07

2.72

1.0

1.2

10.26

11.19

u/l

—

Mental and behavioural disorders due to sedatives or hypnotics

341

1.59

2.71

1.1

1.2

63.15

35.22

u/l

0.55

290

Diseases of inner ear

439

3630

1.17

2.70

1.2

1.3

29.56

37.46

u/l

0.93

384

3146

Endometriosis

186

848

1.29

2.69

1.2

25.14

32.76

u/l

0.55

155

730

Other shoulder lesions

470

1.50

2.67

1.2

42.39

47.01

u/l

0.11

407

Ganglion

141

1069

1.32

2.66

1.2

33.37

38.59

u/l

0.25

126

922

Malignant neoplasm of bronchus and lung

969

0.70

2.65

1.1

1.2

43.92

22.83

u/l

1.15

824

Kela reimbursement Agammaglobulinemia (D80-84)

3.00

2.65

1.5

1.3

268.07

12.99

u/l

0.56

Hyphaema and other vascular disorders of iris and ciliary body

113

2.07

2.64

1.2

42.29

34.60

u/l

0.15

Smoking dependency

488

1.49

2.64

1.2

81.31

44.74

u/l

0.48

419

Varicose veins

495

3227

1.16

2.62

1.3

44.15

32.85

u/l

0.70

433

2779

Kela-code for severe mental illness

266

2183

1.22

2.61

1.2

1.3

28.22

31.93

u/l

0.24

230

1918

Unspecified misadventure during surgical and medical care

337

1.59

2.61

1.1

1.2

29.72

40.26

u/l

0.45

289

Plantar fascial fibromatosis

473

1.49

2.60

1.2

20.63

37.62

u/l

1.29

405

Dysphagia

202

1611

1.26

2.59

1.4

1.3

46.75

37.96

u/l

0.20

178

1365

Mental and behavioural disorders due to tobacco

490

1.48

2.59

1.2

81.31

44.50

u/l

0.48

422

Hallux valgus (acquired)

239

1390

1.24

2.59

1.2

1.3

36.66

34.76

u/l

0.07

203

1200

Colonic or urogenital fistula

210

1684

1.25

2.57

1.3

23.11

34.91

u/l

2.04

182

1467

Pain associated with micturition

623

1.42

2.57

1.4

1.2

23.81

44.99

u/l

1.36

541

Presence of other devices

190

1500

1.27

2.57

1.3

30.83

35.61

u/l

0.42

174

1279

Retinal detachments and breaks

296

2461

1.21

2.56

1.2

1.3

42.56

36.60

u/l

0.31

256

2119

Carbimazole or st.post thyroidectomy, condition for graves disease

139

1059

1.32

2.56

1.2

24.65

33.83

u/l

0.74

120

921

Coeliac disease

608

1.42

2.53

1.2

27.98

35.74

u/l

0.40

528

Raynaud syndrome

403

1.52

2.53

1.2

22.08

31.77

u/l

0.65

345

Other and unspecified urticaria

130

983

1.33

2.52

1.3

1.2

32.03

35.82

u/l

0.08

115

844

Unspecified mental disorder

290

2410

1.21

2.51

1.2

1.3

33.45

31.85

u/l

0.09

253

2104

Orchitis and epididymitis

593

1.42

2.51

1.7

1.2

47.33

42.05

u/l

0.07

514

Female infertility, associated with anovulation

172

1.81

2.49

1.5

1.2

9.21

32.13

u/l

1.37

154

Abnormal serum enzyme levels

275

2219

1.21

2.49

1.6

1.3

44.02

38.70

u/l

0.19

246

1906

Other and unspecified rosacea

421

1.51

2.49

1.2

21.48

28.80

u/l

0.63

364

Systemic lupus erythematosus

173

1.81

2.47

1.1

1.2

125.97

20.58

u/l

1.08

150

Dementia, including avohilmo

302

2480

0.83

2.45

1.3

38.27

43.85

u/l

0.29

254

2136

Open wound of wrist and hand

353

2925

1.18

2.45

1.3

38.11

30.27

u/l

0.39

307

2555

Disorders of vestibular function (Vertigo)

365

3054

1.18

2.44

1.2

1.3

29.19

37.71

u/l

0.88

324

2634

Inflammatory bowel disease

234

1911

1.23

2.44

1.2

1.3

38.75

32.99

u/l

0.23

206

1661

Other hearing loss

233

1861

1.23

2.44

1.2

1.3

49.92

37.26

u/l

0.41

201

1602

Asthma and allergy

441

1.48

2.43

1.3

1.2

14.90

17.06

u/l

0.27

386

Wide developmental disorders

2.25

2.43

1.4

1.2

80.06

41.00

u/l

0.23

Other specified/unspecified soft tissue disorders

242

1.67

2.41

1.3

1.2

28.00

35.37

u/l

0.26

205

Non-allergic asthma

465

1.47

2.40

1.2

28.60

40.22

u/l

0.51

401

Supervision of normal pregnancy

433

0.64

2.38

1.1

1.2

23.46

43.12

u/l

0.81

384

Left bundle-branch block

361

1.53

2.38

1.2

28.80

27.40

u/l

0.05

303

Other female pelvic inflammatory diseases

692

1.38

2.37

1.3

1.2

21.01

24.79

u/l

0.32

597

Medial epicondylitis

183

1.76

2.36

1.2

14.16

28.76

u/l

1.19

156

Acute laryngitis and tracheitis

459

1.46

2.36

1.2

88.56

27.94

u/l

0.69

395

Fracture of skull and facial bones

169

1337

1.27

2.36

1.2

43.05

33.76

u/l

0.39

145

1153

Use of rivastigmine

983

0.70

2.36

1.2

47.09

43.60

u/l

0.08

834

Seborrhoeic dermatitis

584

1.41

2.35

1.3

36.68

34.18

u/l

0.08

503

Lung diseases due to external agents

120

909

1.33

2.34

1.4

1.2

51.42

44.22

u/l

0.18

101

779

Enthesopathies of lower limb, excluding foot

160

1259

1.27

2.34

1.4

1.2

13.89

30.01

u/l

5.24

136

1086

Special screening examination for infectious and parasitic diseases

132

742

1.31

2.33

1.3

32.67

21.44

u/l

0.31

106

645

Chronic viral hepatitis

237

1.66

2.32

1.2

67.30

35.69

u/l

0.43

200

Other disorders of pigmentation

207

1.71

2.31

1.1

1.2

57.97

34.82

u/l

0.43

179

Use of galantamine

497

0.58

2.29

1.2

17.77

44.59

u/l

3.09

428

Synovial cyst of popliteal space [Baker]

381

1.51

2.28

1.1

1.2

23.17

42.19

u/l

1.36

322

Other and unspecified tonsillitis

215

1473

1.23

2.26

1.2

1.3

38.18

29.49

u/l

0.20

185

1305

Frostbite

0.00

2.26

0.0

1.2

—

15.15

—

Achilles tendinitis

606

1.39

2.25

1.5

1.3

15.58

33.22

u/l

2.25

524

Polycystic ovarian syndrome, broad definition

270

1.60

2.25

1.4

1.2

10.06

23.48

u/l

1.81

235

Other maternal disorders predominantly related to pregnancy

289

1518

1.20

2.20

1.2

22.42

30.76

u/l

0.99

257

1330

Viral infections of the central nervous system

384

1.49

2.20

1.2

56.18

35.18

u/l

0.29

324

5-aminosalicylic acid

146

1146

1.28

2.20

1.2

29.94

30.09

u/l

0.01

133

985

Wet age-related macular degeneration

148

1129

1.28

2.19

1.3

48.23

42.65

u/l

0.23

121

967

Congenital malformations of the circulatory system

706

1.35

2.19

1.1

1.3

38.23

40.21

u/l

0.06

620

Persistent delusional disorders

401

1.48

2.19

1.2

20.45

42.53

u/l

1.32

340

Idiopathic pulmonary fibrosis

509

1.42

2.18

1.1

1.2

53.56

46.47

u/l

0.09

432

Mouth breathing

319

2711

1.18

2.18

1.3

25.28

30.17

u/l

0.79

287

2369

Vasomotor and allergic rhinitis

237

1927

1.21

2.18

1.3

1.2

21.35

32.84

u/l

2.01

213

1677

Malignant neoplasm of respiratory system and intrathoracic organs

102

1125

0.75

2.17

1.1

1.2

47.20

23.26

u/l

1.59

958

Other and unspecified nonorganic psychotic disorders

124

955

1.30

2.16

1.3

1.2

33.17

35.18

u/l

0.06

104

834

Dislocation, sprain and strain of joints and ligaments of knee

434

3483

1.15

2.16

1.4

1.3

18.75

33.05

u/l

4.55

383

3064

Adenocarcinoma and papillary adenocarcinoma of stomach

149

0.33

2.15

1.2

20.22

22.39

u/l

—

128

Seronegative rheumatoid arthritis

586

1.39

2.15

1.1

1.3

119.46

36.97

u/l

0.94

512

Other specified and unspecified personality disorders

411

1.47

2.14

1.1

1.2

42.35

40.16

u/l

0.05

353

Spondylolisthesis/Spondylolysis

137

1071

1.28

2.14

1.5

1.2

30.17

31.98

u/l

0.10

126

920

Radial styloid tenosynovitis [de Quervain]

235

1.63

2.14

1.2

12.76

31.68

u/l

1.72

206

Malignant neoplasm of stomach

293

0.47

2.13

2.6

1.2

48.16

23.58

u/l

0.93

249

Other inflammation of eyelid

101

758

1.34

2.13

1.6

1.3

40.62

39.39

u/l

0.02

664

Conjunctivitis

530

3908

1.13

2.12

1.3

27.42

34.35

u/l

1.14

452

3411

Abnormal involuntary movements

102

767

1.34

2.12

1.3

27.68

41.26

u/l

1.09

666

Calculus of kidney and ureter

250

2089

1.20

2.12

1.3

55.00

34.67

u/l

0.68

217

1805

Parkinson's disease, strict definition

988

0.72

2.12

1.1

1.3

31.77

43.52

u/l

0.47

853

Persons with potential health hazards related to communicable diseases

219

1791

1.21

2.11

1.5

1.2

33.64

36.99

u/l

0.16

201

1574

Malignant neoplasm of bronchus and lung, including Hilmo

107

1173

0.76

2.10

1.1

1.2

36.75

22.74

u/l

0.95

998

Encephalopathy

2.31

2.10

1.0

1.1

56.64

28.06

u/l

0.36

Strabismus

183

1480

1.24

2.10

1.3

31.22

34.82

u/l

0.11

168

1290

Acute and transient psychotic disorders

572

1.39

2.09

1.2

18.06

41.75

u/l

2.04

490

Otitis externa

160

1279

1.25

2.09

1.5

1.3

18.24

37.22

u/l

4.38

138

1113

Cerebral palsy and other paralytic syndromes

615

1.37

2.08

1.3

1.2

45.76

45.07

u/l

0.01

528

Viral and other specified intestinal infections

168

1302

1.25

2.08

1.3

1.2

46.26

33.22

u/l

0.32

158

1149

Intestinal stricture

248

2075

1.20

2.08

1.2

1.3

40.75

37.22

u/l

0.12

213

1786

Urolithiasis

272

2295

1.19

2.08

1.3

52.15

34.74

u/l

0.61

234

1984

Benign neoplasm: Skin of eyelid, including canthus

119

919

1.30

2.06

1.3

1.2

51.39

40.89

u/l

0.21

102

799

Nontoxic multinodular goitre

132

1033

1.28

2.06

1.3

1.2

28.25

41.54

u/l

1.04

112

877

Familial hypercholesterolemia, with ischemic heart disease

583

1.38

2.05

1.2

1.3

29.59

54.26

u/l

1.57

496

Malignant neoplasm of breast, HER2-negative

167

1356

0.80

2.05

1.2

27.61

21.19

u/l

0.72

137

1176

Coxarthrosis, primary, with hip surgery

397

3231

1.15

2.05

1.3

57.70

37.50

u/l

1.06

338

2778

Use of donepezil

106

1323

0.76

2.05

1.3

36.76

42.85

u/l

0.27

1129

Rosacea

575

1.38

2.04

1.2

20.26

31.97

u/l

1.44

499

Malignant neoplasm of prostate, including Hilmo

275

1375

1.19

2.04

2.2

1.2

45.52

20.37

u/l

1.61

232

1179

Other congenital malformations

342

1.50

2.03

1.2

63.37

39.75

u/l

0.23

293

Injuries to the ankle and foot

502

3945

1.13

2.01

1.3

39.48

32.23

u/l

0.53

441

3462

Iridocyclitis

169

1367

1.24

2.00

1.6

1.2

53.43

34.19

u/l

0.89

150

1182

Rheumatoid arthritis

230

1721

1.20

1.98

1.2

1.3

69.77

34.79

u/l

1.13

210

1481

Recurrent dislocation and subluxation of joint

296

1.53

1.97

1.2

1.3

41.00

40.14

u/l

0.01

255

Monoamine oxidase A inhibitors

656

1.35

1.97

1.2

18.20

34.11

u/l

2.15

574

Pyoderma gangrenosum

2.62

1.96

1.3

1.2

51.78

14.25

u/l

—

Infections with a predominantly sexual mode of transmission

167

1351

1.24

1.95

1.3

1.2

18.98

32.21

u/l

2.09

141

1186

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

362

1.47

1.95

1.2

1.3

39.39

35.50

u/l

0.08

312

Carcinoma in situ of skin

555

1.38

1.95

1.2

27.82

41.49

u/l

0.90

481

Caries of enamel

664

4308

1.11

1.94

1.3

36.18

33.88

u/l

0.12

567

3784

Malignant neoplasm of digestive organs

215

2036

0.83

1.94

1.3

1.2

55.53

23.12

u/l

1.39

185

1733

malignant neoplasm of male genital organs

269

1384

1.19

1.93

2.2

1.2

46.15

20.66

u/l

1.62

230

1186

Hypertrophy of breast in women and men

115

893

1.29

1.93

1.3

1.2

26.20

34.74

u/l

0.49

783

Chronic pancreatitis

102

780

1.31

1.93

1.2

1.3

19.35

40.61

u/l

2.71

674

Malignant neoplasm of thyroid gland, including Hilmo

347

1.48

1.92

1.4

1.2

16.61

21.11

u/l

0.58

293

Hypoplasia of dental enamel , including avohilmo

2.27

1.92

2.2

1.3

20.36

17.61

u/l

0.09

Other congenital malformations

522

1.38

1.91

1.2

1.3

57.14

36.82

u/l

0.29

449

Noninflammatory disorders of female genital tract

212

877

1.21

1.90

1.4

1.2

19.12

35.61

u/l

2.46

176

756

Other and unspecified nerve root and plexus disorders, also in other diseases

147

1179

1.25

1.90

1.5

1.2

25.14

34.95

u/l

1.04

128

1025

Cervicobrachial syndrome

153

1233

1.24

1.89

1.2

24.31

32.09

u/l

0.69

136

1059

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

1127

0.75

1.89

1.9

1.2

45.27

22.96

u/l

1.04

958

Event of undetermined intent

324

1.49

1.89

1.1

1.2

25.91

43.47

u/l

0.71

280

Tinnitus

178

1459

1.22

1.88

1.3

32.57

34.01

u/l

0.06

153

1272

Male infertility

228

1.59

1.88

1.3

19.60

34.10

u/l

0.49

200

Other specified disorders of kidney and ureter

182

1.66

1.86

1.3

35.77

37.86

u/l

0.03

162

Diseases of middle ear and mastoid

386

2759

1.15

1.86

1.2

1.3

42.28

34.34

u/l

0.42

334

2417

Excessive attrition of teeth

388

3399

1.14

1.85

1.3

27.42

32.65

u/l

0.48

331

2983

Other specified/unspecified systemic involvement of connective tissue

277

1.53

1.84

1.3

1.2

74.60

23.73

u/l

0.63

238

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

577

1.36

1.84

1.3

24.68

20.97

u/l

0.35

501

Sicca syndrome [Sjögren]

425

1.42

1.84

1.2

22.92

29.88

u/l

0.61

369

Malignant neoplasm of breast

171

1362

0.82

1.84

1.2

27.58

21.17

u/l

0.74

141

1180

Use of levodopa decarboxylase inhibitor

950

0.73

1.83

1.0

1.3

27.07

39.56

u/l

0.56

822

Respiratory conditions due to other external agents

123

1.81

1.4

1.2

77.35

32.65

u/l

0.53

106

176

1360

1.22

1.81

1.4

1.3

43.14

41.71

u/l

0.06

138

1176

Disorders of ocular muscles, binocular movement, accommodation and refraction

314

2691

1.16

1.81

1.3

41.76

34.71

u/l

0.24

282

2355

Viral warts

142

1142

1.25

1.81

1.2

1.3

49.83

33.99

u/l

0.40

130

990

Gonarthrosis, primary, with knee surgery

481

3403

1.13

1.80

1.4

1.3

35.37

37.36

u/l

0.10

418

2936

Spinal osteochondrosis

2.38

1.79

1.3

1.2

17.13

12.33

u/l

0.28

Periapical abscess

344

3000

1.15

1.78

1.3

38.78

30.00

u/l

0.35

298

2620

Pollen allergy

728

1.30

1.77

1.4

1.3

19.74

33.89

u/l

1.24

625

Parkinson's disease

1057

0.75

1.76

1.1

1.3

29.45

42.29

u/l

0.60

915

Eating disorder

224

1.56

1.74

1.1

1.3

35.47

29.65

u/l

0.09

189

Acute lymphadenitis

265

1.52

1.74

1.2

76.79

44.56

u/l

0.34

228

Epilepsy

211

1769

1.19

1.73

1.3

52.96

34.73

u/l

0.79

183

1523

Impingement syndrome of shoulder

183

1520

1.21

1.73

1.3

22.91

36.76

u/l

2.48

161

1313

Fibrosarcoma, including Hilmo

0.00

1.72

0.0

1.2

—

16.09

—

Follow-up examination after treatment for malignant neoplasms

499

1.37

1.72

1.1

1.2

71.00

32.51

u/l

0.68

411

Artificial joint re-operation

415

1.41

1.71

1.2

32.19

39.48

u/l

0.22

354

Renal cell carcinoma of kidney

171

1.65

1.71

2.0

1.2

50.62

21.27

u/l

0.45

148

Moderate visual impairment, binocular

148

1.70

1.71

1.3

1.2

26.33

29.44

u/l

0.12

128

Lichen simplex chronicus and prurigo

332

1.45

1.70

1.4

1.2

23.15

40.42

u/l

1.11

283

Carcinoma in situ of skin of trunk

203

1.59

1.69

1.4

1.2

28.09

46.70

u/l

0.89

177

Other disorders of bladder

761

1.29

1.69

1.2

1.3

23.01

42.01

u/l

1.91

665

Benign paroxysmal vertigo

216

1827

1.19

1.68

1.2

25.37

39.32

u/l

1.87

191

1577

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

224

1901

1.18

1.67

1.4

1.3

31.63

31.13

u/l

0.03

205

1656

Isolated proteinuria with specified morphological lesion

2.13

1.67

1.1

22.48

17.56

u/l

0.45

Malignant neoplasm of breast, including Hilmo

177

1379

0.83

1.67

1.2

27.21

21.18

u/l

0.70

146

1197

Malignant neoplasm of breast, HER2-negative, including Hilmo

177

1379

0.83

1.67

1.2

27.21

21.18

u/l

0.70

146

1197

Melanocytic naevi

199

1673

1.19

1.66

1.2

1.3

44.05

33.72

u/l

0.38

176

1459

Chondropathies

105

825

1.28

1.66

1.1

1.3

13.85

39.21

u/l

4.82

719

Spirochaetal infections, other/unspecified

154

1869

0.82

1.66

1.6

1.3

33.17

34.68

u/l

0.07

134

1618

Hypothyroidism due to medicaments and other exogenous substances

2.28

1.65

1.2

13.70

14.61

u/l

0.12

Complications predominantly related to the puerperium

116

923

1.26

1.65

1.2

31.64

29.75

u/l

0.06

101

813

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

346

2951

1.14

1.64

1.3

1.2

28.11

35.75

u/l

0.88

295

2584

Delivery

180

1142

0.83

1.64

1.2

27.23

40.25

u/l

1.03

153

993

Puerperal sepsis

512

1.35

1.64

1.2

44.67

24.06

u/l

0.62

446

Fracture of shoulder and upper arm

268

2309

1.16

1.64

1.3

51.01

34.82

u/l

0.72

235

1992

Other/unspecified synovitis and tenosynovitis

599

1.32

1.63

1.2

56.73

47.13

u/l

0.13

517

Nontoxic goitre/thyroid nodule

203

1713

1.19

1.63

1.3

1.2

26.97

40.10

u/l

1.52

176

1477

Benign neoplasm: Skin of trunk

221

1.55

1.63

1.1

1.2

16.75

45.12

u/l

1.83

193

Hyperfunction of pituitary gland

197

1.58

1.63

1.1

1.2

18.39

40.92

u/l

1.01

172

Other disorders originating in the perinatal period

3.60

1.62

8.8

1.1

177.14

11.10

u/l

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

319

1.45

1.62

1.1

1.2

66.31

34.46

u/l

0.26

279

Sacrococcygeal disorders, not elsewhere classified

143

1.69

1.61

1.2

1.3

13.80

28.05

u/l

0.94

122

Other/unspecified enthesopathies, not elsewhere classified

454

1.37

1.61

1.2

102.37

48.30

u/l

0.42

388

Endometriosis of pelvic peritoneum

530

1.33

1.61

1.2

19.40

29.92

u/l

0.84

459

Impaction of intestines

2.55

1.61

1.1

1.2

10.75

27.06

u/l

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

2.08

1.60

1.0

1.2

12.21

20.23

u/l

0.79

494

3907

1.11

1.60

1.2

1.3

31.16

33.52

u/l

0.22

421

3419

Suppurative and necrotic conditions of lower respiratory tract

354

1.42

1.59

1.4

1.2

42.24

46.71

u/l

0.10

308

Radiculopathy

123

991

1.25

1.59

1.3

1.2

32.55

35.65

u/l

0.12

111

842

Panic disorder

602

1.32

1.58

1.1

1.2

20.73

34.15

u/l

0.99

522

Lyme disease

154

1858

0.83

1.58

1.6

1.3

33.17

34.03

u/l

0.04

134

1607

Other symptoms and signs involving the urinary system

673

1.30

1.57

1.5

1.3

59.66

46.38

u/l

0.27

587

Striking against or struck by other objects

236

2022

1.17

1.57

1.4

1.3

47.88

30.98

u/l

0.68

207

1763

Certain conditions originating in the perinatal period

197

1.54

1.56

2.4

1.2

38.62

17.62

u/l

0.42

171

Other spirochaetal diseases

158

1898

0.83

1.55

1.6

1.3

32.52

34.45

u/l

0.09

138

1640

Malignant neoplasm of prostate

260

1339

1.16

1.55

2.2

1.2

47.59

20.61

u/l

1.66

220

1145

Unknown and unspecified causes of morbidity

339

1.42

1.54

1.1

1.2

37.38

35.11

u/l

0.06

282

Barrett oesophagus

298

1.45

1.54

1.9

1.2

48.29

43.04

u/l

0.10

254

Fibrosarcoma

0.00

1.54

0.0

1.1

—

16.68

—

Allergic conjunctivitis

361

3112

1.13

1.53

1.3

1.2

28.10

35.81

u/l

0.93

305

2728

Use of entacapone

0.00

1.52

0.0

1.1

—

30.15

—

Other and unspecified visual disturbances

528

1.33

1.52

1.3

1.2

32.75

41.27

u/l

0.34

458

473

3843

1.11

1.52

1.2

1.3

31.75

33.75

u/l

0.17

403

3365

Mixed connective tissue disease

299

1.45

1.51

1.3

1.2

56.67

28.28

u/l

0.34

254

Postviral fatigue syndrome

2.89

1.51

1.5

1.3

10.44

10.02

u/l

—

Acute and subacute iridocyclitis

138

1133

1.22

1.51

1.6

1.2

57.65

36.07

u/l

0.80

120

979

Symptoms and signs involving appearance and behaviour

0.00

1.51

0.0

1.2

—

13.82

—

Anterior Iridocyclitis

146

1206

1.21

1.50

1.6

1.2

55.86

37.68

u/l

0.67

128

1049

Cyst of kidney

452

1.36

1.50

1.2

21.96

39.63

u/l

1.45

396

Glaucoma

461

3564

1.11

1.50

1.3

26.87

39.86

u/l

3.51

386

3082

Hereditary corneal dystrophies

178

1.59

1.49

1.2

122.82

33.23

u/l

0.51

155

Diabetic neuropathy

119

959

1.24

1.49

1.3

1.2

25.19

26.65

u/l

0.08

106

843

Other disorders of eye and adnexa

696

1.28

1.49

1.2

53.13

38.62

u/l

0.23

600

Autoimmune hepatitis

2.47

1.49

1.1

15.93

17.19

u/l

—

Drug-induced neutropenia

393

1.38

1.48

1.2

137.98

41.38

u/l

2.34

340

Premature rupture of membranes

494

0.72

1.47

1.1

1.2

14.70

31.19

u/l

1.41

442

Complications following infusion, transfusion and therapeutic injection

1.90

1.46

1.3

1.2

49.57

16.68

u/l

0.46

Other papulosquamous disorders

2.15

1.45

1.5

1.1

73.29

16.64

u/l

0.45

Other prurigo

2.15

1.45

1.4

1.2

11.83

23.40

u/l

0.58

Other/unspecified rheumatoid arthritis

717

1.27

1.45

1.3

1.2

87.77

38.12

u/l

0.62

614

Presbycusis

112

896

1.24

1.44

1.2

1.3

68.30

38.79

u/l

0.51

766

Pulmonary oedema

1.81

1.44

1.3

1.1

47.48

48.07

u/l

0.01

Oligomenorrhoea

110

1.74

1.43

1.1

1.2

14.23

24.00

u/l

0.64

Unspecified urinary incontinence

439

1.35

1.42

1.2

29.19

38.83

u/l

0.51

376

Acute pharyngitis

695

1.27

1.42

1.3

1.2

49.72

29.30

u/l

0.67

615

Adhesive capsulitis of shoulder

121

988

1.23

1.41

1.2

1.3

52.58

37.46

u/l

0.22

112

849

Chronic diseases of tonsils and adenoids

562

3229

1.10

1.41

1.4

1.3

34.98

31.88

u/l

0.14

494

2823

conjunctival haemorrhage

457

1.34

1.41

1.1

1.3

49.92

37.46

u/l

0.31

395

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

2.29

1.41

1.4

1.1

25.17

30.44

u/l

—

Nonorganic sleeping disorders, excluding more controls

116

943

1.23

1.41

1.3

1.2

22.43

33.76

u/l

1.14

106

821

Arteriovenous malformation of cerebral vessels

2.11

1.39

1.2

30.62

20.09

u/l

0.35

Blepharochalasis

221

1908

1.16

1.39

1.2

1.3

31.61

41.58

u/l

0.94

188

1648

Schizophrenia or delusion

213

1834

1.16

1.39

1.2

1.3

28.85

34.33

u/l

0.30

179

1607

Diseases of the myoneural junction and muscle

758

1.26

1.38

1.2

22.50

47.07

u/l

3.13

656

Other spirochaetal diseases

158

1873

0.84

1.37

1.6

1.3

32.52

34.58

u/l

0.10

138

1620

Pyothorax

264

1.45

1.37

1.3

1.2

52.50

48.33

u/l

0.07

228

Hirsutism in women

2.21

1.37

1.0

1.1

13.56

10.85

u/l

—

Single spontaneous delivery

183

1141

0.85

1.37

1.2

27.16

40.25

u/l

1.05

155

993

Conductive hearing loss, unspecified

442

1.34

1.37

1.7

1.2

101.55

44.60

u/l

0.76

383

Cardiac murmurs and other cardiac sounds

352

1.38

1.37

1.3

64.04

39.90

u/l

0.55

299

Neovascular glaucoma

223

1.49

1.36

1.2

1.3

23.29

45.68

u/l

1.16

193

Post-traumatic wound infection, not elsewhere classified

143

1.62

1.36

1.2

28.03

44.76

u/l

0.58

122

Keratitis

255

2231

1.14

1.34

1.3

40.82

32.66

u/l

0.34

225

1934

Other disorders of eyelid

350

2973

1.12

1.34

1.3

33.49

40.28

u/l

0.68

302

2564

Insomnia

629

4204

1.09

1.34

1.3

29.71

35.11

u/l

0.34

553

3662

Alcohol use disorder, Swedish definition

450

3733

1.11

1.33

1.2

1.3

30.31

33.39

u/l

0.30

384

3265

Autism

1.98

1.33

1.5

1.2

107.98

48.65

u/l

0.25

Sequelae of infectious and parasitic diseases

410

1.35

1.33

1.9

1.2

25.54

38.07

u/l

0.73

351

Chronic conjunctivitis

152

1.59

1.32

1.1

1.2

70.54

20.12

u/l

0.78

131

Malignant neoplasm of bladder

410

1.35

1.32

1.1

25.25

22.57

u/l

0.21

346

Dementia in Alzheimer disease

103

1068

0.81

1.30

1.2

1.3

29.83

42.37

u/l

1.36

902

Congenital malformations of heart and great arteries

619

1.27

1.30

1.3

32.10

43.79

u/l

0.54

540

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

765

1.25

1.29

1.6

1.3

19.84

38.94

u/l

2.37

666

Flat foot [pes planus] (acquired)

473

1.32

1.29

1.2

1.3

33.58

33.67

u/l

0.00

407

Ulcer of oesophagus

430

1.33

1.28

1.7

1.2

40.63

40.54

u/l

0.00

372

Injury of muscle and tendon at shoulder and upper arm level

291

2580

1.13

1.27

1.3

26.63

31.44

u/l

0.58

255

2251

Schizophrenia, schizotypal and delusional disorders

214

1859

1.15

1.27

1.2

28.60

34.22

u/l

0.31

180

1630

Seropositive rheumatoid arthritis

166

1410

1.18

1.25

1.3

79.03

36.21

u/l

0.95

149

1203

Varicose veins of other sites

380

1.35

1.25

1.2

98.25

54.14

u/l

0.25

318

Other and unspecified vascular occlusions

590

1.28

1.25

1.4

1.2

31.94

48.67

u/l

0.87

517

Other injuries of lower limb, level unspecified

2.25

1.25

1.0

1.2

26.41

16.51

u/l

—

Papulosquamous disorders

289

2566

1.13

1.24

1.2

1.3

33.35

32.43

u/l

0.05

256

2232

Sequelae of injuries of upper limb

538

1.29

1.23

1.7

1.2

28.11

47.01

u/l

1.12

463

Ulcerative enterocolitis

155

1.56

1.23

1.1

1.3

41.37

38.97

u/l

0.04

130

Postprocedural musculoskeletal disorders, not elsewhere classified

442

1.32

1.23

1.9

1.2

35.03

41.37

u/l

0.22

379

Other neurotic disorders

262

1.42

1.23

1.8

1.2

39.33

40.22

u/l

0.02

223

2.19

1.22

1.1

10.61

11.91

u/l

—

Vestibular neuronitis

525

0.72

1.21

1.2

23.06

41.73

u/l

1.43

454

Behavioural syndromes associated with physiological disturbances and physical factors

678

4447

1.08

1.21

1.3

30.13

34.94

u/l

0.32

597

3877

Bell's palsy

673

1.25

1.21

1.4

1.2

28.69

46.09

u/l

1.12

580

Voice disturbances

185

1597

1.16

1.21

1.3

42.35

35.36

u/l

0.33

167

1392

Sleep disorders

650

4339

1.08

1.21

1.3

29.58

35.05

u/l

0.36

572

3780

Psoriasis

205

1784

1.15

1.20

1.2

1.3

34.02

32.52

u/l

0.07

186

1553

Injury of muscle and tendon at forearm level

1.72

1.18

1.5

1.1

21.53

32.60

u/l

0.35

Other disorders of conjunctiva

106

874

1.22

1.18

1.2

1.3

57.42

40.15

u/l

0.46

760

Pleural plaque

676

1.25

1.18

1.2

1.3

25.02

41.52

u/l

2.02

591

Other surgical follow-up care

157

1.54

1.17

1.2

33.47

22.53

u/l

0.26

134

Deep bite

397

1.31

1.17

1.3

16.57

31.64

u/l

1.38

343

Symptoms and signs involving speech and voice

236

2078

1.14

1.17

1.2

1.3

44.86

34.71

u/l

0.48

209

1803

Circumscribed brain atrophy

127

0.47

1.17

1.3

1.2

7.84

35.98

u/l

—

111

Social phobias

307

1.37

1.17

1.2

55.53

30.34

u/l

0.33

264

Tetraplegia

0.00

1.17

0.0

1.1

—

13.86

—

Dental pulpitis, including avohilmo

659

3958

1.08

1.17

1.2

1.3

27.38

31.48

u/l

0.40

581

3467

Failed attempted abortion

0.00

1.16

0.0

1.1

—

12.54

—

Parkinson's disease, including avohilmo

1102

0.81

1.16

1.1

1.3

27.58

42.06

u/l

0.84

953

Sudden idiopathic hearing loss

597

1.26

1.16

1.3

1.2

42.73

42.97

u/l

0.01

521

Abnormal spermatozoa

112

932

1.21

1.15

1.9

1.3

58.53

42.40

u/l

0.20

802

Pain and other conditions associated with female genital organs and menstrual cycle

589

1.25

1.15

1.4

1.2

17.86

35.58

u/l

1.77

513

Autism spe

1.86

1.13

1.5

1.2

107.98

46.22

u/l

0.26

Ocular pain

387

1.32

1.13

1.2

71.78

38.43

u/l

0.32

330

Corns and callosities

344

1.34

1.13

1.1

1.2

18.88

35.86

u/l

2.03

289

Other disorders of iris and ciliary body

151

1.53

1.12

1.2

42.28

31.60

u/l

0.25

135

Other and unspecified effects of external causes

168

1450

1.16

1.12

1.5

1.3

38.57

35.01

u/l

0.09

145

1261

Secondary parkinsonism, excluding more controls

135

1.57

1.12

1.1

1.2

21.92

38.87

u/l

0.60

118

Adenomyosis (Endometriosis of uterus)

582

1.26

1.11

1.3

1.2

26.53

35.33

u/l

0.33

493

Hypertrichosis

1.97

1.11

1.0

1.2

13.86

11.50

u/l

—

Pneumonitis due to solids and liquids

521

1.27

1.10

1.5

1.2

20.99

44.04

u/l

2.52

453

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.74

1.09

1.4

1.2

41.02

41.16

u/l

0.00

Preterm labour and delivery

118

992

1.19

1.08

1.2

37.81

23.95

u/l

0.80

101

864

Ulcerative colitis, NAS

765

1.22

1.08

1.2

24.14

40.97

u/l

1.77

664

False labour

609

0.81

1.08

1.2

1.3

13.21

35.68

u/l

2.01

545

Perforation of tympanic membrane

541

1.26

1.07

1.2

24.90

39.64

u/l

0.68

461

Perforation of oesophagus

2.16

1.06

1.0

1.1

23.87

26.75

u/l

—

Olecranon bursitis

409

1.30

1.06

1.2

1.3

29.84

48.56

u/l

1.03

356

Other symptoms and signs involving the digestive system and abdomen

106

885

1.20

1.06

1.2

20.98

39.41

u/l

2.18

764

Benign lipomatous neoplasm

213

1881

1.13

1.04

1.4

1.3

31.18

34.39

u/l

0.13

190

1635

Intercostal neuropathy

1.99

1.04

1.1

1.2

104.56

15.53

u/l

—

Unspecified parasitic disease

1.99

1.04

1.4

1.1

93.29

38.59

u/l

—

Fall on and from stairs and steps

183

1600

1.15

1.04

1.2

1.3

32.69

35.49

u/l

0.14

157

1389

Malignant neoplasm of penis, including Hilmo

2.09

1.04

6.9

1.2

20.73

13.91

u/l

—

Dermatophytosis

459

4219

1.09

1.03

1.3

30.41

35.87

u/l

0.45

385

3689

Superficial injury of ankle and foot

553

1.25

1.03

1.1

1.3

57.36

40.70

u/l

0.37

480

Invasive ventilation

420

1.29

1.03

1.2

57.95

48.04

u/l

0.18

368

Infections with a predominantly sexual mode of transmission

205

1683

1.14

1.03

1.3

1.2

17.97

38.32

u/l

4.11

174

1485

Superficial injury of thorax

107

898

1.19

1.02

1.6

1.2

52.37

43.21

u/l

0.31

776

Seborrhoeic keratosis

164

1426

1.15

1.02

1.3

53.48

38.77

u/l

0.60

151

1233

Reactive arthropathies

447

1.28

1.02

1.9

1.3

27.22

46.34

u/l

1.09

387

Congenital malformations and deformations of the musculoskeletal system

427

1.28

1.01

1.9

1.2

81.44

30.72

u/l

0.45

368

Special screening examination for neoplasms

290

1.35

1.01

1.2

67.00

31.35

u/l

0.90

243

Other/unspecified crystal arthropathies

2.03

1.01

1.3

1.2

14.71

14.54

u/l

—

Other (seronegative) rheumatoid arthritis, wide

130

1113

1.17

0.99

1.2

95.59

39.84

u/l

0.95

116

970

Dislocation, sprain and strain of joints and ligaments at neck level

728

1.21

0.99

1.3

17.17

37.48

u/l

3.00

629

Adverse effects, not elsewhere classified

115

976

1.18

0.98

1.6

1.2

47.36

34.70

u/l

0.28

105

840

Follicular adenocarcinoma of thyroid gland, including Hilmo

1.87

0.97

1.3

1.2

10.81

13.58

u/l

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

531

1.25

0.97

1.8

1.2

36.63

37.81

u/l

0.03

459

Single delivery by caesarean section

388

0.78

0.97

1.1

1.3

12.49

43.71

u/l

2.25

345

Glaucoma secondary to other eye disorders

241

1.38

0.97

1.2

23.29

45.42

u/l

1.24

208

Other and unspecified abdominal hernia

224

1.39

0.97

1.1

1.2

70.78

33.49

u/l

0.38

197

Assault

676

1.22

0.96

1.3

1.2

34.90

40.01

u/l

0.14

587

Sequelae of injuries, of poisoning and of other consequences of external causes

165

1443

1.15

0.96

1.4

1.2

23.35

34.06

u/l

1.40

148

1257

Fracture of foot, except ankle

156

1359

1.15

0.96

1.4

1.3

42.62

33.70

u/l

0.30

130

1186

Primary coxarthrosis, bilateral

221

1970

1.12

0.96

1.2

1.3

59.68

36.38

u/l

0.67

193

1690

Other and unspecified injuries of head

381

1.29

0.95

1.1

1.2

19.97

42.14

u/l

1.62

321

Erosion of teeth , including avohilmo

149

1295

1.15

0.95

1.4

1.3

58.55

33.50

u/l

0.82

133

1131

Tularaemia

1.79

0.95

1.2

61.87

12.43

u/l

0.51

Benign neoplasm of brain and other parts of central nervous system

355

1.30

0.94

1.5

1.2

31.43

43.46

u/l

0.46

301

Cutis laxa senilis

1.91

0.94

1.6

1.2

53.48

19.00

u/l

—

Toxic effect of carbon monoxide

1.63

0.94

1.4

1.2

35.91

24.53

u/l

0.21

Contact with other and unspecified heat and hot substances

2.25

0.94

1.7

1.2

6.71

13.43

u/l

—

Allergic rhinitis

169

1466

1.14

0.94

1.3

1.2

23.35

32.42

u/l

0.97

152

1281

Benign neoplasm of major salivary glands

588

1.23

0.93

1.2

29.89

37.38

u/l

0.29

507

Benign neoplasm of ovary

788

1.20

0.93

1.2

24.83

28.82

u/l

0.22

685

Malignant melanoma, including Hilmo

121

1037

1.17

0.93

1.2

83.04

22.17

u/l

1.50

109

892

Benign neoplasm: Spinal meninges

1.75

0.93

1.2

30.03

19.87

u/l

—

Glucosamine medication

376

2752

1.09

0.92

1.3

50.77

36.51

u/l

0.68

329

2374

Salpingitis and oophoritis

781

1.19

0.91

1.3

1.2

51.47

24.44

u/l

0.58

685

therapeutic use

176

1.43

0.91

1.0

1.2

40.49

37.57

u/l

0.04

155

Assault by bodily force

375

1.28

0.91

1.4

1.2

17.26

41.30

u/l

1.59

325

Severe visual impairment, binocular

2.10

0.90

1.0

1.2

22.13

18.49

u/l

—

Herpesviral [herpes simplex] infections

142

1236

1.15

0.90

1.2

28.00

34.04

u/l

0.46

125

1077

Other and unspecified myopathies

537

1.23

0.90

1.2

24.07

44.60

u/l

1.90

463

Occupational exposure to risk-factors

202

1.39

0.89

1.2

1.3

33.84

43.22

u/l

0.19

177

Other and unspecified disorders of vitreous body

306

2749

1.10

0.89

1.3

44.06

33.77

u/l

0.71

261

2383

Follow-up care involving plastic surgery

185

1.41

0.89

1.6

1.2

32.60

19.96

u/l

0.47

158

Acute alcohol intoxication

153

1742

0.88

1.3

33.36

32.73

u/l

0.03

122

1520

Other predominantly sexually transmitted diseases, not elsewhere classified

683

1.20

0.88

1.4

1.2

20.71

25.35

u/l

0.33

593

Injury of muscle and tendon at wrist and hand level

821

1.18

0.88

1.2

1.3

27.53

38.76

u/l

0.73

713

Pedal cyclist injured in transport accident

110

1282

0.86

0.88

1.3

24.98

35.68

u/l

0.93

100

1119

Reactive arthropathies, FINNGEN

342

1.29

0.87

2.1

1.2

25.18

38.23

u/l

0.55

292

Contusion of other and unspecified parts of foot

203

1.38

0.87

1.1

1.2

46.73

36.22

u/l

0.17

172

Non-small cell lung cancer, including Hilmo

881

0.83

0.87

1.1

1.2

34.02

22.50

u/l

0.72

745

Unspecified/other endometriosis

272

1.33

0.87

1.1

1.2

17.53

23.84

u/l

0.34

236

Adult respiratory distress syndrome

1.74

0.87

1.5

1.1

172.87

34.10

u/l

0.45

Congenital malformations of cardiac septa

289

1.31

0.86

1.1

1.4

42.92

47.01

u/l

0.08

250

Whooping cough

1.83

0.86

1.3

1.2

5.63

13.27

u/l

—

Other otitis externa (chronic)

361

1.28

0.85

1.2

18.33

37.69

u/l

1.58

306

Pedal cyclist injured in noncollision transport accidents

626

0.80

0.85

1.2

15.85

43.43

u/l

3.87

546

Car occupant injured in other and unspecified transport accidents

116

1000

1.16

0.85

1.2

1.3

29.58

39.66

u/l

0.52

107

868

Spondyloarthritis

123

1065

1.16

0.85

1.3

1.2

56.04

37.77

u/l

0.50

108

919

Melanocytic naevi, other sites/unspecified

406

1.26

0.85

1.2

25.91

41.22

u/l

0.58

350

Hydrocele

807

1.18

0.84

1.4

1.3

33.03

42.77

u/l

0.48

701

Ménière disease

542

1.22

0.84

1.3

1.2

35.25

35.05

u/l

0.00

466

Other degenerative diseases of the nervous system

193

1286

1.12

0.83

1.2

1.3

39.11

45.38

u/l

0.28

168

1098

Personal history of risk-factors, not elsewhere classified

1.75

0.83

1.5

1.2

14.65

11.06

u/l

—

Superficial injury of wrist and hand

120

1041

1.15

0.82

1.2

1.3

18.52

36.23

u/l

2.39

104

908

Other keratitis

598

1.21

0.82

1.3

1.2

38.09

44.78

u/l

0.12

517

Inflammatory diseases of prostate (prostatitis)

101

865

1.17

0.82

1.2

1.3

18.46

40.36

u/l

4.30

746

Spontaneous abortion

181

1369

0.89

0.81

1.2

51.72

30.25

u/l

0.57

154

1207

Female infertility

126

663

1.15

0.81

1.3

1.2

15.98

29.67

u/l

2.31

113

575

Inguinal hernia

494

3079

1.07

0.81

1.4

1.3

37.89

33.08

u/l

0.29

435

2685

Early lumbar disc prolapse, operated

436

1.24

0.80

1.2

11.82

33.42

u/l

2.12

382

Otitis externa, unspecified

572

1.21

0.80

1.4

1.2

18.17

45.22

u/l

2.80

493

Other osteochondropathies

365

1.26

0.80

1.1

1.2

13.88

44.17

u/l

2.50

313

Malignant melanoma

849

1.17

0.79

1.2

97.23

22.55

u/l

1.51

729

Congenital obstruction of the pelviureteric junction

1.83

0.79

1.0

1.2

12.41

20.70

u/l

—

Malignant neoplasm of floor of mouth, including Hilmo

1.68

0.79

1.4

1.2

11.71

16.54

u/l

—

Ankylosis of joint

0.00

0.79

0.0

1.2

—

12.14

—

Caught, crushed, jammed or pinched in or between objects

242

1.33

0.79

1.2

34.54

53.58

u/l

0.36

208

Dependence on enabling machines and devices, not elsewhere classified

1.67

0.78

1.1

13.95

13.66

u/l

—

Malignant neoplasm of tonsil, including Hilmo

0.51

0.78

1.0

1.2

33.86

16.91

u/l

—

Pyoderma

1.60

0.78

1.3

1.2

21.69

17.59

u/l

0.23

Juvenile Open Angle Glaucoma

0.00

0.78

0.0

1.3

—

11.87

—

Calcific tendinitis of shoulder

278

1.30

0.77

1.2

14.85

44.08

u/l

1.85

243

Bronchiectasis

466

1.23

0.77

1.2

1.3

19.05

44.31

u/l

2.61

400

Benign leiomyoma with endometriosis

759

1.17

0.77

1.3

1.2

40.79

34.39

u/l

0.19

661

Sequelae of other and unspecified infectious and parasitic diseases

287

1.29

0.77

2.2

1.2

26.26

25.99

u/l

0.01

244

Schizoaffective disorder

358

1.26

0.77

1.2

41.26

35.55

u/l

0.12

310

Inflammatory diseases of the central nervous system

448

1.23

0.77

1.2

110.54

43.02

u/l

0.63

385

Unspecified jaundice

305

1.28

0.76

1.2

36.42

47.63

u/l

0.40

262

Dependent personality disorder

107

1.51

0.76

1.1

1.2

84.13

29.28

u/l

0.34

Endometriosis ASRM stages 1,2

649

1.19

0.76

1.2

18.95

20.39

u/l

0.10

571

Supplementary factors related to causes of morbidity and mortality classified elsewhere

213

1928

1.11

0.75

1.4

1.3

32.80

33.94

u/l

0.07

176

1686

Cerebral atherosclerosis

1.70

0.75

1.1

1.2

16.50

57.57

u/l

—

Otitis media, unspecified

388

1.24

0.75

1.3

43.30

35.99

u/l

0.11

339

Hydrocephalus

482

0.79

0.75

1.3

1.2

11.33

42.58

u/l

4.24

410

Foreign body in alimentary tract

297

1.28

0.75

1.2

24.40

40.52

u/l

0.99

257

Other symptoms and signs involving general sensations and perceptions

192

1.36

0.75

1.3

1.2

26.01

37.62

u/l

0.35

165

Alcohol use disorder, ICD-based

319

2943

1.09

0.75

1.2

1.3

32.02

31.00

u/l

0.07

270

2570

Malignant neoplasm of breast, HER-negative

923

0.85

0.75

1.2

30.99

24.77

u/l

0.44

797

IBD patients in KELA-register

148

1313

1.13

0.75

1.2

43.95

34.81

u/l

0.25

136

1148

Oesophageal obstruction

201

1.35

0.74

1.3

1.2

19.32

33.44

u/l

0.83

173

Congenital malformations and deformations of the musculoskeletal system

331

1.26

0.74

2.1

1.2

95.23

32.10

u/l

0.40

283

Embedded and impacted teeth

121

873

1.14

0.74

1.1

1.3

77.80

37.14

u/l

0.66

104

766

Herpesviral [herpes simplex] infections

587

1.20

0.74

1.3

1.2

32.70

41.74

u/l

0.41

508

Mental and behavioural disorders due to alcohol

399

3571

1.07

0.74

1.2

1.3

32.20

31.25

u/l

0.07

337

3135

Injury of muscle and tendon at hip and thigh level

560

1.20

0.74

1.2

1.3

18.90

45.58

u/l

2.65

487

!Aliquae complicationes praecoces traumatis

228

1.32

0.73

1.2

28.40

56.10

u/l

1.10

195

Early complications of trauma

228

1.32

0.73

1.2

28.40

56.10

u/l

1.10

195

Other bursitis, not elsewhere classified

1.62

0.73

1.1

18.32

37.40

u/l

—

Flatulence and related conditions

1.62

0.73

1.2

1.1

14.64

22.22

u/l

—

Other degenerative diseases of the basal ganglia

110

0.54

0.72

1.0

1.3

64.23

41.30

u/l

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

424

1.23

0.72

1.4

1.2

30.80

40.07

u/l

0.40

360

Spontaneous rupture of synovium and tendon

452

1.22

0.72

1.2

1.3

16.98

42.02

u/l

2.57

388

Schizophrenia

103

895

1.15

0.72

1.2

1.3

19.33

38.71

u/l

1.98

782

Benign neoplasm: Bone and articular cartilage, unspecified

1.77

0.72

1.4

1.3

397.97

12.82

u/l

—

Mucosal proctocolitis

682

1.18

0.71

1.2

25.96

41.57

u/l

1.18

588

Mental and behavioural disorders due to alcohol, excluding acute intoxication

349

3227

1.08

0.70

1.2

1.3

31.59

30.31

u/l

0.09

295

2826

Ethmoidectomy

711

1.17

0.70

1.7

1.3

22.68

41.84

u/l

1.52

622

Anomalies of dental arch relationship, including avohilmo

101

791

1.15

0.70

1.6

1.2

35.45

37.02

u/l

0.04

692

Other disorders of patella

860

1.15

0.70

1.5

1.3

18.98

35.47

u/l

2.15

746

Ulcerative colitis

163

1463

1.12

0.69

1.2

31.39

33.11

u/l

0.09

144

1274

Pregnancy, childbirth and the puerperium

138

813

0.89

0.69

1.2

46.79

36.69

u/l

0.18

119

698

Unspecified lump in breast

695

0.83

0.69

1.3

1.2

19.95

25.10

u/l

0.51

597

Other specified/unspecified necrotizing vasculopathies

1.61

0.69

1.5

1.2

93.47

39.94

u/l

0.41

Migraine without aura, drug-induced

1.68

0.68

1.6

1.2

18.95

17.21

u/l

—

Atopic dermatitis

301

2666

0.92

0.68

1.3

1.2

43.91

29.79

u/l

0.45

266

2340

Alcohol abuse counselling and surveillance

0.55

0.67

1.0

1.2

14.44

31.62

u/l

—

Benign neoplasm: Other and unspecified parts of small intestine

1.50

0.67

1.1

69.75

23.48

u/l

0.48

Malignant neoplasm of oropharynx

0.53

0.67

1.2

1.1

37.62

17.33

u/l

—

Malignant melanoma of skin, including Hilmo

845

1.15

0.67

1.2

89.75

23.15

u/l

1.27

723

Primary open-angle glaucoma

242

2147

1.09

0.67

1.3

29.40

40.94

u/l

1.72

202

1845

Inflammatory disease of uterus

484

1.20

0.66

1.5

1.2

17.23

19.37

u/l

0.18

424

Disorders of optic nerve and visual pathways

466

1.20

0.66

1.2

30.29

43.90

u/l

0.65

401

Early lumbar disc prolapse operation

466

1.20

0.66

1.2

12.00

34.51

u/l

2.41

402

Abrasion of teeth

181

1996

0.91

0.66

1.2

55.25

33.87

u/l

0.47

160

1733

Morphin

111

1.45

0.66

1.1

1.2

48.84

27.76

u/l

0.35

100

Supervision of high-risk pregnancy

431

0.84

0.66

1.1

1.2

10.54

42.85

u/l

2.54

380

Other diseases of biliary tract

494

1.20

0.66

1.2

66.00

37.63

u/l

0.62

426

Carcinoma in situ of rectum

1.63

0.65

1.4

1.1

184.43

22.78

u/l

—

Other predominantly sexually transmitted diseases, not elsewhere classified

809

1.15

0.65

1.4

1.3

19.90

30.56

u/l

0.94

705

Hemiplegia

250

1.28

0.65

1.2

26.47

37.92

u/l

0.54

216

Lichen sclerosus et atrophicus

476

1.20

0.65

1.7

1.2

17.58

30.42

u/l

2.17

405

Persons encountering health services in circumstances related to reproduction

334

2414

0.93

0.63

1.3

1.2

32.62

31.10

u/l

0.07

297

2120

Impacted teeth

630

1.16

0.63

1.1

1.3

94.92

36.79

u/l

0.63

552

Fenamates

587

1.15

0.63

1.5

1.2

25.56

49.75

u/l

1.88

503

Organic, including symptomatic, mental disorders

374

2843

0.94

0.63

1.3

38.88

43.29

u/l

0.26

320

2440

Oral leukoplakia, including avohilmo

164

1.35

0.62

2.8

1.2

37.87

28.27

u/l

0.28

139

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

102

0.58

0.62

1.3

1.2

142.93

20.02

u/l

—

Contusion of toe(s) with damage to nail

1.64

0.62

1.0

1.2

62.91

11.91

u/l

—

Injuries to the elbow and forearm

493

4094

1.06

0.62

1.5

1.2

50.21

33.40

u/l

1.10

432

3558

Lesion of plantar nerve

324

0.77

0.61

1.1

1.2

14.94

27.27

u/l

1.45

274

Dysplastic lesion of unknown severity of the cervix uteri

1.68

0.61

1.0

1.1

14.77

16.25

u/l

—

Rash and other nonspecific skin eruption

498

1.19

0.61

1.3

1.2

74.67

41.77

u/l

0.64

428

Infective bursitis

174

1.33

0.60

1.0

1.3

13.58

52.81

u/l

2.02

148

Abscess of lung

1.51

0.60

1.7

1.2

18.62

43.61

u/l

0.78

Malignant neoplasm of gum, including Hilmo

1.55

0.60

1.1

11.54

17.21

u/l

—

Pediculosis, acariasis and other infestations

308

1.24

0.59

2.0

1.2

47.97

49.71

u/l

0.02

263

Alzheimer’s disease (Late onset), excluding more controls

687

0.88

0.59

1.4

1.3

41.78

43.53

u/l

0.06

581

Impacted cerumen

621

1.16

0.59

1.2

42.61

44.39

u/l

0.03

538

Inflammatory bowel disease, strict (require KELA)

148

1338

1.11

0.58

1.2

43.95

35.55

u/l

0.22

136

1167

Haemorrhage in early pregnancy

114

988

1.12

0.58

1.3

1.2

25.02

29.52

u/l

0.25

871

Haemangioma and lymphangioma, any site

464

1.19

0.58

1.2

44.01

34.20

u/l

0.29

400

Infective dermatitis

659

1.16

0.58

1.2

1.3

30.32

33.67

u/l

0.12

571

Fall on same level involving ice and snow

406

3826

1.06

0.58

1.3

43.54

34.11

u/l

0.39

369

3309

Other deformity of hallux (acquired)

1.73

0.58

1.0

1.3

33.84

12.15

u/l

—

Parkinson's disease, strict definition, excluding more controls

781

0.86

0.58

1.1

1.3

31.77

45.69

u/l

0.55

667

Postpartum haemorrhage

673

0.86

0.57

1.2

36.04

25.81

u/l

0.29

589

Other bursitis of elbow

1.49

0.57

1.6

1.3

17.79

41.38

u/l

—

Benign neoplasm: Parotid gland

465

1.19

0.57

1.2

22.95

40.49

u/l

1.11

401

Overexertion and strenuous or repetitive movements

539

1.17

0.57

1.2

35.93

43.70

u/l

0.17

460

Atopic conjunctivitis

202

1.29

0.57

1.2

42.17

30.14

u/l

0.26

176

Carcinoma in situ, bladder

229

1.27

0.57

1.1

1.2

44.87

66.74

u/l

0.35

198

Disorders of parathyroid gland, other and/or unspecified

1.68

0.57

1.8

1.1

32.67

14.99

u/l

—

Malignant neoplasm of lip

1.68

0.57

5.8

1.2

26.51

20.12

u/l

—

Burns and corrosions

773

1.14

0.57

1.3

1.2

38.20

42.55

u/l

0.09

671

Malignant neoplasm of other connective and soft tissue, including Hilmo

229

1.27

0.57

1.1

1.2

18.80

18.88

u/l

0.01

201

Other disorders of cornea

549

1.17

0.57

1.3

1.2

70.96

40.55

u/l

0.39

468

Delivery, wide proxy

162

947

0.91

0.56

1.2

27.15

42.18

u/l

1.03

135

814

Type of accident

195

1791

1.09

0.56

1.4

1.3

33.70

35.15

u/l

0.08

161

1566

Atrophic disorders of skin

689

1.15

0.56

1.6

1.2

17.77

34.19

u/l

2.63

604

Psoriasis (vulgaris), strict definition

176

1.31

0.56

1.4

1.3

14.76

49.38

u/l

1.76

152

Acute appendicitis, with complications

135

1218

1.11

0.56

1.1

1.3

61.75

36.44

u/l

0.48

119

1056

Benign neoplasm: Short bones of upper limb

1.52

0.56

1.3

1.2

22.87

15.60

u/l

0.26

Malignant neoplasm of breast, ER-negative, including Hilmo

1002

0.88

0.56

1.2

28.90

23.93

u/l

0.38

866

Sequelae of other accidents

0.56

1.2

55.30

45.40

u/l

—

Trichomoniasis

1.63

0.56

1.2

1.1

14.52

38.77

u/l

—

Chorioretinal inflammation

148

0.67

0.55

1.2

19.31

33.29

u/l

—

130

Other disorders of amniotic fluid and membranes

397

0.81

0.55

1.2

7.91

26.48

u/l

2.97

352

Melanocytic naevi of trunk

644

1.15

0.55

1.2

23.05

43.13

u/l

1.57

561

Benign neoplasm: salivary glands, exclude unknown (D119)

523

1.17

0.55

1.2

21.98

38.36

u/l

1.19

453

Ptosis of eyelid

691

1.15

0.55

1.2

1.3

27.47

40.69

u/l

0.93

598

Nonorganic sleeping disorders

116

1040

1.12

0.55

1.3

22.43

37.10

u/l

1.65

106

907

Carcinoma in situ of breast, intraductal

395

0.81

0.55

1.2

43.92

25.07

u/l

0.67

340

Muscular dystrophy

1.59

0.54

1.0

1.2

11.08

14.58

u/l

—

Other encephalitis

142

1.34

0.54

1.2

134.94

40.49

u/l

0.36

124

Placenta praevia

125

0.64

0.54

1.5

1.2

8.87

20.54

u/l

—

103

Other and unspecified degenerative diseases of nervous system

159

0.69

0.54

1.1

1.2

38.39

50.85

u/l

0.16

136

Focal epilepsy

141

1278

1.10

0.54

1.4

1.2

58.93

37.33

u/l

0.62

124

1112

Benign neoplasm of mouth and pharynx

636

1.15

0.54

1.7

1.2

47.97

35.67

u/l

0.21

547

Uterine polyps

413

1.19

0.54

1.3

1.2

23.13

30.38

u/l

0.47

354

Occlusion and stenosis of arteries, not leading to stroke

1.48

0.54

1.1

20.52

34.85

u/l

—

Triptan medication for migraine, min. 3 purchases

295

2104

1.07

0.54

1.2

20.61

33.82

u/l

1.69

262

1846

Viral haemorrhagic fevers, not elsewhere classified/unspecified

941

0.88

0.54

1.4

1.3

30.55

41.25

u/l

0.45

819

Other benign neoplasms of uterus

249

1.25

0.54

1.3

1.2

26.40

27.21

u/l

0.04

210

Bacterial, viral and other infectious agents

460

1.18

0.53

1.5

1.2

58.16

43.06

u/l

0.24

394

Other strabismus

125

1124

1.11

0.53

1.4

1.3

17.84

35.43

u/l

2.88

118

984

Malignant neoplasm of rectosigmoid junction

0.60

0.52

1.2

59.16

17.63

u/l

—

Purulent endophthalmitis

1.51

0.52

1.0

1.2

21.56

18.06

u/l

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

191

1565

0.92

0.52

1.2

30.97

28.27

u/l

0.12

167

1366

Malignant neoplasm of parotid gland

1.51

0.52

1.3

1.1

24.98

13.86

u/l

—

Disorders of tooth development and eruption

584

1.14

0.52

1.5

1.2

48.89

30.77

u/l

0.26

511

Ankle and foot

1.51

0.52

1.0

1.2

63.65

14.83

u/l

—

Eating disorders

350

1.20

0.52

1.1

1.3

33.92

32.03

u/l

0.03

299

Other superficial mycoses

471

1.17

0.51

1.3

1.2

16.03

37.30

u/l

2.25

408

Cauda equina syndrome

1.39

0.51

1.3

1.2

202.27

19.95

u/l

—

Torsion of ovary, ovarian pedicle and fallopian tube

1.39

0.50

1.2

228.32

28.84

u/l

—

Nasal polyp

135

1228

1.10

0.50

1.5

1.3

32.14

32.96

u/l

0.03

119

1053

Psoriasis vulgaris

127

1152

1.10

0.50

1.3

26.79

36.35

u/l

0.59

114

1008

Astigmatism

279

1.22

0.49

1.2

38.54

48.04

u/l

0.18

245

Childhood asthma (age<16), excluding more controls

306

1.19

0.49

1.2

1.1

84.66

19.21

u/l

0.42

272

Anankastic personality disorder

167

0.72

0.49

1.1

1.2

27.80

31.90

u/l

0.10

141

Other specified/unspecified disorders of bone/cartilage

145

1.32

0.49

1.2

23.52

33.06

u/l

0.34

125

Migraine, single triptan purchase ok & required. ICD-code if available is included

487

3141

1.05

0.48

1.2

1.3

18.69

35.24

u/l

5.73

431

2762

Triptan medication for migraine, single purchase ok

487

3141

1.05

0.48

1.2

1.3

18.69

35.24

u/l

5.73

431

2762

Other specified and unspecified disorders of conjunctiva

1.50

0.48

1.1

1.3

214.31

14.24

u/l

—

Use of antiglaucoma preparations and miotics

503

1.16

0.47

1.3

1.2

34.86

47.57

u/l

0.45

433

Pediculosis, acariasis and other infestations

804

1.12

0.47

1.5

1.3

28.43

37.34

u/l

0.35

695

Drug-induced osteoporosis

1.48

0.47

1.3

211.17

17.23

u/l

—

Deep endometriosis

387

0.83

0.47

1.2

27.93

23.85

u/l

0.11

330

Dysplasia of cervi uteri

636

1.12

0.47

1.2

27.25

31.03

u/l

0.11

552

Injury of eye and orbit

846

0.89

0.47

1.3

33.92

37.03

u/l

0.10

726

Endometriosis of ovary

647

1.13

0.46

1.3

1.2

34.29

33.29

u/l

0.03

560

Benign neoplasm: Long bones of lower limb

164

1.29

0.46

1.4

1.2

16.28

27.31

u/l

0.72

142

Other obstructed labour

255

0.78

0.46

1.1

1.2

13.90

21.47

u/l

0.95

216

Malignant neoplasm of rectum, including Hilmo

739

0.88

0.46

1.2

121.45

23.55

u/l

0.97

633

Alcoholic gastritis

0.60

0.46

1.4

1.3

32.74

22.41

u/l

—

Benign neoplasm: Skin of scalp and neck

129

1.32

0.46

1.3

1.2

103.38

37.03

u/l

0.34

108

Colectomy operation

121

1102

1.10

0.46

1.2

1.3

29.09

42.24

u/l

1.51

108

955

Assault by blunt object

0.59

0.46

1.0

1.2

19.92

28.59

u/l

—

Inguinal of femoral hernia, unilateral

153

0.72

0.45

1.1

1.2

13.28

38.30

u/l

1.11

134

Inguinal hernia, unilateral

153

0.72

0.45

1.1

1.2

13.28

38.30

u/l

1.11

134

Femoral hernia, unilateral

153

0.72

0.45

1.1

1.2

13.28

38.30

u/l

1.11

134

Chronic suppurative otitis media

347

1.18

0.45

1.2

90.44

45.21

u/l

0.36

299

Maternal care related to the fetus and amniotic cavity and possible delivery problems

161

1025

0.92

0.45

1.2

12.97

30.93

u/l

3.15

140

899

Scabies

228

1.23

0.45

2.1

1.2

32.04

30.00

u/l

0.04

195

Nontoxic single thyroid nodule

338

1.19

0.45

1.3

1.2

21.64

43.70

u/l

1.16

285

Secondary parkinsonism

165

1.28

0.45

1.1

1.2

21.92

35.25

u/l

0.75

145

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

599

0.87

0.45

1.1

1.2

108.58

24.06

u/l

0.72

517

Other and unspecified nail disorders

112

1.35

0.45

1.3

140.73

15.42

u/l

0.48

Use of biperiden

286

0.80

0.44

1.1

1.2

49.86

39.50

u/l

0.10

244

Childhood asthma (age<16)

310

1.17

0.44

1.2

84.66

19.12

u/l

0.42

276

Ectopic pregnancy

676

1.13

0.44

1.1

1.2

49.64

27.72

u/l

0.33

596

Delirium, not induced by alcohol and other psychoactive substances

798

1.11

0.44

1.2

1.3

39.69

46.89

u/l

0.26

685

Glaucoma suspect

257

2418

1.06

0.44

1.3

24.33

38.04

u/l

2.75

221

2089

Other abnormal products of conception

704

0.90

0.43

1.1

1.2

32.64

24.43

u/l

0.23

624

Brachial plexus disorders

433

1.16

0.43

1.2

16.50

39.60

u/l

1.85

375

Burns and corrosions of external body surface, specified by site

593

1.13

0.42

1.4

1.2

45.89

43.97

u/l

0.03

515

Maze procedure for atrial fibrillation

1.58

0.42

1.2

32.58

11.49

u/l

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

0.66

0.42

1.0

1.1

35.42

20.06

u/l

—

Struck by thrown, projected or falling objec

273

0.80

0.42

1.3

1.2

15.10

53.21

u/l

2.38

237

Viral conjunctivitis

0.63

0.42

1.5

1.2

11.40

18.80

u/l

—

Chronic mastoiditis

139

0.72

0.42

1.2

32.21

36.90

u/l

—

120

Other hammer toe(s) (acquired)

108

907

1.10

0.42

1.3

1.2

42.83

41.95

u/l

0.02

774

Endometriosis of rectovaginal septum and vagina

327

0.82

0.42

1.1

1.2

31.89

29.05

u/l

0.06

278

Adenocarcinomas of cervix

0.00

0.41

0.0

1.1

—

12.92

—

Dentofacial anomalies [including malocclusion]

396

3332

0.95

0.41

1.3

1.2

26.47

34.32

u/l

0.90

341

2918

Cramp and spasm

231

1.22

0.41

1.3

1.2

29.26

39.33

u/l

0.34

195

Malignant neoplasm of vagina, including Hilmo

0.00

0.41

0.0

1.1

—

22.08

—

Thiamine deficiency

1.48

0.40

1.6

1.1

23.70

24.65

u/l

—

1.48

0.40

1.0

1.1

18.32

31.94

u/l

—

Other acute viral hepatitis

1.34

0.40

1.4

1.3

13.13

15.07

u/l

—

Nontraumatic intracranial haemmorrhage

144

1332

1.08

0.40

1.3

1.2

29.44

39.51

u/l

0.74

130

1139

Encephalitis

150

1.27

0.40

1.2

134.94

38.97

u/l

0.37

132

Unspecified organic or symptomatic mental disorder

0.00

0.40

0.0

1.1

—

13.04

—

Focal epilepsy, strict definition

131

1207

1.09

0.40

1.4

1.2

62.08

38.32

u/l

0.64

115

1053

Tuberculosis, IBD comorbidity

427

1.15

0.40

1.2

35.64

41.86

u/l

0.21

365

Malignant neoplasm of other and unspecified urinary organs, including Hilmo

1.44

0.39

1.2

14.88

23.50

u/l

—

Atypical facial pain

260

1.20

0.39

1.4

1.3

22.19

24.44

u/l

0.13

219

Tularaemia

106

1.33

0.39

1.1

1.2

50.78

20.83

u/l

0.37

Carcinoma in situ of other and unspecified sites

251

1.20

0.39

1.1

1.2

45.12

62.71

u/l

0.29

219

Hepatocellular carcinoma, including Hilmo

169

1.25

0.39

1.5

1.1

52.13

21.29

u/l

0.71

149

Alzheimer’s disease (Atypical or mixed)

649

0.89

0.38

1.3

1.2

33.01

50.17

u/l

0.76

545

Microscopic polyangiitis

1.40

0.38

1.0

1.1

21.46

21.21

u/l

—

Other and unspecified primary disorders of muscles

1.40

0.38

1.0

1.2

10.62

12.47

u/l

—

Other acquired deformities of ankle and foot

1.40

0.38

1.0

1.2

23.64

14.63

u/l

—

Focal brain injury

363

1.16

0.38

1.1

1.3

33.26

46.52

u/l

0.44

312

Tic disorders

1.39

0.38

1.0

1.2

26.84

18.18

u/l

—

Glaucoma-related operations

354

1.16

0.38

1.5

1.2

41.57

40.99

u/l

0.01

300

Pleural plaque with presence of asbestos

533

1.13

0.38

1.1

1.3

26.21

45.08

u/l

1.75

465

Malignant cancer of tonsil and base of tongue

114

0.70

0.37

1.1

33.85

19.62

u/l

—

Unspecified abortion

179

1.23

0.37

1.3

1.2

12.63

20.30

u/l

0.96

160

Kyphosis

1.40

0.37

1.1

1.2

44.57

15.20

u/l

—

Palmar fascial fibromatosis [Dupuytren]

114

1050

1.09

0.37

1.3

73.13

39.77

u/l

0.49

885

Scissor bite

1.29

0.37

5.3

1.2

20.14

11.67

u/l

—

Failed induction of labour

134

1.27

0.37

1.3

1.2

13.52

16.88

u/l

0.53

112

Hypersomnia

1.29

0.37

1.0

1.2

11.11

35.09

u/l

—

Abnormal findings on antenatal screening of mother

169

0.77

0.37

1.3

1.2

7.29

23.98

u/l

1.36

144

Tonsillectomy and adenotomy

310

2053

1.05

0.36

1.5

1.2

35.29

32.00

u/l

0.11

267

1826

Stenosis and insufficiency of lacrimal passages

516

1.13

0.36

1.5

1.2

20.22

32.84

u/l

1.43

442

Traction detachment of retina

1.47

0.36

1.3

20.97

12.12

u/l

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

122

1128

1.08

0.36

1.5

1.2

62.36

39.16

u/l

0.56

107

984

Respiratory tuberculosis

328

1.16

0.36

1.1

1.2

40.72

41.80

u/l

0.03

284

Respiratory tuberculosis, confirmed and not-confirmed

328

1.16

0.36

1.1

1.2

40.72

41.70

u/l

0.02

283

Bacterial, viral and other infectious agents

488

1.13

0.36

1.5

1.2

57.38

41.76

u/l

0.26

415

Spondylopathies (FG)

697

1.11

0.36

1.4

1.3

41.00

36.44

u/l

0.11

605

Shoulder region

0.64

0.36

1.0

1.1

128.00

22.67

u/l

—

Patellar tendinitis

0.65

0.36

1.2

1.1

9.72

31.56

u/l

—

Benign neoplasm: Prostate

1.44

0.36

1.2

12.28

27.04

u/l

—

All dysplastic lesions of the cervix uteri

824

1.10

0.35

1.3

1.2

28.70

31.07

u/l

0.06

725

Other disorders of binocular vision

1.40

0.35

1.2

9.31

13.55

u/l

—

Other fall from one level to another

125

1346

0.93

0.35

1.4

1.3

29.70

35.56

u/l

0.36

116

1169

Parkinson's disease, excluding more controls

818

0.91

0.35

1.1

1.3

29.45

45.05

u/l

0.73

699

Spirochaetal infections, other/unspecified

480

1.13

0.34

1.2

34.11

44.38

u/l

0.34

416

Motorcycle rider injured in other and unspecified transport accidents

264

1.18

0.34

1.2

13.31

40.08

u/l

1.53

229

Female genital prolapse

148

779

1.07

0.34

1.2

43.32

31.18

u/l

0.24

126

666

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

1.37

0.34

7.8

1.1

18.63

16.33

u/l

—

Viral conjunctivitis

167

0.78

0.34

1.2

24.23

20.73

u/l

0.09

142

Faecal incontinence

479

0.88

0.34

1.2

24.31

39.52

u/l

0.97

408

Torsion of testis

1.35

0.34

1.3

1.2

10.85

30.56

u/l

0.80

Degenerative macular diseases

758

1.10

0.33

1.3

1.2

90.57

40.68

u/l

0.53

664

Macular pucker

112

1037

1.08

0.33

1.3

35.90

37.12

u/l

0.03

908

Benign neoplasm of eye and adnexa

604

0.89

0.33

1.1

1.2

59.06

41.67

u/l

0.33

523

Adenocarcinoma and papilloma adenocarcinoma of rectum

572

0.89

0.33

1.1

1.2

110.92

23.16

u/l

0.74

493

Use of interferon beta-1a

0.68

0.33

1.2

12.27

11.69

u/l

—

Secondary parkinsonism+Parkinsonism in other disease

173

1.22

0.33

1.1

1.2

21.92

34.00

u/l

0.70

154

Lung cancer and mesothelioma

110

1017

0.93

0.33

1.1

1.3

37.48

30.76

u/l

0.33

865

Other disorders of nervous system

407

1.13

0.32

1.2

53.05

42.69

u/l

0.21

345

Inhalation and ingestion of food causing obstruction of respiratory tract

1.28

0.32

1.2

1.1

28.23

41.97

u/l

—

Panhypopituitarism

101

1.29

0.32

1.0

1.2

13.46

32.34

u/l

0.82

FESS (DNB20)

684

1.10

0.31

1.8

1.3

23.66

40.72

u/l

1.17

597

Arthropod-borne viral fevers and viral haemorrhagic fevers

100

1080

0.92

0.31

1.4

1.3

28.81

38.45

u/l

0.48

937

Spermatocele

522

1.11

0.31

1.1

1.2

22.13

45.30

u/l

2.33

451

Malignant neoplasm of rectum

580

0.89

0.31

1.1

1.2

108.26

24.09

u/l

0.65

500

Primary adrenocortical insufficiency

1.35

0.31

1.0

1.3

8.23

16.99

u/l

—

Other sexually transmitted chlamydial diseases

202

1.19

0.31

1.1

1.2

10.33

30.00

u/l

0.96

177

Postpartum hemorraghe, all women as controls

745

0.91

0.30

1.2

36.04

27.95

u/l

0.22

659

Tuberculosis, wide

447

1.12

0.30

1.2

36.48

47.88

u/l

0.42

381

Colitis, primary sclerosing, strict definition

1.30

0.30

1.0

1.3

36.86

10.69

u/l

—

Endovascular or surgical operations to intracerebral aneurysms

336

0.86

0.30

1.1

1.2

18.28

34.78

u/l

1.35

282

Carcinoma in situ of skin, other sites/unspecified

1.34

0.30

1.1

38.28

26.47

u/l

—

Paralytic ileus

218

0.82

0.30

1.3

1.2

19.23

40.78

u/l

1.28

184

Contact with and exposure to communicable diseases

142

1327

1.07

0.30

1.6

1.2

24.95

35.90

u/l

0.93

132

1166

Visual field defects

495

1.11

0.30

1.1

1.2

38.70

41.90

u/l

0.05

428

Malignant neoplasm of parotid gland, including Hilmo

1.28

0.30

1.3

1.2

28.91

14.42

u/l

—

Temporomandibular joint disorders, including avohilmo

206

2137

0.95

0.30

1.2

26.31

35.32

u/l

0.88

176

1878

Use of cabergoline

1.28

0.30

1.3

1.1

16.63

20.33

u/l

—

malignant neoplasm of female genital organs

709

0.91

0.29

1.2

72.02

26.11

u/l

0.44

603

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.25

0.29

1.6

1.2

12.47

u/l

—

Effects of foreign body entering through natural orifice

164

1549

1.06

0.29

1.2

1.3

30.53

33.66

u/l

0.11

149

1356

Injury of urinary and pelvic organs

108

0.74

0.29

1.0

1.2

10.12

35.26

u/l

—

Malignant neoplasm of base of tongue, including Hilmo

1.23

0.29

1.3

1.2

56.71

14.08

u/l

—

Crushing injury of wrist and hand

1.30

0.28

1.1

1.2

67.05

42.17

u/l

0.21

Thyrotoxicosis with diffuse goitre

632

1.09

0.28

1.2

18.29

33.42

u/l

1.50

539

Early syphilis

1.27

0.28

1.1

1.2

10.29

17.06

u/l

—

D07AA Corticosteroids, weak (group I)

708

1.09

0.28

1.2

1.3

34.82

37.85

u/l

0.11

611

Nonsuppurative otitis media

113

914

1.07

0.27

1.2

69.26

40.88

u/l

0.44

100

797

Tuberculosis

375

1.12

0.27

1.1

1.2

39.25

46.62

u/l

0.21

322

Foreign body on external eye

958

0.93

0.27

1.2

1.3

18.54

34.58

u/l

2.16

841

Benign neoplasm: Skin of other and unspecified parts of face

643

1.09

0.27

1.1

1.2

22.98

42.03

u/l

2.01

552

Dissection of aorta

196

1.18

0.27

1.1

1.2

47.84

43.40

u/l

0.06

173

Graves disease, strict definition

442

1.11

0.27

1.2

17.63

29.06

u/l

0.77

383

Demyelinating diseases of the central nervous system

366

1.12

0.26

1.1

1.2

14.94

35.89

u/l

1.77

317

Sequelae of injuries of head

281

1.14

0.26

1.2

27.63

53.15

u/l

0.83

241

Early syphilis

1.20

0.26

1.1

1.2

10.29

16.70

u/l

—

Malignant neoplasm of anus and anal canal, including Hilmo

0.66

0.26

1.4

1.2

8.58

18.36

u/l

—

Carcinoma in situ of other and unspecified digestive organs

216

1.16

0.25

1.3

115.75

48.89

u/l

0.50

187

Fracture at wrist and hand level

228

2180

1.04

0.25

1.2

1.3

42.83

31.53

u/l

0.43

204

1900

Other noninflammatory disorders of vulva and perineum

358

1.12

0.25

1.3

1.2

11.19

27.27

u/l

3.92

309

Entropion and trichiasis of eyelid

550

0.91

0.25

1.2

32.79

42.09

u/l

0.25

475

Alcohol abuse, main dg

944

0.93

0.25

1.4

1.3

25.53

40.31

u/l

0.77

824

Hereditary retinal dystrophy

1.22

0.25

1.1

1.3

39.10

28.13

u/l

—

Other condition

810

1.08

0.25

1.2

39.18

41.14

u/l

0.06

705

Malignant melanoma of skin

646

1.08

0.25

1.2

89.95

22.54

u/l

1.05

554

Hypertrophy of breast

685

1.08

0.25

1.3

1.2

25.27

25.83

u/l

0.02

601

Procreative management

186

1479

1.05

0.25

1.5

1.2

47.12

37.22

u/l

0.30

165

1298

Myositis

142

1.20

0.24

1.3

19.25

53.60

u/l

1.27

123

Burn and corrosion of ankle and foot

0.73

0.24

1.0

1.2

78.90

29.76

u/l

—

Acute alcohol intoxication, ICD10

120

1271

0.94

0.24

1.3

25.36

35.95

u/l

0.72

1119

Beningn neoplasm: Meninges, unspecified

0.72

0.24

1.0

1.2

40.45

18.23

u/l

—

Other meningitis

0.72

0.24

1.2

94.92

33.99

u/l

—

Abdominal aortic aneurysm (AAA)

657

0.92

0.24

1.2

1.3

30.30

44.71

u/l

0.75

564

Atopic dermatitis, strict definition with reimbursement

144

1319

1.05

0.24

1.4

1.2

46.18

32.33

u/l

0.26

129

1158

Chronic suppurative otitis media, including avohilmo

417

1.10

0.24

1.2

80.51

41.93

u/l

0.35

358

Malignant neoplasm of colon

880

1.07

0.24

1.2

33.75

24.19

u/l

0.91

749

Haemangioma, any site

446

1.10

0.24

1.2

45.29

33.70

u/l

0.31

384

Calculus of lower urinary tract

360

1.11

0.23

1.2

80.59

46.97

u/l

0.26

319

Golimumab

158

0.82

0.23

1.2

20.98

26.38

u/l

0.17

138

Other menopausal disorders

118

705

0.94

0.23

1.3

1.2

23.08

30.22

u/l

0.49

106

613

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

389

1.11

0.23

1.1

1.2

16.36

38.66

u/l

2.53

336

Malignant cancer of tonsil and base of tongue, including Hilmo

147

0.81

0.23

1.2

47.19

17.77

u/l

0.84

129

Disorders of refraction and accommodation

146

1382

1.05

0.23

1.3

52.48

32.67

u/l

0.42

128

1208

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

1.32

0.23

1.0

1.1

14.77

16.53

u/l

—

Other specified disorders of external ear

237

1.14

0.23

2.8

1.2

36.20

49.66

u/l

0.26

207

Urethral stricture

399

1.10

0.23

1.5

1.2

47.74

56.16

u/l

0.14

352

Sequelae of injuries of lower limb

495

1.09

0.23

1.4

1.2

17.12

44.45

u/l

2.62

424

Pregnancy examination and test

321

0.91

0.23

1.2

19.78

45.13

u/l

0.95

288

Muscle wasting and atrophy, not elsewhere classified

1.29

0.23

1.2

1.1

17.55

24.64

u/l

—

Dissection of cerebral arteries, nonruptured

1.29

0.23

1.2

1.3

30.32

15.86

u/l

—

Maternal care for other known or suspected fetal problems

452

0.92

0.23

1.1

1.3

41.73

37.97

u/l

0.06

402

Tic and related disorders

1.28

0.23

1.0

1.2

26.84

17.92

u/l

—

Colorectal adenocarcinoma

116

1222

0.95

0.22

1.2

65.37

23.41

u/l

0.88

102

1039

Exposure to uncontrolled fire in building or structure

1.22

0.22

1.2

16.60

13.65

u/l

—

LSIL lesion of the cervix uteri, vagina or vulva

493

0.91

0.22

1.3

1.2

44.84

19.20

u/l

0.41

430

Disorders of hypoglossal nerve

0.00

0.21

0.0

1.0

—

22.77

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

0.21

0.0

1.0

—

24.50

—

Vertical strabismus

167

0.84

0.21

1.9

1.2

15.72

34.95

u/l

0.99

147

Fibrothorax

0.00

0.21

0.0

1.0

—

30.04

—

Dengue fever [classical dengue]

0.00

0.21

0.0

1.3

—

11.76

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.21

0.0

1.1

—

22.31

—

Normotensive glaucoma

544

0.92

0.21

1.5

1.2

24.62

45.24

u/l

1.56

474

Benign neoplasm: Lymph nodes

0.00

0.21

0.0

1.3

—

10.25

—

Suppurative otitis media, unspecified

1.23

0.21

1.2

13.47

62.78

u/l

1.18

Complications following abortion and ectopic and molar pregnancy

154

1.17

0.21

1.2

15.65

24.50

u/l

0.58

133

Intentional self-harm by unspecified means

1.16

0.21

1.2

7.27

11.32

u/l

—

Campylobacter enteritis

145

1.18

0.20

1.6

1.3

24.24

35.60

u/l

0.32

125

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

236

0.87

0.20

1.4

76.63

32.96

u/l

0.28

204

Maltreatment syndromes

208

0.86

0.20

1.2

15.61

35.31

u/l

0.88

179

Other inflammation of vagina/vulva

115

0.78

0.20

1.2

12.66

21.80

u/l

—

Somnolence

1.20

0.20

1.3

1.1

13.09

12.28

u/l

—

Pedestrian injured in other and unspecified transport accidents

1.18

0.19

1.0

1.2

14.45

15.70

u/l

—

Postpartum hemorraghe, parous women as controls

627

0.94

0.19

1.2

36.04

23.66

u/l

0.37

567

Ankylosing spondylitis, ICD10

478

0.92

0.19

1.5

1.2

36.95

46.13

u/l

0.24

411

Ulcerative colitis (strict definition, all Crohn cases excluded)

773

1.06

0.19

1.2

32.29

39.60

u/l

0.28

670

Alcohol dependence

195

1880

1.04

0.19

1.2

1.3

38.46

32.04

u/l

0.35

165

1641

Combined immunodeficiencies

1.13

0.18

1.3

1.2

723.92

16.13

u/l

—

Additional codes for the location of defect, injury or illness

301

0.90

0.18

1.1

1.2

79.26

46.02

u/l

0.47

257

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

148

1524

0.96

0.18

3.4

1.2

42.56

22.87

u/l

1.83

129

1301

Complications of labour and delivery

281

1611

0.97

0.18

1.2

26.76

32.88

u/l

0.63

245

1411

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

132

0.83

0.18

1.1

1.2

22.07

41.72

u/l

0.61

114

Operations for atrial fibrillation

100

1.20

0.18

1.3

1.1

26.33

37.73

u/l

0.40

Desensitization to allergens

185

0.86

0.18

2.4

1.2

70.08

36.13

u/l

0.23

163

Other injuries of upper limb, level unspecified

1.19

0.18

1.1

1.2

10.54

13.63

u/l

—

Mild mental retardation

121

0.82

0.18

1.5

1.2

24.67

22.09

u/l

—

107

Maternal care for known or suspected abnormality of pelvic organs

584

0.94

0.18

1.3

1.2

21.41

29.39

u/l

0.53

516

Thyroiditis, unspecified

1.15

0.17

1.1

1.2

16.28

14.85

u/l

—

Benign neoplasm: Appendix

1.11

0.17

1.1

1.2

92.13

16.46

u/l

—

Exfoliative dermatitis

1.11

0.17

2.1

1.1

36.74

52.59

u/l

—

Other factor of the environment

0.76

0.17

1.0

1.2

34.91

22.54

u/l

—

Malignant neoplasm of vulva, including Hilmo

0.74

0.17

1.8

1.2

18.10

22.22

u/l

—

Varicella [chickenpox]

253

1.11

0.17

1.3

1.2

37.79

27.71

u/l

0.22

219

Lagophthalmos

0.71

0.17

1.4

1.2

79.68

42.40

u/l

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

200

1926

1.03

0.17

1.2

1.3

40.32

33.76

u/l

0.21

179

1697

Hepatocellular carcinoma

120

0.83

0.16

1.9

1.1

69.93

21.42

u/l

—

107

Fistulae involving female genital tract

1.16

0.16

1.5

1.2

9.96

25.55

u/l

—

Hallux rigidus

813

0.95

0.16

1.2

1.3

41.53

39.22

u/l

0.06

702

Methotrexate

729

1.06

0.16

1.2

51.23

37.53

u/l

0.21

631

Other salmonella infections

225

0.89

0.16

1.2

69.72

26.20

u/l

0.79

193

Atopic dermatitis, strict definition

126

1285

0.96

0.16

1.5

1.2

51.26

36.73

u/l

0.23

112

1130

Pedestrian injured in collision with car, pick-up truck or van

130

1.16

0.15

1.1

1.2

92.12

24.08

u/l

0.66

112

Melanoma in situ of trunk

0.76

0.15

1.5

1.1

306.85

43.42

u/l

—

Universal erythroderma, KELA reimbursement

1.21

0.15

1.0

1.2

14.44

54.95

u/l

—

Bitten or struck by other mammals

516

1.07

0.15

1.4

1.2

15.43

35.07

u/l

2.32

450

Leisure time condition

110

1054

1.04

0.15

1.6

1.3

28.20

41.37

u/l

0.93

925

Fracture of forearm

343

3213

0.98

0.15

1.7

1.2

56.99

34.05

u/l

1.20

296

2775

Other/unspecified reactive arthropathies

332

1.09

0.15

2.4

1.2

27.58

36.76

u/l

0.32

287

Carcinoma in situ of colon

121

1.16

0.15

1.3

73.01

33.00

u/l

0.59

106

Toxic liver disease

1.11

0.15

1.0

1.2

14.91

18.84

u/l

—

Benign mammary dysplasia

656

0.94

0.14

1.2

18.65

32.21

u/l

1.38

568

Intracerebral haemorrhage

830

1.05

0.14

1.2

1.3

33.70

42.33

u/l

0.33

706

Sequelae of tuberculosis

1.19

0.14

1.2

1.1

30.12

43.52

u/l

0.38

Lichen planus, including avohilmo

108

1125

0.96

0.14

1.2

31.85

36.89

u/l

0.20

981

Bicipital tendinitis

285

0.91

0.14

1.2

48.49

53.98

u/l

0.07

243

Oral lichen planus, including avohilmo , including avohilmo

347

0.92

0.14

1.3

24.90

32.41

u/l

0.38

298

Other noninflammatory disorders of vagina

314

1.08

0.14

1.3

1.2

47.42

25.55

u/l

0.34

270

Pedal cyclist injured in other and unspecified transport accidents

593

0.94

0.14

1.4

1.2

30.97

41.85

u/l

0.42

509

Injury of other and unspecified intrathoracic organs

402

1.07

0.13

1.5

1.2

26.97

52.04

u/l

1.02

353

Benign neoplasm of breast

521

0.94

0.13

1.1

1.2

26.16

27.97

u/l

0.08

453

Autonomic disorders

128

0.86

0.13

1.1

1.2

74.74

24.08

u/l

0.49

111

Benign lipomatous neoplasm of other sites/unspecified

531

0.94

0.13

1.1

1.2

27.94

42.94

u/l

0.91

454

Allergic contact dermatitis

623

0.95

0.13

1.2

19.46

30.26

u/l

0.91

533

Other salmonella infections

201

0.89

0.13

1.2

1.3

78.70

27.51

u/l

0.82

175

Injuries to the neck

135

1305

1.03

0.13

1.2

1.3

21.31

35.19

u/l

2.11

120

1140

Sleep disorders, other/unspecified

151

1.13

0.13

1.4

1.2

13.25

31.80

u/l

1.38

130

Right hemicolectomy

364

1.07

0.13

1.1

1.2

32.67

45.66

u/l

0.60

317

Memory loss

579

1.05

0.13

1.3

1.2

26.80

45.21

u/l

1.18

503

Colon adenocarcinoma

693

0.95

0.13

1.3

1.2

34.96

22.86

u/l

0.95

589

Mumps

142

1.13

0.12

1.2

10.91

31.54

u/l

1.45

121

Contact with other hot metals

1.18

0.12

1.6

1.2

15.57

37.62

u/l

—

Ankylosing spondylitis

488

0.94

0.12

1.5

1.3

35.91

38.64

u/l

0.07

422

Other ill-defined and unspecified causes of mortality

512

1.06

0.12

1.2

76.56

46.98

u/l

0.29

438

Psoriatic and enteropathic arthropathies

610

1.05

0.12

1.3

39.91

35.95

u/l

0.09

531

Scabies

620

1.05

0.12

1.5

1.3

19.98

39.32

u/l

1.30

538

Retinal breaks without detachment

102

984

1.04

0.11

1.2

1.3

56.19

37.15

u/l

0.45

858

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

292

0.92

0.11

1.3

1.2

20.74

30.20

u/l

0.65

252

Corneal ulcer

104

1076

0.97

0.11

1.4

1.2

25.67

35.24

u/l

0.87

934

Benign neoplasm of middle ear and respiratory system

484

1.05

0.11

1.2

40.18

40.05

u/l

0.00

418

Left ventricular outflow tract obstruction, narrow definition

240

1.08

0.11

1.1

1.2

20.60

46.95

u/l

1.23

207

Myopia

537

0.95

0.11

1.2

103.68

31.34

u/l

0.57

467

Other enthesopathy of foot (+metatarsalgia)

494

1.05

0.11

1.1

1.2

27.30

41.91

u/l

0.55

426

Medical treatment for female infertility

584

0.95

0.11

1.3

1.2

13.07

31.81

u/l

2.48

521

Other mental disorders due to brain damage and dysfunction and to physical disease

780

1.04

0.10

1.2

25.56

43.78

u/l

1.38

670

Obstructed labour due to malposition and malpresentation of fetus

642

0.96

0.10

1.2

19.05

24.55

u/l

0.37

567

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

162

1580

1.03

0.10

1.3

1.2

80.05

38.26

u/l

0.88

145

1372

Benign neoplasm: Pharynx, unspecified

1.11

0.10

1.4

1.1

12.90

14.60

u/l

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

129

1325

0.97

0.09

1.2

1.3

31.10

37.97

u/l

0.35

107

1162

Glaucoma, exfoliation

693

1.04

0.09

1.2

41.00

50.56

u/l

0.39

601

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

164

1602

1.02

0.09

1.2

1.3

28.16

31.23

u/l

0.12

144

1400

Benign neoplasm: Rectum/anal canal icd-9

1.06

0.09

1.2

1.1

30.59

47.91

u/l

—

Iliotibial band syndrome

1.06

0.09

1.4

1.2

8.42

26.56

u/l

—

Contraceptive management

231

1651

0.98

0.09

1.2

19.26

30.86

u/l

1.98

205

1457

Ulcerative colitis (strict definition, require KELA)

911

1.03

0.09

1.2

1.3

32.39

36.57

u/l

0.17

794

Malignant neoplasm of corpus uteri, including Hilmo

458

1.05

0.09

1.2

85.06

25.92

u/l

0.43

392

Other benign neoplasms of connective and other soft tissue

533

0.96

0.09

1.3

1.2

15.64

36.89

u/l

3.07

458

LSIL lesion of the cervix uteri

370

0.95

0.09

1.4

1.2

50.14

19.07

u/l

0.41

322

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

439

1.05

0.08

1.6

1.2

19.24

35.78

u/l

1.86

376

Anorexia

1.07

0.08

1.0

1.1

19.55

13.76

u/l

—

Seropositive rheumatoid arthritis, wide

166

1625

1.02

0.08

1.3

1.2

79.03

38.12

u/l

0.89

149

1412

Ectropion of eyelid

253

1.07

0.08

2.7

1.2

35.54

43.45

u/l

0.25

218

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

1.03

0.08

1.2

14.00

15.09

u/l

—

Lifestyle-related condition

0.82

0.08

1.0

1.2

34.91

16.64

u/l

—

Other disorders of optic disc

0.82

0.08

1.0

1.1

38.64

22.52

u/l

—

Inguinal or femoral hernia, bilateral

775

0.97

0.08

1.2

1.3

90.86

35.79

u/l

0.55

674

Certolizumab pegol

0.83

0.08

1.2

19.94

14.51

u/l

—

Malignant neoplasm of heart, mediastinum and pleura

0.79

0.08

1.0

1.1

24.76

22.69

u/l

—

Otosclerosis

430

0.95

0.08

1.2

1.3

40.94

39.14

u/l

0.04

369

Benign neoplasm: Tonsil

0.77

0.08

1.0

1.2

19.98

16.04

u/l

—

Benign neoplasm: Parathyroid gland

1.10

0.08

1.3

1.2

51.57

23.44

u/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

348

0.95

0.08

1.3

1.2

18.21

19.94

u/l

0.09

301

Rheumatoid arthritis, including avohilmo

246

2423

1.02

0.07

1.2

66.96

35.86

u/l

1.05

224

2083

Contact with machinery

763

0.97

0.07

1.1

1.3

33.23

44.58

u/l

0.55

665

Use of disulfiram, acamprosate or naltrexone

530

0.96

0.07

1.2

28.11

45.45

u/l

0.68

458

Other disorders of binocular movement

0.86

0.07

1.1

20.44

12.68

u/l

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

430

1.04

0.07

1.3

1.2

33.64

44.76

u/l

0.38

365

Fracture of lower leg, including ankle

369

3693

0.99

0.07

1.3

21.34

33.52

u/l

3.17

314

3223

Female infertility, cervical, vaginal, other or unspecified origin

102

647

1.03

0.07

1.3

1.2

17.56

29.52

u/l

1.66

560

Other and unspecified injuries of thorax

1.13

0.07

1.0

1.1

23.81

23.67

u/l

—

Malignant neoplasm of eye and adnexa, including Hilmo

0.89

0.07

1.1

26.89

21.12

u/l

—

Other lack of coordination

0.87

0.07

1.4

1.2

8.45

36.49

u/l

—

HSIL lesion of the cervix uteri

571

1.03

0.06

1.2

15.31

20.70

u/l

0.73

499

Medical abortion

312

1713

0.99

0.06

1.2

46.55

33.59

u/l

0.46

266

1501

Pneumothorax

423

1.04

0.06

1.2

21.57

49.98

u/l

2.00

378

Graves ophthalmopathy, strict

1.11

0.06

1.4

1.2

14.78

21.69

u/l

0.55

Family history of malignant neoplasm

467

0.96

0.06

1.2

40.65

26.37

u/l

0.43

403

Vascular dementia

577

0.97

0.06

1.3

1.2

67.82

48.48

u/l

0.22

489

Endometriosis ASRM stages 3,4

968

1.02

0.06

1.3

1.2

29.08

24.92

u/l

0.19

843

Postmenopausal atrophic vaginitis

134

725

1.02

0.06

1.2

52.69

31.96

u/l

0.42

120

620

Reimbursement for rheumatic diseases

372

3741

0.99

0.06

1.2

1.3

53.90

33.19

u/l

1.01

332

3238

Other facial nerve disorders

158

1.08

0.06

1.1

1.2

25.56

40.33

u/l

0.45

131

Malignant neoplasm of colon, including Hilmo

118

1156

1.02

0.06

1.2

38.18

23.61

u/l

1.18

104

980

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

172

0.93

0.06

2.3

1.2

15.74

24.38

u/l

0.56

152

Hyperprolactinaemia

129

1.09

0.05

1.1

1.2

16.75

20.36

u/l

—

111

Injury of muscle and tendon at lower leg level

960

0.98

0.05

1.5

1.2

25.51

37.32

u/l

0.78

844

Excessive earwax

404

3907

1.01

0.05

1.3

42.83

36.15

u/l

0.22

350

3387

Mixed conductive and sensorineural hearing loss

758

0.98

0.05

1.7

1.2

62.70

41.72

u/l

0.50

663

Benign neoplasm: Skin of lower limb, including hip

151

0.93

0.05

1.1

1.2

249.95

25.77

u/l

—

135

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

534

1.02

0.05

1.1

1.3

16.88

37.64

u/l

1.51

477

Lichen planus

743

1.02

0.05

1.2

35.51

39.87

u/l

0.11

643

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

248

1.05

0.05

1.4

1.2

13.65

38.01

u/l

1.91

211

Injury of intra-abdominal organs

130

0.92

0.04

1.1

1.2

9.91

49.88

u/l

1.36

112

Primary open-angle glaucoma, strict

181

1784

1.01

0.04

1.3

1.2

27.11

41.55

u/l

2.15

146

1537

Alcoholic liver disease

685

0.98

0.04

1.3

36.62

38.16

u/l

0.05

589

Other disorders of the genitourinary system

685

1.02

0.04

1.2

26.52

35.59

u/l

0.82

592

Ulcerative rectosigmoiditis

433

0.97

0.04

1.2

20.25

48.56

u/l

2.19

376

Disorders of breast

236

2121

1.01

0.04

1.2

23.30

34.52

u/l

1.45

206

1843

Acute nasopharyngitis (common cold)

710

0.98

0.04

1.1

1.3

19.89

26.35

u/l

0.69

621

Alzheimer disease, excluding more controls

121

809

0.99

0.04

1.3

50.95

46.28

u/l

0.12

105

685

Benign neoplasm: Larynx

180

1.06

0.04

1.1

1.2

102.55

41.88

u/l

0.54

155

Other/unspecified seropositive rheumatoid arthritis

162

1602

1.01

0.03

1.3

1.2

80.05

38.30

u/l

0.88

145

1392

Other sexually transmitted chlamydial diseases

309

1.04

0.03

1.1

1.3

11.57

27.89

u/l

1.24

265

Melanocytic naevi of lower limb, including hip

220

1.05

0.03

1.2

1.3

22.09

29.28

u/l

0.27

188

Nummular dermatitis

498

1.02

0.03

1.2

19.35

36.41

u/l

2.23

430

Inguinal hernia, bilateral

763

0.98

0.03

1.2

1.3

90.86

36.15

u/l

0.54

662

Disorders of eyelid in diseases classified elsewhere

169

0.95

0.03

1.3

1.2

18.15

28.75

u/l

0.62

152

Residual foreign body in soft tissue

280

0.96

0.03

1.5

1.2

27.28

66.20

u/l

1.39

242

Benign neoplasm of meninges

579

1.02

0.02

1.1

1.2

30.96

37.33

u/l

0.29

494

Other obstetric conditions, not elsewhere classified

558

1.01

0.02

1.1

1.3

16.88

36.45

u/l

1.47

498

Obstructed labour due to maternal pelvic abnormality

621

0.98

0.02

1.3

1.2

23.21

24.38

u/l

0.06

546

Chalazion

629

1.02

0.02

1.3

1.2

30.92

43.46

u/l

0.60

544

Pregnancy with abortive outcome

328

1721

0.99

0.02

1.2

35.23

33.56

u/l

0.06

279

1506

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

328

2582

1.01

0.02

1.4

1.2

39.70

33.44

u/l

0.21

288

2246

Transient global amnesia

570

0.98

0.02

1.3

1.2

15.41

40.51

u/l

3.77

493

Superficial injury of shoulder and upper arm

620

1.02

0.02

1.3

1.2

38.30

40.38

u/l

0.05

536

UC patients in KELA-register (code 208), prior to 1994

252

1.03

0.02

1.1

1.2

19.10

43.63

u/l

1.60

216

Colorectal cancer

149

1446

1.01

0.02

1.2

57.51

23.17

u/l

0.89

126

1230

Childhood allergy (age < 16)

287

0.98

0.02

2.3

1.2

106.40

39.10

u/l

0.32

258

Graves ophthalmopathy

113

1.06

0.02

1.3

1.2

14.35

20.32

u/l

0.53

Eustachian salpingitis and obstruction

338

0.98

0.01

1.2

21.54

35.26

u/l

0.53

290

Loose body in joint

127

0.94

0.01

1.2

1.3

28.56

37.00

u/l

0.16

104

Benign neoplasm: Cerebral meninges

512

1.02

0.01

1.1

1.2

27.12

36.31

u/l

0.45

435

Retinal detachment with retinal break

842

1.01

0.01

1.3

39.59

39.82

u/l

0.00

734

Other disorders of breast

513

1.01

0.01

1.3

1.2

31.41

24.02

u/l

0.21

437

Speech disturbances, not elsewhere classified

553

1.01

0.01

1.1

1.2

50.28

36.51

u/l

0.17

474

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

103

1023

1.01

0.00

1.2

1.3

30.26

37.96

u/l

0.40

890

Short Achilles tendon (acquired)

124

1.05

0.00

1.3

1.2

61.69

24.01

u/l

0.40

107

Cysts of oral region, not elsewhere classified

326

0.98

0.00

1.2

12.91

53.53

u/l

3.06

281

Other congenital malformations of skin

346

0.98

0.00

1.2

86.64

40.57

u/l

0.31

296

Metatarsalgia

454

1.01

0.00

1.1

1.2

29.58

40.08

u/l

0.32

391

L02BB Anti-androgens

686

0.99

0.00

3.8

1.3

58.23

44.01

u/l

0.41

594

Alcohol abuse, main dg, excluding more controls

874

1.01

0.00

1.4

1.3

25.53

35.39

u/l

0.45

773

Sulfasalazine

167

1664

1.00

0.00

1.3

1.2

52.80

29.98

u/l

0.52

148

1432

Malignant neoplasm of head and neck

484

1.01

0.00

1.8

1.2

23.67

22.45

u/l

0.10

418

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

877

1.00

0.00

1.2

1.3

33.36

37.24

u/l

0.15

764

All dysplastic lesions of the cervix uteri, vagina or vulva

102

1000

1.00

0.00

1.3

1.2

27.36

29.48

u/l

0.06

880

Speech therapy

169

1686

1.00

0.00

1.6

1.2

85.69

38.16

u/l

1.19

160

1460

Somnolence, stupor and coma

235

0.98

0.00

1.3

53.65

32.88

u/l

0.21

206

Impacted maxillary molar

149

1.01

0.00

1.4

196.92

36.61

u/l

0.41

130

Fall on and from ladder

515

1.01

0.00

1.9

1.3

35.28

47.25

u/l

0.39

448

Ill-defined and unknown causes of mortality

575

0.99

0.00

1.2

78.42

47.11

u/l

0.34

494

Infections of breast associated with childbirth

1.04

0.00

1.4

1.2

15.21

17.07

u/l

—

Burn and corrosion of wrist and hand

184

0.98

0.00

1.5

1.2

12.45

40.32

u/l

1.58

157

Other noninflammatory disorders of cervix uteri

224

0.98

0.00

1.2

42.54

26.69

u/l

0.35

194

Retained placenta and membranes, without haemorrhage

454

0.99

0.00

1.2

22.85

19.19

u/l

0.23

396

Malignant neoplasm of corpus uteri

396

1.01

0.00

1.2

102.38

25.49

u/l

0.45

339

Dislocation, sprain and strain of joint and ligaments of hip

201

0.99

0.00

1.1

1.2

19.06

45.73

u/l

1.39

175

HSIL lesion of the cervix uteri, vagina or vulva

639

1.00

0.00

1.2

14.95

25.76

u/l

1.41

559

Disorders of lacrimal system and orbit in diseases classified elsewhere

121

0.99

0.00

1.3

1.2

14.35

18.60

u/l

0.37

103

Exposure to other specified electric current

1.01

0.00

1.5

1.1

10.84

19.32

u/l

—

Contusion of toe(s) without damage to nail

1.01

0.00

1.1

1.2

19.70

22.26

u/l

—

Contact with sharp object, undetermined intent

115

0.96

0.00

1.0

1.3

24.20

31.15

u/l

0.17

100

Disorders of vagus nerve

0.00

0.0

1.1

—

12.47

—

CR(E)ST syndrome

0.88

0.00

1.0

1.2

50.40

16.21

u/l

—

Cleft lip

0.00

0.0

1.4

—

9.63

—

Pemphigus foliaceus

0.00

0.0

1.3

—

8.53

—

Benign neoplasm: Trachea

0.00

0.0

1.3

—

13.38

—

Environmental-pollution-related condition

0.00

0.0

1.1

—

12.08

—

Dysplastic lesion of the vulva of unknown severity

0.00

0.0

1.0

—

34.48

—

Tympanosclerosis

0.00

0.0

1.2

—

14.95

—

Injury of muscle and tendon at neck level

0.00

0.0

1.3

—

12.07

—

Fibrosis and sclerosis of liver

0.00

0.0

1.2

—

18.10

—

Congenital malformations of uterus and cervix

0.96

0.00

1.0

1.1

8.02

24.85

u/l

—

Retained (old) foreign body following penetrating wound of orbit

0.00

0.0

1.2

—

6.13

—

Liveborn infants according to place of birth

0.00

-0.00

0.0

1.5

—

10.73

—

Lumbosacral root disorders, not elsewhere classified

0.93

-0.00

1.0

1.2

21.27

19.42

u/l

—

Cellulitis of external ear

0.98

-0.00

1.7

1.1

21.73

20.49

u/l

—

Disorders of multiple cranial nerves

0.00

-0.00

0.0

1.0

—

17.36

—

Disorders of brain, other and unspecified

1.02

-0.00

3.8

1.2

162.80

16.61

u/l

—

Adhesive middle ear disease

0.97

-0.00

1.3

1.2

12.41

25.71

u/l

—

Guillain-Barre syndrome

0.99

-0.00

1.4

1.2

10.48

34.31

u/l

—

Hypersensitivity pneumonitis due to organic dust

0.95

-0.00

3.8

1.2

216.11

41.23

u/l

—

Disorders of olfactory nerve

0.00

-0.00

0.0

1.2

—

13.12

—

Deep bite that required surgery

0.93

-0.00

1.0

1.2

10.84

11.04

u/l

—

Primary ovarian failure

0.88

-0.00

1.2

7.52

15.16

u/l

—

Calcium deposit in bursa

0.00

-0.00

0.0

1.1

—

18.04

—

Other and unspecified pemphigoid

1.00

-0.00

1.0

1.1

19.62

53.18

u/l

—

Causalgia

0.90

-0.00

1.1

1.2

9.57

35.31

u/l

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

-0.00

0.0

1.0

—

6.75

—

Vitamin D deficiency

0.97

-0.00

2.1

1.2

58.64

12.69

u/l

—

Ascorbic acid deficiency

0.00

-0.00

0.0

1.2

—

35.48

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

-0.00

0.0

1.3

—

29.94

—

Porphyria cutanea tarda

0.00

-0.00

0.0

1.0

—

17.93

—

Follicular keratosis (Darier-White)

0.00

-0.00

0.0

1.5

—

13.70

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

-0.00

0.0

1.1

—

9.48

—

Drug-induced tics and other tics of organic origin

0.00

-0.00

0.0

1.0

—

16.34

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.0

—

12.20

—

Congenital nasolacrimal duct obstruction or stenosis

0.00

-0.00

0.0

1.0

—

11.30

—

Pectus carinatum

0.00

-0.00

0.0

1.4

—

10.76

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

-0.00

0.0

1.3

—

9.61

—

Syndactyly

0.00

-0.00

0.0

1.4

—

10.23

—

Benign neoplasm: Oesophagus

0.87

-0.00

1.2

1.1

123.92

37.03

u/l

—

Secondary sideroblastic anaemia due to drugs and toxins

0.00

-0.00

0.0

1.0

—

16.82

—

Benign neoplasm: Skin of lip

0.99

-0.00

1.0

1.2

13.41

18.56

u/l

—

Other sudden death, cause unknown

0.00

-0.00

0.0

1.4

—

34.84

—

Toxic effect of other and unspecified substances

0.93

-0.00

1.4

1.2

8.99

11.45

u/l

—

Bacterial sepsis of newborn

0.00

-0.00

0.0

1.1

—

9.90

—

Injury of nerves at forearm level

0.98

-0.00

1.2

1.1

24.75

15.03

u/l

—

Traumatic subcutaneous emphysema

0.00

-0.00

0.0

1.1

—

12.08

—

Sequelae of poisoning by drugs, medicaments and biological substances

0.00

-0.00

0.0

1.2

—

15.92

—

Drowning to ice

0.00

-0.00

0.0

1.0

—

11.20

—

Cardiovascular devices associated with adverse incidents

0.00

-0.00

0.0

1.2

—

14.90

—

Malignant neoplasm of vagina

0.00

-0.00

0.0

1.2

—

10.62

—

0.95

-0.00

1.0

1.2

6.35

12.19

u/l

—

Bacterial meningoencephalitis and meningomyelitis

0.00

-0.00

0.0

1.4

—

13.03

—

Disorders of muscle in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

11.06

—

Congenital malformation of optic disc

0.00

-0.00

0.0

1.0

—

12.15

—

Ovarian dysfunction: estrogen excess

0.00

-0.00

0.0

1.0

—

6.28

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.0

—

7.54

—

Acrodermatitis chronica atrophicans

0.00

-0.00

0.0

1.1

—

16.50

—

Myopathy due to other toxic agents

0.00

-0.00

0.0

1.4

—

11.66

—

Malignant neoplasm of testis

0.90

-0.00

1.0

1.3

12.00

16.55

u/l

—

Other immunodeficiencies

1.00

-0.00

1.2

1.1

22.00

14.05

u/l

—

Other hypertrichosis

0.00

-0.00

0.0

1.0

—

13.07

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

0.99

-0.00

1.4

1.2

7.70

42.51

u/l

—

Q fever

0.00

-0.00

0.0

1.8

—

12.30

—

Dengue fever [classical dengue]

0.00

-0.00

0.0

1.3

—

11.88

—

Human immunodeficiency virus [HIV] disease resulting in other specified diseases

0.00

-0.00

0.0

1.2

—

16.94

—

Vascular dementia (multiple infarctions)

0.92

-0.00

1.3

1.1

7.82

53.23

u/l

—

Atypical mycobacterium lung infection

0.91

-0.00

1.2

21.77

20.84

u/l

—

Malignant neoplasm of testis, including Hilmo

0.94

-0.00

1.0

1.3

45.44

16.43

u/l

—

Myiasis

0.00

-0.00

0.0

1.1

—

28.80

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Erythropoietin (EPO) [Units/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS